CSA
Recommendations
Read the report at California State Auditor ↗
August 2016
California’s Foster Care System
The State and Counties Have Failed to Adequately Oversee
the Prescription of Psychotropic Medications to Children
in Foster Care
Report 2015-131
COMMITMENT
INTEGRITY
LEADERSHIP
CALIFORNIA STATE AUDITOR
621 Capitol Mall, Suite 1200 | Sacramento | CA | 95814
916.445.0255 | TTY 916.445.0033
For complaints of state employee misconduct,
contact us through the Whistleblower Hotline:
1.800.952.5665
Don’t want to miss any of our reports? Subscribe to our email list at auditor.ca.gov
For questions regarding the contents of this report, please contact Margarita Fernández, Chief of Public Aff airs at 916.445.0255
This report is also available online at www.auditor.ca.gov | Alternate format reports available upon request | Permission is granted to reproduce reports
Elaine M. Howle State Auditor
Doug Cordiner Chief Deputy
August 23, 2016 2015-131
Th e Governor of California
President pro Tempore of the Senate
Speaker of the Assembly
State Capitol
Sacramento, California 95814
Dear Governor and Legislative Leaders:
As requested by the Joint Legislative Audit Committee, the California State Auditor presents this audit report
concerning the oversight of psychotropic medications prescribed to California’s foster children. Th is report concludes
that the State and counties have failed to adequately oversee the prescribing of these medications. Specifi cally, some
counties have yet to adopt the State’s prescribing guidelines (state guidelines), a valuable tool that counties should use
to ensure that foster children do not receive inappropriate or unnecessary psychotropic medications. Consequently,
when we reviewed the case fi les for a total of 80 foster children at Los Angeles, Madera, Riverside, and Sonoma
counties, we found that many foster children were authorized psychotropic medications in quantities and dosages
that exceeded the state guidelines. Although exceeding the state guidelines may be medically appropriate in some
cases, we found no evidence that the counties had followed up with the health care providers to ensure the safety and
necessity of the medications. When counties do not follow up with providers about prescriptions that exceed the state
guidelines, the counties cannot ensure that they are reducing foster children’s exposure to potentially inappropriate
medication interventions.
Further, the counties have not always ensured that they follow best practices relating to the health services that foster
children should receive in conjunction with their psychotropic medications. Specifi cally, one-third of the foster children
whose records we reviewed did not receive follow-up appointments with their prescribers or other healthcare providers
within 30 days after they began taking new psychotropic medications, thus increasing the risk that any harmful side
eff ects would go unaddressed. Further, our review of the 80 case fi les indicates that foster children did not always receive
corresponding psychosocial services before or while they were taking psychotropic medications. Additionally, and in
violation of state law, counties did not always obtain required court authorizations or parental consents before foster
children received prescriptions for psychotropic medications.
Finally, we found that the fragmented structure of the State’s child welfare system contributes to the problems we identifi ed.
Oversight of psychotropic medications prescribed to foster children is vested among diff erent levels and branches of
government, leaving us unable to identify a comprehensive plan that coordinates the various mechanisms in place.
Although the diff erent public entities involved have made eff orts to collaborate, the State’s overall approach has exerted
little system-level oversight to help ensure that these entities’ collective eff orts actually work as intended and produce
desirable results. For instance, the fragmented oversight structure has contributed to the State’s failure to ensure it and other
stakeholders have the reliable information necessary to monitor the prescription of psychotropic medications to foster
children. Even when combined, the results from data systems operated by two state departments still contain inaccurate
and incomplete data related to foster children who are prescribed psychotropic medications. Consequently, neither of
the two departments can completely identify which foster children statewide are prescribed psychotropic medications
or which medications those children are prescribed. We recommend that the State collaborate with counties and other
stakeholders to develop and implement a reasonable oversight structure for psychotropic medications prescribed to
foster children.
Respectfully submitted,
ELAINE M. HOWLE, CPA
State Auditor
621 Capitol Mall, Suite 1200 Sacramento, CA 95814 916.445.0255 916.327.0019 fax www.auditor.ca.gov
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 v
August 2016
Contents
Summary 1
Introduction 7
Chapter 1
The Counties Have Not Always Provided Adequate Oversight to
Ensure the Appropriateness of the Psychotropic Medications That
Children in Foster Care Receive 21
Recommendations 48
Chapter 2
Fragmented Oversight and Poor Data Have Hampered State and
County Eff orts to Ensure the Appropriate Prescribing of
Psychotropic Medications to Children in Foster Care 51
Recommendations 74
Appendix
Summary Tables Showing Statewide and County Data Regarding
Psychotropic Medications Prescribed to Foster Children 79
Responses to the Audit
California Department of Social Services 95
California State Auditor’s Comment on the Response From
the California Department of Social Services 103
Department of Health Care Services 105
Medical Board of California 109
Los Angeles County 111
California State Auditor’s Comments on the Response From
Los Angeles County 115
Riverside County 117
California State Auditor’s Comments on the Response From
Riverside County 121
Sonoma County 123
California State Auditor’s Comments on the Response From
Sonoma County 129
vi California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 1
August 2016
Summary
Results in Brief Audit Highlights . . .
Psychotropic medications such as antidepressants, mood stabilizers, Our audit concerning the oversight of
and antipsychotics can provide signifi cant benefi ts in the treatment psychotropic medications prescribed
of psychiatric illnesses, but they can also cause serious adverse to California’s foster children revealed
side eff ects. Although the American Psychological Association has the following:
mentioned that studies since the 1970s have found that children in
foster care (foster children) often have a greater need for mental health » Nearly 12 percent of California’s more
treatment, public and private entities have expressed concerns about than 79,000 foster children were
the higher prescription rates of psychotropic medication among foster prescribed psychotropic medications
children than among nonfoster children. Th is issue is of particular during fi scal year 2014–15.
importance to California, which has the largest population of foster
children in the country. In fact, our analysis of the available state data » Some foster children were prescribed
found that nearly 12 percent of California’s more than 79,000 foster psychotropic medications in amounts and
children were prescribed psychotropic medications during fi scal dosages that exceeded state guidelines
year 2014–15, whereas studies suggest that only about 4 to 10 percent and counties did not follow up with
of nonfoster children are prescribed these medications. prescribers to ensure the appropriateness
of these prescriptions.
To examine the oversight of psychotropic medications prescribed to
foster children, we reviewed case fi les for a total of 80 foster children » Many foster children did not receive
in Los Angeles, Madera, Riverside, and Sonoma counties and follow-up visits or recommended
analyzed available statewide data. We found that many foster children psychosocial services in conjunction
had been authorized to receive psychotropic medications in amounts with their prescriptions for
and dosages that exceeded the State’s recommended guidelines (state psychotropic medications.
guidelines), circumstances that should have prompted the counties
responsible for their care to follow up with the children’s prescribers. » Counties did not always obtain
For example, 11 of the 80 children whose fi les we reviewed had been required court or parental approval for
authorized to take multiple psychotropic medications within the psychotropic medications prescribed to
same drug class. Further, 18 of the 80 children had been authorized foster children as required by law.
to take psychotropic medications in dosages that exceeded the State’s
recommended maximum limits. Medications that exceed the » The State’s fragmented oversight structure
State’s recommended guidelines may be appropriate under some of its child welfare system has contributed
circumstances, and we are not questioning prescribers’ medical to weaknesses in the monitoring of foster
expertise. However, in the instances above, the counties did not children’s psychotropic medications.
contact the prescribers to ensure the safety and necessity of the
medications in question, as the state guidelines recommend. » The California Department of Social
Services’ and the Department of
Compounding these concerns is the fact that many of these children Health Care Services’ data systems
do not appear to have received follow-up visits or recommended together cannot completely identify
psychosocial services in conjunction with their prescriptions for which foster children are prescribed
psychotropic medications. Th e American Academy of Child and psychotropic medications.
Adolescent Psychiatry recommends that children should receive
follow-up visits with their health care providers ideally within » Foster children’s Health and Education
two weeks, but at least within a month, after they start psychotropic Passports—documents summarizing
medications. Nonetheless, one-third of the 67 foster children who critical health and education
started at least one psychotropic medication during our audit period information—contained inaccurate and
did not receive follow-up appointments with their prescriber or incomplete mental health data.
2 California State Auditor Report 2015-131
August 2016
other health care provider within 30 days after they began taking
new psychotropic medications, thus increasing the risk that any
harmful side eff ects would go unaddressed. In addition, our review of
the 80 case fi les indicates that foster children did not always receive
corresponding psychosocial services before or while they were taking
psychotropic medications, even though such services are critical
components of most comprehensive treatment plans.
In response to a recent state law, the Judicial Council of California
adopted new and revised forms—which became eff ective in
July 2016—to be used in the court authorization process for foster
children’s psychotropic medications. Th e proper completion
of these newly revised forms should provide county staff with
additional information necessary to identify instances when foster
children are prescribed psychotropic medications in amounts or
dosages that exceed the state guidelines. Among other things, these
revised forms require prescribers to explain for each foster child
why they prescribed more than one psychotropic medication in a
class or dosages that are outside the state guidelines. If these forms
are not properly completed, county staff will need to follow up
with prescribers to obtain information necessary to ensure that the
prescriptions beyond the state guidelines are appropriate.
We also found that, in violation of state law, counties did not always
obtain required court or parental approval before foster children
received prescriptions for psychotropic medications. Specifi cally,
when we reviewed the case fi les for 67 foster children who should
not have received psychotropic medications without authorization
from a juvenile court, we found that 23 (34 percent) did not contain
evidence of such authorization for at least one psychotropic
medication. Similarly, when we reviewed the case fi les for
13 foster children who should not have received psychotropic
medications without the consent of their parents, we found that
fi ve (38 percent) did not contain evidence of such consent for at
least one psychotropic medication. In eff ect, these children were
prescribed psychotropic medications without proper oversight
from the counties responsible for their care.
Further, the fragmented structure of the State’s child welfare system
contributed both to the specifi c problems we identifi ed in our
review of the 80 case fi les and to larger oversight defi ciencies that
we noted statewide. Specifi cally, oversight of the administration
of psychotropic medications to foster children is spread among
diff erent levels and branches of government, leaving us unable
to identify a comprehensive plan that coordinates the various
mechanisms currently in place to ensure that the foster children’s
health care providers prescribe these medications appropriately.
Although the diff erent public entities involved have made eff orts
California State Auditor Report 2015-131 3
August 2016
to collaborate, the State’s overall approach has exerted little
system-level oversight to help ensure that these entities’ collective
eff orts actually work as intended and produce desirable results.
Th e State’s fragmented oversight structure has also contributed to its
failure to ensure it has the data necessary to monitor the prescription
of psychotropic medications to foster children. Th e two state entities
most directly involved in overseeing foster children’s mental health care
are the California Department of Social Services (Social Services) and
the Department of Health Care Services (Health Care Services). Even
when combined, results from data systems these two departments
operate still contain inaccurate and incomplete data related to foster
children who are prescribed psychotropic medications. Consequently,
neither agency can completely identify which foster children statewide
are prescribed psychotropic medications or which medications those
children are prescribed.
Further, the inaccurate and incomplete information in Social Services’
data system is used to produce Health and Education Passports,
which are critical documents that are meant to follow foster
children should their placement change. We found that all 80 of the
Health and Education Passports we reviewed contained instances
of incorrect start dates for psychotropic medications. Moreover,
13 of these 80 Health and Education Passports did not identify all the
psychotropic medications that the courts authorized, and all 80 were
missing information about the corresponding psychosocial services
the foster children should have received for at least one psychotropic
medication. Th ese errors and omissions appear to have been caused
in large part by a lack of county staff to enter foster children’s health
information into Social Services’ data system and an unwillingness
of some county departments to share foster children’s information
with each other. However, caretakers, health care providers, social
workers, and others rely on the Health and Education Passports
to make decisions about foster children’s care; without accurate
information, they may inadvertently make decisions that do not
refl ect the children’s best interests.
Also, the State has missed opportunities to ensure that the
counties have reasonable processes for overseeing the prescription
of psychotropic medications to foster children. For example,
Social Services’ California Child and Family Services Reviews of the
counties only recently began examining in more depth psychotropic
medications prescribed to foster children. Because Social Services
and Health Care Services have not historically examined the
prescription of psychotropic medications to foster children in their
periodic reviews, they have missed opportunities for in-depth,
county-by-county reviews of this issue. However, as of March 2016,
both departments had begun collecting from the counties certain
information about these medications.
4 California State Auditor Report 2015-131
August 2016
Finally, rather than publishing this audit report in June 2016 as
originally intended, we had to delay publication by two months to
allow us time to obtain and analyze additional data from Health Care
Services and to revise the report’s text and graphics accordingly. In
November 2015, our offi ce began analyzing data originally provided
by Health Care Services in response to our request for all Medi-Cal
data related to the provision of psychotropic medications and
related psychosocial services to foster children. Th ese data provided
the basis for the audit report we intended to publish in June 2016.
However, about one week before we were to originally publish our
audit report, Health Care Services confi rmed that it had not provided
all the medical services data that we originally requested. Although
it had provided us data for medications, treatment authorizations,
and services provided by specialty mental health plans, it had not
given us services data for managed care plans or fee-for-service
providers.1 Our review showed that the additional June 22, 2016, data
consisted of approximately 617 million medical service records. Th e
related text and graphics in our audit report refl ect a consolidation of
the original more than 46 million medical service records provided
by Health Care Services in November 2015 and the additional
617 million medical service records it subsequently provided on
June 22, 2016, for a total of more than 663 million claims for medical
services. Because the results from the consolidated data did not
substantively aff ect the conclusions we reached originally or the
recommendations we made, we did not ask the auditees to resubmit
their written responses to our June 2016 draft report.
Recommendations
Legislature
Th e Legislature should require Social Services to collaborate with
its county partners and other relevant stakeholders to develop
and implement a reasonable oversight structure that addresses,
at a minimum, the insuffi ciencies in oversight and monitoring of
psychotropic medications prescribed to foster children highlighted
in this report.
California Department of Social Services
To improve the oversight of psychotropic medications prescribed
to foster children, Social Services should collaborate with counties
and other relevant stakeholders to develop and implement a
1 Please see Figure 2 on page 11 for a depiction of the types of Medi-Cal providers.
California State Auditor Report 2015-131 5
August 2016
reasonable oversight structure that addresses, at a minimum, the
monitoring and oversight weaknesses highlighted in this report and
that ensures the accuracy and completeness of Social Services’ data
system and the resulting Health and Education Passports.
Counties
To better ensure that foster children only receive psychotropic
medications that are appropriate and medically necessary, counties
should take the following actions:
• Implement procedures to more closely monitor requests for
authorizations for psychotropic medications for foster children
that exceed the state guidelines for multiple prescriptions or
excessive dosages. When prescribers request authorizations for
prescriptions that exceed the state guidelines, counties should
ensure the new court authorization forms contain all required
information and, when necessary, follow up with the prescribers
about the medical necessity of the prescriptions. Counties
should also document their follow-up in the foster children’s
case fi les. In instances in which counties do not believe that
prescribers have adequate justifi cation for exceeding the state
guidelines, counties should relay their concerns and related
recommendations to the courts or the children’s parents.
• Ensure that all foster children are scheduled to receive a
follow-up appointment within 30 days of starting a new
psychotropic medication.
• Implement a process to ensure that foster children receive
any needed mental health, psychosocial, behavioral health, or
substance abuse services before and concurrently with receiving
psychotropic medications.
• Implement a systemic process for ensuring that court
authorizations or parental consents are obtained and documented
before foster children receive psychotropic medications.
Agency Comments
Th e state entities and the counties agreed with our recommendations.
Further, Madera County told us that because it agreed with our report’s
recommendations, it did not intend to submit a written response. We
look forward to assessing Madera County’s implementation of our
recommendations when it provides updates to us at 60 days, 6 months,
and one year following the issuance of our report.
6 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 7
August 2016
Introduction
Background
In the last decade, both public and private entities have expressed
concerns about the higher prescription rates for psychotropic
medications for children in foster care (foster children) than for
nonfoster children.2 In the context of foster care, state law defi nes
psychotropic medications as those medications administered for
the purpose of aff ecting the central nervous system
to treat psychiatric disorders or illnesses. Such
illnesses may include anxiety disorders, Classifi cations of Psychotropic Medications
attention-defi cit/hyperactivity disorder, bipolar
• Antianxiety medications
disorder, post-traumatic stress disorder, as well as
others. As the text box shows, psychotropic • Antidepressants
medications can fall into several categories,
• Antipsychotics
depending on the types of affl ictions they treat.3
• Mood stabilizers
Although some circumstances warrant the use of
psychotropic medications, these medications can • Stimulants
have serious side eff ects, including weight gain or
Sources: California State Auditor’s review of websites for
loss, depression, movement disorders, pain, and
organizations such as the National Institute of Mental Health,
sleep disturbance. Also, journal articles have linked the National Alliance on Mental Illness, and the Stanford
University School of Medicine.
antipsychotics to the increased risk of sudden
cardiac death.
Studies have shown that foster children are prescribed psychotropic
medications more frequently than nonfoster children, raising
questions about whether foster children are receiving these
medications appropriately. For example, in a 2010 multistate
study on psychotropic medication oversight in foster care, the
Tufts Clinical and Translational Science Institute cited research
showing that the use of psychotropic medication in the general
child population was only 4 percent while the use of psychotropic
medication for foster children ranged from 13 percent to 52 percent.
Additionally, a 2011 Government Accountability Offi ce report
found that 21 percent to 39 percent of foster children received
prescriptions for psychotropic medications in 2008, compared with
only 5 percent to 10 percent of nonfoster children. According to the
American Psychological Association, studies since the 1970s have
found that children in foster care often have greater need for mental
health treatment than children in the general population. However,
given the potential risks associated with psychotropic medications,
the higher rates at which they are prescribed to foster children is a
cause for concern.
2 Throughout this report, we use the term foster children to refer to children ages zero to 17 in the
foster care system.
3 Examples of psychotropic medications include the following brand names: Abilify, Ativan,
Cymbalta, Haldol, Prozac, Ritalin, Seroquel, Wellbutrin, Xanax, and Zoloft.
8 California State Auditor Report 2015-131
August 2016
The Prescription of Psychotropic Medications to Children in California’s
Foster Care System
Questions regarding the prescription of psychotropic medications
to foster children are of particular importance to California, which
has the largest population of foster children in the country. To
determine how many of the State’s more than 79,000 foster children
were prescribed psychotropic medications, we used statewide data
(state data) from the California Department of Social Services (Social
Services) and the Department of Health Care Services (Health Care
Services), two key state agencies that work with foster children. As
we discuss in Chapter 2, we have concerns about the accuracy and
comprehensiveness of the state data; nonetheless, they represent the
best information available regarding the number of foster children
statewide who were prescribed these medications. As shown in
Figure 1, the state data show that nearly 12 percent of California’s
foster children received nearly 96,000 prescriptions for psychotropic
medications paid by Medi-Cal in fi scal year 2014–15, or an average of
about 10 prescriptions per child per year.4
Th e state data show the number of foster children prescribed
psychotropic medications paid through Medi-Cal decreased by
more than 7 percent from fi scal year 2012–13 to fi scal year 2014–15.
At the same time, the number of paid prescriptions for psychotropic
medications for these children decreased by nearly 13 percent.
Further, our analysis of the state data shows that older foster
children were more likely to have paid prescriptions for psychotropic
medications than younger ones. Nearly three quarters (74 percent)
of the foster children with paid prescriptions for psychotropic
medications in fi scal year 2014–15 were aged 12 to 17, compared to
less than 2.5 percent aged 5 years or less.
Despite the decrease in the overall number of foster children
receiving psychotropic medications, state data show that nearly
half of these foster children had paid antipsychotic medication
prescriptions in fi scal year 2014–15. Antipsychotics pose a
particular risk for children because they have a high risk of severe
side eff ects. Nevertheless, the state data show that antipsychotics
made up nearly 35 percent of all paid prescriptions for psychotropic
medications for foster children, as Figure 1 shows.
We provide summary data about foster children prescribed
psychotropic medications in the Appendix beginning on page 79.
4 The average number of paid prescriptions per foster child may refl ect that some foster children
received more than one type of psychotropic medication. Alternatively, it may indicate that some
foster children had paid prescriptions of a single medication fi lled a number of times during the
year (perhaps on a monthly or bimonthly basis).
California State Auditor Report 2015-131 9
August 2016
Figure 1
Statewide Number and Proportion of Children in Foster Care With Prescriptions for Psychotropic Medications
Paid for by Medi-Cal During Fiscal Year 2014–15
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case Management
System and matched Medi-Cal pharmacy data.
Foster Children and Health Care
Foster care is a social welfare program funded and administered
by federal, state, and county governments. Children enter foster
care through one of two channels: the child welfare system or
the probation system. Within the child welfare system, state law
authorizes a juvenile court to declare a child to be a dependent of
the court for certain specifi ed reasons that generally involve the
parents’ or caregivers’ unwillingness or inability to provide adequate
care, including protecting children from physical or sexual abuse.
Within the probation system, state law authorizes the juvenile court
10 California State Auditor Report 2015-131
August 2016
to declare a child to be a ward of the court because the child is
beyond the control of his or her parent, guardian, or custodian; fails
to comply with curfews or attend school; or has committed a crime.
State data show that from fi scal years 2012–13 through 2014–15 about
80 percent of California’s foster children with paid prescriptions for
psychotropic medications were in the child welfare system, compared
to about 20 percent in the probation system.
Th e federal Social Security Act requires that, in order to be eligible
for federal payment, a state must have a plan for child welfare services
that provides foster children with health care, including mental health
care services. In addition, Medicaid requires—and helps pay for—
the provision of necessary health services, including psychosocial
services, to children covered by Medicaid, which includes foster
children up to age 21. In response to these requirements, the State
provides basic health care to foster children that includes health
screenings within 30 days of the children entering foster care;
periodic screenings and mental health assessments thereafter; and
services, treatments, and medications, as needed.
Medicaid funding covers part of the health care costs of foster
children, including those related to mental health care services. Its
reimbursement levels vary depending upon the type of cost. For
example, Medicaid will reimburse 50 percent for the costs of health
care services provided to foster children. It will also reimburse
75 percent of the costs for skilled professional medical personnel—
such as public health nurses—and their support staff who provide
services to the foster care program.
Th e State and counties generally provide or acquire the remainder of
the necessary funding for foster children’s health care. State funding
for psychosocial services for foster children can come from a variety
of sources, including state public safety realignment funding from
sales taxes, vehicle taxes, and fees. In addition, the Mental Health
Services Act imposes a 1 percent tax on income in excess of 1 million
to expand mental health services. Counties also provide their own
funding and may acquire additional funding through grants.
Counties are responsible for ensuring the provision of health care
services to foster children. Specifi cally, state law enacted in 2012
moved programmatic responsibility for child welfare services,
including the support and care of foster children, from the State to
the counties (child welfare services realignment). However, Social
Services—which under state law is jointly responsible with the
counties for establishing and supporting the child welfare services
system—is still responsible for providing oversight and technical
assistance to the counties. Under child welfare services realignment,
the counties provide psychosocial services through diff erent types
of health care systems, as shown in Figure 2.
California State Auditor Report 2015-131 11
August 2016
Figure 2
A Child in Foster Care’s Path to Mental Health Services in California
Child enters the
foster care system through
one of two channels.
Child Welfare Department Probation Department
Actions of adult(s) in child’s life Actions of child
result in placement. result in placement.
Child placed in
out-of-home care:
• Foster family home
• Group home
• Kin/relative home
Organizations or individuals offering mental health care services to foster children
Medi-Cal
Medi-Cal Medi-Cal Medi-Cal State Plan
Mental Health Plans Managed Care Plans (fee-for-service) Other:
Administered by county Administered by health Providers enrolled and paid • Community health centers.
behavioral/mental health plans through contracts by the Department of
• Community-based
departments through with the Department of Health Care Services.
organizations.
contracts with the Health Care Services,
Department of Health Care providing mental health • Free clinics.
Services, providing “specialty services described in
• Individual providers
mental health” services the contracts.
paid by county child
described in the contracts.
welfare departments.
Serving children with Serving children with Serving children with Serving children with various
“moderate to severe” mental “mild to moderate” mental “mild to moderate” mental mental health needs.
health needs based on health needs based on health needs based on
medical-necessity criteria. medical-necessity criteria. medical-necessity criteria.
Sources: California laws, state and county agency documents, and the California State Auditor’s review of other information.
12 California State Auditor Report 2015-131
August 2016
Oversight of the Provision of Psychotropic Medications to Foster Children
Diff erent levels and branches of government are responsible for
overseeing the provision of psychotropic medications to foster children
in California. As shown in Table 1, executive branch entities at the
federal, state, and county levels oversee foster children who receive
psychotropic medications. Further, the judicial branch at the state and
county levels also has an oversight role for these foster children.
Th e federal government provides oversight of the prescription of
psychotropic medications through the U.S. Department of Health and
Human Services (Health and Human Services). Before 2011, Health
and Human Services provided general guidance to states regarding
psychotropic medications and Medicaid benefi ciaries but did not
require the states to take any specifi c actions. However, in response to
a change in federal law in September 2011, Health and Human Services
established certain requirements with which states must now comply.
For example, states must now include an outline of their protocols for
ensuring the appropriate use and monitoring of psychotropic
medications in their Child and Family Services Plans, which set forth
the states’ strategic plans for strengthening their overall child welfare
systems. Health and Human Services requires states to submit these
plans every fi ve years and to submit annual progress and services
reports related to their plans in the interim. Health and Human
Services then uses information from the Child and Family Services
Plans as well as the states’ annual reports as part of the statewide
assessment component of the federal child and family services review
(federal review), which assesses each state’s child welfare system.
Since Health and Human Services’ implementation of the
federal review in 1997, it has twice reviewed all the states and is
currently reviewing them for the third time. Although California’s past
federal reviews have included little discussion of foster children who
received psychotropic medications, its third review is likely to more
directly address this issue. Specifi cally, California’s most recent federal
review, for which Health and Human Services published a report
in 2008, included just two references to psychotropic medications: it
acknowledged that stakeholders had expressed concerns that foster
children had been prescribed psychotropic medications rather than
being given adequate psychosocial services, and it mentioned the
role of public health nurses in monitoring psychotropic medications.
However, California’s upcoming 2016 federal review will include
information from its 2015–2019 Child and Family Services Plan,
which describes California’s protocols for the appropriate use and
monitoring of psychotropic medications. In particular, the protocols
address fi ve key components specifi ed by Health and Human Services’
guidance: screening, assessment, and treatment plans; informed
and shared decision making; medication monitoring; mental health
expertise and consultation; and mechanisms for sharing accurate and
up-to-date information.
We discuss the State’s and counties’ oversight mechanisms in more
detail in Chapter 2 of our report.
California State Auditor Report 2015-131 13
August 2016
Table 1
Key Entities and Mechanisms for the Oversight of Psychotropic Medications Prescribed to Children in Foster Care
PUBLIC ENTITY OVERSIGHT ROLE FOR FOSTER CHILDREN PRESCRIBED PSYCHOTROPIC MEDICATIONS
FEDERAL
Executive Branch
U.S. Department of Health and Human Services— Provides guidance and instructions to states regarding foster children and
Administration for Children and Families & psychotropic medications.
Centers for Medicare and Medicaid Services
STATE
Judicial Branch
Judicial Council Provides guidance and instruction—through court rules, template forms, trainings,
and some technical support—to county superior courts related to approving
psychotropic medications for foster children.
Executive Branch
California Department of Social Services Oversees and administers programs serving California’s most vulnerable residents.
(Social Services)
Child and Family Services Division Provides assistance in adoptions, foster care, children’s programs, and child welfare
services. In collaboration with the Department of Health Care Services (Health
Care Services), Social Services maintains the Health Care Program for Children in
Foster Care, a public health nursing program administered by local public health
departments to provide public health nursing expertise to ensure the health care
needs of children in out-of-home placement or foster care.
Community Care Licensing Division Administers the Children’s Residential Licensing Program, which issues licenses to
homes and facilities that house foster children.
Health Care Services Administers the Medi-Cal program, which includes specialty mental health,
managed care, and fee-for-service programs.
Clinical Assurance and Reviews and adjudicates treatment authorization requests for medications under
Administrative Support Division the Medi-Cal fee-for-service program.
Mental Health Services Division Administers, oversees, and monitors community mental health program service
delivery and compliance for the Medi-Cal Specialty Mental Health Services program
and the Mental Health Services Act.
Managed Care Quality and Monitors and oversees California’s Medi-Cal managed care health plans and
Monitoring Division Medi-Cal managed care policy development.
Pharmacy Benefi ts Division Administers Health Care Services’ Medi-Cal fee-for-service drug program and
responsible for the management of the Medi-Cal managed care pharmacy program.
Provider Enrollment Division Reviews applications for providers seeking to participate directly or indirectly in the
fee-for-service Medi-Cal program.
Medical Board of California Licenses and oversees medical doctors, with the authority to investigate and
discipline any physicians alleged to have committed acts of wrongdoing. It is
currently in the process of acquiring Medi-Cal pharmacy claims data related to
foster children and psychotropic medications to review and identify physicians who
may have inappropriately prescribed psychotropic medications to foster children.
LOCAL—ALL COUNTIES
Judicial Branch
Superior Court Administers the court authorization review process, which adjudicates requests to
administer psychotropic medications to foster children.
Executive Branch
Child Welfare Department/Divisions Oversees dependents of the court and administers the counties’ foster care programs.
Probation Department Oversees wards of the court, including those who are placed into foster care.
Mental Health/Behavioral Health Administers county Medi-Cal mental health plans that provide mental health services,
Department/Divisions including case management, psychosocial therapies, and psychiatric medication
support to Medi-Cal benefi ciaries, including foster children and wards of the court.
Sources: California State Auditor’s review of federal and state laws and various agency documents.
14 California State Auditor Report 2015-131
August 2016
Guidelines for the Safe and Appropriate Use of Psychotropic
Medications in the Treatment of Foster Children
A number of diff erent entities have developed or established
guidelines that can help to ensure the appropriate use of
psychotropic medications in the treatment of foster children. For
example, in 2009 the American Academy of Child and Adolescent
Psychiatry (Academy) developed a document titled Practice
Parameter on the Use of Psychotropic Medication in Children and
Adolescents. Th e purpose of the document was to promote the
appropriate and safe use of psychotropic medications in children
and adolescents with psychiatric disorders by
emphasizing best practice principles that underlie
Select Recommendations from the American medication prescribing. Further, in 2012 the
Academy of Child and Adolescent Psychiatry
Academy developed another document titled A
Guide for Community Child Serving Agencies on
• Health providers should follow up within at least a month
Psychotropic Medications for Children and
of a child starting a psychotropic medication.
Adolescents. Th e purpose of this document was to
• Generally, a child should receive nonpharmaceutical
provide entities that serve children, including
psychosocial services before starting a psychotropic
child welfare and juvenile justice agencies, with
medication, and should receive such services when
information regarding the role of psychotropic
receiving a psychotropic medication.
medications in treatment plans for children.
Sources: California State Auditor’s review of the American Th roughout our report, we refer to these
Academy of Child and Adolescent Psychiatry’s 2009 Practice
two documents collectively as academy guidelines.
Parameter on the Use of Psychotropic Medication in Children
and Adolescents, and its 2012 A Guide for Community Child We summarize the academy guidelines in the
Serving Agencies on Psychotropic Medications for Children
text box and discuss them in more detail in
and Adolescents.
applicable sections of our report.
Th e State also recently developed its own
guidelines for the safe administration of psychotropic medications
to foster children. In 2012, Social Services and Health Care Services
initiated a statewide quality improvement project to improve
techniques for monitoring psychotropic medication use among
children in foster care. Th is project included the creation of a
clinical workgroup to develop statewide guidelines for the ongoing
oversight and coordination of health care services for children
in foster care, including protocols and strategies to improve the
appropriate use and monitoring of psychotropic medication for
these children.
In March 2015, as part of this quality improvement project, Social
Services and Health Care Services jointly released a document titled
California Guidelines for the Use of Psychotropic Medication with
Children and Youth in Foster Care (state guidelines), which they
consider to be a summary of the best practices for the treatment of
children who are placed in foster care. Th e state guidelines
represent the fi rst comprehensive eff ort at the state level to address
the use of psychotropic medication by children in out-of-home care
who are being served by the child welfare and/or probation system.
California State Auditor Report 2015-131 15
August 2016
In developing these guidelines, Social Services and Health Care
Services reviewed the Academy’s publications, the American
Academy of Pediatrics’ policies, California county child welfare and
behavioral health policies and practices, and the policies of child
welfare and mental health agencies in other states.
Th e state guidelines include prescribing standards
that counties can, but are not required to, use when Key Standards Within the State’s Guidelines
reviewing applications to courts for authorization for Prescribing Psychotropic Medications
to prescribe psychotropic medications to foster to Foster Children
children. According to Social Services and Health
• A foster child should generally not take multiple
Care Services, these prescribing standards
psychotropic medications within the same
represent the current best practices and incorporate
class concurrently.
evidence-based support. Th e departments do
• A foster child should generally be limited to taking a total
not intend these prescribing standards to stifl e
number of psychotropic medications, regardless of class,
independent treatment or care by providers but
that is appropriate for his or her age:
rather to form a foundation for review, with the goal
to ensure that children receive the minimum number FOR CHILDREN AGED: NO MORE THAN:
of psychotropic medications necessary in the lowest 0–5 years one psychotropic medication
therapeutic doses that are appropriate for their ages. 6–11 years two psychotropic medications
12–17 years three psychotropic medications
As shown in the text box, these prescribing
standards recommend limiting the number of • A foster child should generally only take psychotropic
concurrent psychotropic medications by class that medications within recommended dosage parameters,
foster children should take. Th ey also recommend as outlined in the Los Angeles County Department of
limiting psychotropic medications by dosage Mental Health’s Parameters 3.8: For Use of Psychotropic
and by a child's age. According to the prescribing Medication in Children and Adolescents.
standards, counties should identify prescriptions Source: California State Auditor’s review of the California
that exceed these limitations and ask prescribers to Guidelines for the Use of Psychotropic Medication with Children
and Youth in Foster Care.
submit additional information to justify or explain
the prescriptions.
Scope and Methodology
Th e Joint Legislative Audit Committee (audit committee)
directed the California State Auditor to examine state and county
agencies’ monitoring and oversight of foster children who have
been prescribed psychotropic medications. It also directed us to
review the availability and adequacy of other supportive services
for foster children, such as mental health and substance abuse
counseling. Table 2, beginning on the following page, lists the audit
committee’s objectives and the methods we used to address them.
Also, rather than publishing this audit report in June 2016 as
originally intended, we had to delay publication by two months to
allow us time to obtain and analyze additional data from Health Care
Services and to revise the report’s text and graphics accordingly.
In November 2015, our offi ce began analyzing data originally
16 California State Auditor Report 2015-131
August 2016
provided by Health Care Services in response to our request for all
Medi-Cal data related to the provision of psychotropic medications
and related psychosocial services to foster children. Th ese data
provided the basis for the audit report we intended to publish in
June 2016. However, about one week before we were to originally
publish our audit report, Health Care Services confi rmed that it had
not provided all medical services data that we originally requested.
Although it had provided us data for medications, treatment
authorizations, and services provided by specialty mental health
plans, it had not given us services data for managed care plans or
fee-for-service providers.5 Our review showed that the additional
June 22, 2016, data consisted of approximately 617 million medical
service records. Th e related text and graphics in our audit report
refl ect a consolidation of the original more than 46 million medical
service records provided by Health Care Services in November 2015
and the additional 617 million medical service records it subsequently
provided on June 22, 2016, for a total of more than 663 million claims
for medical services. Because the results from the consolidated data
did not substantively aff ect the conclusions we reached originally
or the recommendations we made, we did not ask the auditees to
resubmit their written responses to our June 2016 draft report.
Table 2
Audit Objectives and the Methods Used to Address Them
AUDIT OBJECTIVE METHOD
1 Review and evaluate the laws, rules, and regulations • We reviewed relevant laws, rules, regulations, and guidelines related to children
signifi cant to the audit objectives. in foster care (foster children) and psychotropic medications.
• We interviewed key staff at state and county agencies that oversee the
administration and approval of psychotropic medications prescribed to
foster children.
2 Identify the respective roles in overseeing the mental • We interviewed staff and reviewed relevant documents to identify the
health care of foster children of the California Department responsible state entities and the processes they use to oversee psychotropic
of Social Services (Social Services), the Department of medications prescribed to foster children.
Health Care Services (Health Care Services), county child • For each of the four counties we visited (Los Angeles, Madera, Riverside, and
welfare service agencies and probation agencies, as well Sonoma), we interviewed staff and reviewed relevant documents to identify the
as the county mental or behavioral health departments county agencies involved and the processes they use to oversee psychotropic
that oversee the specialty mental health services that medications prescribed to foster children.
foster children receive. Specifi cally identify which
agencies are responsible for ensuring that foster children
eligible for Medi-Cal are receiving the mental and
behavioral health services to which they are entitled
under federal and state laws.
5 Please see Figure 2 on page 11 for a depiction of the types of Medi-Cal providers.
California State Auditor Report 2015-131 17
August 2016
AUDIT OBJECTIVE METHOD
3 Examine the adequacy and accuracy of data tracked • For our review, we selected 20 foster children overseen by the child welfare
by these agencies on whether foster children who are services and probation agencies at each of the four counties we visited, for a
being prescribed psychotropic medications also receive total of 80 children. For each of these 80 children, we examined the following:
other appropriate nonpharmacological supportive - Hard-copy case fi les and electronic records, if available, at the counties.
services, such as counseling. In particular, evaluate
- Electronic case fi le information from Social Services’ Child Welfare Services/
whether these data are suffi cient to determine the
Case Management System (Social Services’ data system).
extent to which foster children are receiving mental
health, psychosocial, behavioral health, and substance - Electronic claims information from Health Care Services for psychosocial
abuse services. services, psychotropic medications, follow-up visits, and treatment
authorization requests.
a. Evaluate how the above data are tracked and
used, how their accuracy is ensured, and whether • To assess the adequacy and accuracy of the data tracked by Social Services’ data
opportunities exist to better gather and use this system, we compared information from all three of these sources. We summarize
information. To the extent that barriers exist the results of our review in Table 3 and provide more detailed information in
to eff ective data collection and use, identify Chapters 1 and 2, including Table 15 on page 57, of our audit report.
potential solutions. • For the purposes of our audit, we limited our review to foster children
b. For a selection of foster children at the aged zero through 17.
four counties visited, determine how well the • Using relevant criteria and oversight processes identifi ed in Objectives 1 and 2,
entities listed in Objective 2 have carried out their we reviewed available documents for the 80 selected foster children to identify
applicable responsibilities. Using these results, information related to their fi lled prescriptions for psychotropic medications,
if applicable, identify ways in which oversight of their court authorizations or parental consents for psychotropic medications, the
these practices could be improved. psychosocial services they were provided, and the follow-up visits they received.
• We reviewed the Health and Education Passports for the 80 selected foster
children and determined the accuracy and completeness of the information
within them.
• Using Health Care Services’ data for Medi-Cal claims and treatment authorization
requests and documentation from the case fi les, we determined whether Health
Care Services received and reviewed treatment authorization requests according
to its regulations and policies related to psychotropic medications.
• We reviewed data reports identifying potential discrepancies regarding court
authorizations and the prescription of psychotropic medications for foster
children in the four counties we visited to assess how the State and counties help
assure accuracy of the information within Social Services’ data system.
• We calculated the number of foster children without a Medi-Cal claim for
at least one follow-up medication service within 30 days after fi lling a new
psychotropic medication prescription. To do so, we adapted the National
Committee for Quality Assurance’s methodology for follow-up care for
children with newly prescribed attention-defi cit/hyperactivity disorder (ADHD)
medication. Specifi cally, at the recommendation of Health Care Services, we
applied this methodology to foster children of all ages who had any new
psychotropic medication—not just for children aged six to twelve with a new
ADHD medication—and counted follow-up medication services if the prescriber
recorded a mental health diagnosis in the Medi-Cal service data.
4 Determine whether any structural defi ciencies, network Using results from our case fi le review described under Objective 3, we identifi ed
inadequacies, or adverse incentives exist within the defi ciencies in the oversight process. To identify the causes for these defi ciencies,
county child welfare services, behavioral health, or we examined relevant documents and interviewed state and county staff .
Medi-Cal systems that may be leading to the overuse
of psychotropic medications among foster children.
Specifi cally, evaluate whether viable alternatives to
these medications are being underutilized because
of funding defi ciencies, disincentives, or other
identifi able reasons.
continued on next page . . .
18 California State Auditor Report 2015-131
August 2016
AUDIT OBJECTIVE METHOD
5 Examine the existing level of oversight of doctors To determine the extent of their involvement in the oversight of prescribing
prescribing psychotropic medications to foster children, physicians, we interviewed staff at the Medical Board of California and staff in
evaluate whether this oversight is suffi cient to identify ombudsman offi ces within Social Services and Health Care Services and examined
and remedy noncompliance with accepted standards relevant documents.
of practice, and if appropriate, identify opportunities to
strengthen this oversight.
6 Evaluate existing processes used by the courts, the We included the work associated with this objective—examining physician follow up—
county child welfare services system, and mental health as part of Objective 3.
plans and providers to ensure that ongoing use of
psychotropic medication by foster children is monitored
for negative reactions, side eff ects, or overdoses.
7 Identify whether county child welfare services agencies We included the work associated with this objective—examining Health and
are ensuring that necessary health documentation Education Passports—as part of Objective 3.
is being transmitted to caregivers, prescribers, and
other stakeholders when foster children receiving
psychotropic medication change placement.
8 Determine whether any other states have implemented • We identifi ed and reviewed documents, including bulletins issued by the
innovations or oversight systems that have successfully U.S. Department of Health and Human Services, reports, studies, and
reduced the use of psychotropic medications journal/media articles regarding practices states have in place for the oversight
in foster children or improved their access to of psychotropic medications.
nonpharmacological supports, and evaluate whether • We maintained awareness for potential best practices during our review of
California could benefi t from some of these policies county oversight processes as part of Objectives 2 and 3.
or practices.
• Other than certain county practices we describe in Chapter 1, we identifi ed
no innovations or oversight practices used by other entities that we would
recommend for use in California.
9 Review and assess any other issues that are signifi cant We did not identify any other signifi cant issues.
to the audit.
Sources: California State Auditor’s analysis of state law, federal law, planning documents, and information and documentation identifi ed in the table
column titled Method.
Assessment of Data Reliability
In performing this audit, we obtained electronic data fi les
extracted from the information systems listed in Table 3. Th e
U.S. Government Accountability Offi ce, whose standards we are
statutorily required to follow, requires us to assess the suffi ciency
and appropriateness of computer-processed information that
we use to support fi ndings, conclusions, or recommendations.
Table 3 describes the analyses we conducted using data from
these information systems, our methods for testing, and the
results of our assessments. Although these determinations may
aff ect the precision of the numbers we present, there is suffi cient
evidence in total to support our audit fi ndings, conclusions,
and recommendations.
California State Auditor Report 2015-131 19
August 2016
Table 3
Methods Used to Assess Data Reliability
INFORMATION SYSTEM PURPOSE METHOD AND RESULT CONCLUSION
Department of To identify psychosocial and We performed data-set verifi cation procedures and Undetermined reliability
Health Care Services medication services through electronic testing of key data elements and did not for these audit purposes.
(Health Care Services) Medi-Cal for children in foster identify signifi cant issues. Although this
care (foster children) who had determination may
We did not perform accuracy or completeness
Paid Claims and Encounters paid psychotropic medication testing on these data because the source aff ect the precision of
System (PCES), prescriptions fi lled during fi scal documentation is located at various locations the numbers we present,
as of November 2015 year 2013–14. throughout the State, making such testing there is suffi cient
evidence in total to
Health Care Services To identify foster children who cost-prohibitive.
support our audit
had multiple psychotropic
fi ndings, conclusions,
California Medicaid medication prescriptions fi lled In our review of the more than 663 million claims and recommendations.
Management Information in the same medication class, for Medi Cal services, we found that more
System (CA-MMIS), or who had more psychotropic than 2.7 million of these claims—or less than
as of November 2015 medication prescriptions fi lled half a percent—did not have suffi cient identifying
than recommended by the information for us to determine if the claim was
State’s guidelines during fi scal for a child in foster care. We determined that
year 2014–15. none of these more than 2.7 million claims were
for psychosocial services for children and only
6,155 were for follow-up medication services
provided to children between July 1, 2013, and
July 31, 2014. Because these claims did not have
suffi cient identifying information, such as a social
security number, we were not able to determine
whether the claim was for a child in foster care.
Therefore, we excluded them from our analyses.
Health Care Services To identify whether a selection of We performed data-set verifi cation procedures and
80 foster children’s psychotropic electronic testing of key data elements and did not
Service Utilization Review, medication prescriptions had identify signifi cant issues.
Guidance, and Evaluation approved Treatment Authorization We did not perform accuracy and completeness
(SURGE) system, Requests from July 2013 through testing on these data because the SURGE system is
as of March 2016 December 2015. a mostly paperless system. Alternatively, we could
have reviewed the adequacy of selected application
controls, but we determined that this level of review
was cost-prohibitive.
California Department • To identify foster children in the We performed data-set verifi cation procedures and Not suffi ciently reliable.
of Social Services State and in each county for electronic testing of key data elements and did not Although this
(Social Services) each fi scal year from 2012–13 identify signifi cant issues. determination may
through 2014–15. aff ect the precision of
We reviewed existing information to determine
Child Welfare Services/ • To calculate various statistics what is already known about the data and found the numbers we present,
Case Management related to foster children who that prior audit results indicate there are pervasive there is suffi cient
System (CWS/CMS), had psychotropic medication weaknesses in Social Services’ general controls over evidence in total to
as of November 2015, prescriptions fi lled during fi scal its information systems. Further, as discussed in support our audit
and matched Medi-Cal years 2012–13 through 2014–15. Chapter 2, we observed inaccurate and incomplete fi ndings, conclusions,
pharmacy data, • To identify foster children who medical information in CWS/CMS. and recommendations.
as of December 2015
had psychotropic medication
prescriptions fi lled during fi scal
year 2014–15 and who had
court authorizations or parental
consents to receive medication
recorded in CWS/CMS.
• To choose a selection of cases
for foster children who had
psychotropic medication
prescriptions fi lled from
April 2014 through March 2015.
Sources: California State Auditor’s analysis of various documents, interviews, and data from Health Care Services and Social Services.
20 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 21
August 2016
Chapter 1
THE COUNTIES HAVE NOT ALWAYS PROVIDED ADEQUATE
OVERSIGHT TO ENSURE THE APPROPRIATENESS OF
THE PSYCHOTROPIC MEDICATIONS THAT CHILDREN IN
FOSTER CARE RECEIVE
Chapter Summary
In 2015, the California Department of Social Services (Social Services)
and the Department of Health Care Services (Health Care Services)
adopted guidelines (state guidelines) for the safe administration of
psychotropic medications to children in foster care (foster children).
Although the state guidelines are a valuable tool that counties should
use to ensure that foster children do not receive inappropriate or
unnecessary psychotropic medications, some counties have yet
to adopt them. Consequently, when we reviewed the case fi les for
80 foster children at the four counties we visited—Los Angeles,
Madera, Riverside, and Sonoma—we found that many foster
children had been authorized to receive psychotropic medications in
quantities and dosages that exceeded the state guidelines. Although
exceeding the state guidelines may be medically appropriate in some
circumstances, we found no evidence that the counties had followed
up with the health care providers in these cases. When counties do
not follow up regarding prescriptions that exceed state guidelines,
they cannot ensure that they are reducing foster children’s exposure
to potentially inappropriate medication interventions.
Further, the counties have not always ensured that they followed
best practices relating to the health services that foster children
should receive in addition to their psychotropic medications.
Guidelines from the American Academy of Child and Adolescent
Psychiatry (academy guidelines) state that follow-up visits and
corresponding psychosocial services are important aspects of
mental health treatment. However, the State’s data show that in
fi scal year 2013–14, more than 29 percent of the State’s foster
children who had a fi lled prescription for a new psychotropic
medication did not have a corresponding Medi-Cal claim for a
follow-up medication service within 30 days after the prescription
was fi lled, thus increasing the risk that any harmful side eff ects
would go unaddressed. In addition, a signifi cant number of foster
children do not appear to have received psychosocial services
around the time of their prescriptions for new psychotropic
medications; therefore, the children may not have received the
services needed to treat their conditions.
22 California State Auditor Report 2015-131
August 2016
Finally, we found that a signifi cant number of foster children had
at least one paid prescription for psychotropic medications without
required court approval or parental consent, which is a violation
of state law. Specifi cally, 28 of the 80 foster children in our case fi le
review had at least one prescription for psychotropic medications
without court or parental authorization. Further, when we looked
at the state data, we found 65 percent of the foster children
statewide with paid prescriptions for psychotropic medications
were prescribed at least one psychotropic medication without the
appropriate authorization recorded.
By Failing to Adopt the State Guidelines, Some Counties May Be
Missing an Opportunity to Better Protect Foster Children From the
Risks of Inappropriate or Unnecessary Psychotropic Medications
As we discuss in the Introduction, Social Services and Health Care
Services developed recommended state guidelines in 2015 for the
safe administration of psychotropic medications to foster children.
By following these guidelines when reviewing health care providers’
requests to prescribe psychotropic medications, counties can
better ensure the appropriateness and necessity of the psychotropic
medications foster children receive. However, we found that some
counties have yet to adopt the state guidelines and thus may be missing
an opportunity to better protect the foster children under their care.
In developing the state guidelines, Social Services and Health Care
Services intended to create a tool that prescribers, pharmacists,
and courts could use when reviewing foster children’s prescriptions
According to state law, a foster for psychotropic medications. According to state law, a foster child
child cannot receive psychotropic cannot receive psychotropic medications without the authorization of
medications without the either a juvenile court or the child's parents, depending upon whether
authorization of either a juvenile the court has delegated the ability to make such decisions to the child’s
court or the child's parents. parents. To receive court authorization, a health care provider must
fi ll out an application requesting approval to prescribe the medication.
Th e county then reviews these applications and should determine
whether the prescription complies with the state guidelines. To the
extent that a prescription exceeds the guidelines, the county should
follow up with the provider to inquire about the prescription’s medical
necessity, if the prescriber did not thoroughly explain this in the
application. If the county does not believe a provider has adequate
justifi cation for exceeding the state guidelines, the county should
recommend to the court that it not authorize the prescription.
However, only two of the four counties that we reviewed have adopted
either the 2015 state guidelines or very similar guidelines. For example,
Los Angeles County adopted guidelines that are very similar to the
state guidelines. Like the state guidelines, Los Angeles County’s
guidelines generally only allow foster children to be concurrently
California State Auditor Report 2015-131 23
August 2016
prescribed one psychotropic medication per class.6 Furthermore,
the State adopted Los Angeles County’s dosage parameters as part
of its guidelines. Th e only signifi cant diff erence between the two sets
of guidelines is that Los Angeles’ guidelines allow three psychotropic Los Angeles’ guidelines allow
medications for children nine years and older rather than for children three psychotropic medications
who are 12 and older, as the state guidelines recommend. According to for children nine years and older
the medical director of Los Angeles County’s Juvenile Court Mental rather than for children who
Health Services (LA Juvenile Court Services), Los Angeles’ guidelines are 12 and older, as the state
for children aged 9 to 11 diff er from the state guidelines because anxiety guidelines recommend.
disorders often manifest in children around the age of nine.
In part to ensure that health care providers comply with its
guidelines, Los Angeles County established the LA Juvenile Court
Services, a unit within its Department of Mental Health. LA Juvenile
Court Services assists the juvenile court in making decisions
to approve or deny prescribers’ requests to initiate or continue
psychotropic medications for foster children. LA Juvenile Court
Services’ staff includes a child psychiatrist and a pharmacist, both of
whom review each request to ensure its adherence to the county’s
guidelines. If a request for medication is outside these parameters,
the LA Juvenile Court Services reviewers will generally follow up
with the prescriber to determine if the prescription in question is
medically necessary. If the reviewers determine that the request is
not safe and appropriate, they will recommend that the court either
deny the request or approve it for only 45 days, with the expectation
that the child’s medication regimen will be changed after that time.
Similarly, Madera County relies upon the state guidelines when
reviewing prescriptions for psychotropic medications for foster
children. For example, the policies of Madera County’s Child
Welfare Services Division (Madera Child Services) require the
county’s public health nurse to review all requests for court
authorizations to identify proposed psychotropic medications
that are outside Los Angeles County’s dosage parameters (which
are also the parameters the State adopted). In addition, the public
health nurse also determines whether prescribers are seeking court
approval to prescribe multiple psychotropic medications within the
same class or more psychotropic medications than foster children
should take based on their age according to the state guidelines.
Th e public health nurse documents her review of these and other
risk factors on a psychotropic medication monitoring review
form. If the public health nurse has concerns about the proposed
medications based on the risk factors she has identifi ed, the nurse
and the child’s assigned social worker will contact the health
care provider. If county staff are unable to resolve their concerns
with the provider, they will document their opposition to the
prescription authorization request with the court.
6 We describe the classifi cations for psychotropic medications in the Introduction.
24 California State Auditor Report 2015-131
August 2016
In contrast, Sonoma County uses its own standards, which are
less specifi c than the state guidelines, when reviewing requests
for psychotropic medications. Specifi cally, in May 2015 the
Sonoma County Department of Health Services, Behavioral Health
Division (Behavioral Health Division) entered into an intracounty
memorandum of understanding with the Sonoma County Department
of Human Services, Family, Youth and Children’s Division (Children’s
Division) to provide pediatric psychiatrists to review requests for
court authorization for prescriptions for psychotropic medications
for foster children. However, according to the Behavioral Health
Division’s Medical Director, the reviewing psychiatrists are
expected to ensure that proposed prescriptions adhere to a
1999 county policy rather than to the state guidelines. Although
this county policy is consistent with the state guidelines in certain
areas, it references another document that contains dosage
restrictions based on Los Angeles County’s 1997 dosage parameters
rather than the State’s current dosage standards. In addition, the
policy does not contain any specifi c age-related restrictions on
psychotropic medications. Behavioral Health Divisions’ medical
director acknowledged that Sonoma County’s internal policies
are outdated, and he stated that the county is in the process of
updating its policies to refl ect the guidelines that Social Services
and Health Care Services released in 2015.
Riverside County also uses its own, less specifi c guidelines when
reviewing foster children’s psychotropic medication prescriptions.
According to Riverside County’s policies, a Riverside University
Health System—Behavioral Health (Riverside Behavioral Health)
child and adolescent psychiatrist reviews all requests for court
authorization for foster children’s psychotropic medications.
However, according to Riverside Behavioral Health’s medical
director, the psychiatrist ensures that the prescriptions adhere
to a 2011 county policy that diff ers signifi cantly from the state
Riverside County’s policy allows guidelines. For example, Riverside’s policy allows the concurrent
the concurrent prescriptions prescriptions of two medications within the same class without
of two medications within requiring documentation; however, the state guidelines recommend
the same class, and the policy that children receive no more than one medication within the
does not contain any specifi c same class without justifi cation. Further, unlike the state guidelines,
age-related restrictions on Riverside County’s policy does not contain any specifi c age-related
psychotropic medications. restrictions on psychotropic medications. Finally, Riverside
County’s policy contains specifi c maximum dosage limitations for
antipsychotic medications only; it requires all other prescriptions
for psychotropic medications to comply with the U.S. Food and
Drug Administration’s recommended maximum dosages unless the
providers document their reasons for exceeding these limits.
According to Riverside Behavioral Health’s mental health services
administrator, Riverside County has been working to implement
the state guidelines. Riverside County’s Public Health, Behavioral
California State Auditor Report 2015-131 25
August 2016
Health, and Public Social Services departments have met and agreed
to develop a memorandum of understanding that will adhere to the
state guidelines. Riverside County’s Public Social Services department
has developed a draft of this memorandum, and Riverside Behavioral
Health will off er an amended draft for all three county departments’
consideration after our audit report is released.
When counties such as Sonoma and Riverside do not use state
guidelines, they miss a valuable opportunity to improve their
oversight practices. Not surprisingly, we generally found more
instances in Sonoma and Riverside County of authorizations of
prescriptions for foster children that exceeded the state guidelines State guidelines are a valuable
than we did for Los Angeles and Madera counties. We believe that tool that counties should leverage
the state guidelines are a valuable tool that counties should leverage to improve their oversight of
to improve their oversight of foster children who are prescribed foster children who are prescribed
psychotropic medications. psychotropic medications.
Foster Children Throughout the State Have Been Authorized to
Receive Amounts of Psychotropic Medications That Exceed the
State Guidelines
As previously discussed, the state guidelines include maximum
amounts and dosages of psychotropic medications that foster
children should receive. Nonetheless, when we reviewed the case
fi les for 80 foster children at the counties we visited, we found
that many had been prescribed psychotropic medications in
amounts and dosages that exceeded the state guidelines. Although
prescriptions that exceed the state guidelines may be appropriate
under some circumstances, we often found little indication that
the counties had followed up with the providers in question to
ensure the appropriateness of the medications. Further, our review
of statewide data (state data) from Social Services and Health Care
Services indicates that many foster children prescribed psychotropic
medications statewide may have received these medications in
excess of the state guidelines. As discussed in the Introduction
as well as in Chapter 2, we have concerns about the accuracy and
comprehensiveness of the state data. Nevertheless, we used them
in our analysis because they are currently the best data available
that speak to the number of foster children prescribed psychotropic
medications statewide.
In response to a recent state law, the Judicial Council of California
(Judicial Council) adopted new and revised forms—which became
eff ective in July 2016—to be used in the court authorization
process for foster children’s psychotropic medications. Th e proper
completion of these newly revised forms should provide county
staff with additional information necessary to identify instances
when foster children are prescribed psychotropic medications
26 California State Auditor Report 2015-131
August 2016
in amounts or dosages that exceed the state guidelines. Among
other things, these revised forms require prescribers to explain for
each foster child why they prescribed more than one psychotropic
medication in a class and dosages that are outside the state
guidelines. If these forms are not properly completed, county
staff will need to follow up with prescribers to obtain information
necessary to ensure that the prescriptions beyond the state
guidelines are appropriate.
Fourteen Percent of the Foster Children We Reviewed Were Authorized to
Receive Multiple Psychotropic Medications From the Same Drug Class
Th e state guidelines recommend that a foster child should take
no more than one psychotropic medication at a time from each
medication class. Common classes of psychotropic medications
include antipsychotics, antidepressants, mood stabilizers,
stimulants, and antianxiety medications. Th e concurrent use of
multiple psychotropic medications from the same class can lead to
extremely harmful side eff ects. For example, a foster child taking
multiple antidepressants could experience serotonin syndrome,
which can be life-threatening and can cause symptoms including
high fever, seizures, irregular heartbeat, and unconsciousness.
When we reviewed the case fi les for Nevertheless, when we reviewed the case fi les for 80 foster children,
80 foster children, we found that we found that 11 (14 percent) were authorized to simultaneously
11 (14 percent) were authorized take multiple psychotropic medications within the same drug class
to simultaneously take multiple during our audit period. As shown in Table 4, fi ve of the foster
psychotropic medications within children whose cases fi les we reviewed were authorized by the
the same drug class during our courts or their parents to simultaneously take multiple psychotropic
audit period. medications within the same class even after the State released
its guidelines. All fi ve of these cases were from Riverside and
Sonoma counties, which have yet to adopt the state guidelines.
Further, none of these fi ve case fi les contained any documentation
demonstrating that the counties followed up with providers
to question the need for simultaneously prescribing multiple
psychotropic medications from the same class.
Th e juvenile court in Riverside County authorized the prescriptions
in three of these cases, while parents consented to prescriptions
for Sonoma County foster children in the other two cases. In
one of these cases, a teenaged foster child in Riverside County
was prescribed three psychotropic medications at the same
time: two antidepressants and a mood stabilizer. In another
case, a teenaged foster child in Sonoma County was prescribed
two antipsychotics concurrently, which studies have called out as a
potentially dangerous combination that should generally be avoided.
California State Auditor Report 2015-131 27
August 2016
Table 4
Cases in Which Counties Did Not Have Records That They Questioned
Prescriptions That Exceeded the State’s Recommended Guidelines Related to
Classes of Psychotropic Medications
AT LEAST ONE INSTANCE WHERE PRESCRIPTIONS
EXCEEDED GUIDELINES FOR NUMBER OF
PSYCHOTROPIC MEDICATIONS WITHIN SAME CLASS
BEFORE THE STATE AFTER THE STATE
COUNTY PUBLISHED GUIDELINES PUBLISHED GUIDELINES
Los Angeles 0/20 cases 0/20 cases
Madera 1/20 0/20
Riverside 2/20 3/20
Sonoma 7/20 2/20
Totals 10/80 cases 5/80 cases*
13% 6%
Sources: California State Auditor’s analysis of records at county welfare services and behavioral
health departments.
* We identifi ed four cases in which foster children were prescribed numbers of psychotropic
medications that exceeded the State’s recommended guidelines both before and after the State
adopted those guidelines. Therefore, a total of 11 (14 percent) of the 80 foster children whose
case fi les we reviewed were authorized to simultaneously take multiple medications within the
same drug classifi cation during our audit period.
Four of these fi ve children had also been authorized to take multiple
medications before the State adopted its guidelines. Including
these four children, we found a total of 10 foster children who were
authorized to take multiple medications before the state guidelines
took eff ect. Seven of these children lived in Sonoma County. For
three of these children, we did not see any evidence that Sonoma
county staff followed up with providers to verify that the concurrent
medications were medically necessary before they forwarded the
requests to the Superior Court of California, County of Sonoma
(Sonoma County Court) for approval. For example, in one of these
cases, a foster child was prescribed fi ve diff erent psychotropic
medications at the same time, two of which were antipsychotics,
yet we did not see any evidence that the county questioned the
prescriber on the need to prescribe two antipsychotic medications
simultaneously. In the other four instances, the Sonoma County
Court delegated to the children’s parent(s) the authority to approve
their psychotropic medications. Since Sonoma County does not
have a process for reviewing prescriptions that parents authorize, it
did not follow up with the prescribers in these cases.
According to a program manager in the Children’s Division,
Sonoma County plans to expand its current review process—which
we described previously—to include prescriptions authorized by
parental consent in the future. In addition, similar to the county’s
current process for advising the court about the appropriateness
of proposed psychotropic medications, the reviewing psychiatrist
28 California State Auditor Report 2015-131
August 2016
should provide these parent(s) an opinion on the effi cacy and
appropriateness of proposed medications so that they are able
to make a more informed decision about whether to approve
these medications for their children. It is imperative that Sonoma
County make this change as soon as possible because the state
data for fi scal year 2014–15 indicates that more than 20 percent
of Sonoma County’s foster children receive parental consent to
take psychotropic medications. In contrast, less than 1 percent of
Los Angeles, Madera, and Riverside counties’ foster children receive
parental consent to take these medications. Further, a deputy
director at Social Services stated that foster children should receive
the same level of oversight from the county with regard to their
psychotropic medications whether a court or parent authorizes
the medication.
As discussed previously, LA Juvenile Court Services’ staff use
guidelines that are nearly identical to the state guidelines to
oversee proposed psychotropic medications that require court
authorization. Th is is the likely reason that we did not note any
instances in the cases we reviewed in which Los Angeles County
did not follow up with providers who prescribed foster children
multiple medications in the same class. Similarly, we only noted
one instance in which a court authorized a Madera County foster
child to take multiple medications in the same classifi cation without
evidence that the county followed up with the provider, and this
instance occurred before the State issued its guidelines, which
Madera subsequently adopted.
As shown in Table 5, the state data indicate that of the 9,317 foster
children with fi lled psychotropic medication prescriptions statewide
in fi scal year 2014–15, 851 were prescribed multiple antidepressants
at the same time; 330 were prescribed multiple antipsychotics at
the same time; and 193 were prescribed multiple stimulants at the
same time.7 Th e state data show that a lower percentage of foster
children in Los Angeles County who were prescribed psychotropic
medications received multiple medications from the same class
than the statewide average, likely refl ecting the fact that this county
adopted the state guidelines. Conversely, the statewide data indicate
that a greater proportion of Sonoma and Riverside county’s foster
children who were prescribed psychotropic medications were
concurrently prescribed multiple antidepressants compared to the
statewide average. For example, nearly 18 percent of Sonoma County’s
foster children prescribed psychotropic medications received multiple
antidepressants at the same time, which is nearly double the statewide
average of 9 percent. Similarly, Riverside County’s percentage of foster
7 The state guidelines state that the antidepressant trazodone is excepted when prescribed as a
hypnotic. Because the state data did not identify when trazodone was prescribed as a hypnotic,
we did not exclude it.
California State Auditor Report 2015-131 29
August 2016
children with fi lled prescriptions for more than one antidepressant
at the same time was nearly 12 percent, which is also greater than the
statewide average.
As discussed earlier, the Judicial Council recently adopted new
and revised forms to request court authorization of psychotropic
medications for foster children. Th ese forms now require physicians
to describe why they prescribed more than one psychotropic
medication in a class for the child. County staff can use this
information to better ensure that foster children were properly
prescribed psychotropic medications.
Table 5
Number and Proportion of Children in Foster Care With Filled Prescriptions for Multiple Psychotropic Medications in
the Same Class, Statewide and for Four Counties, Fiscal Year 2014–15
FOSTER CHILDREN WITH FOSTER CHILDREN WITH FOSTER CHILDREN WITH
TOTAL NUMBER OF FOSTER
MORE THAN ONE FILLED MORE THAN ONE FILLED MORE THAN ONE FILLED
CHILDREN WITH FILLED
ANTIDEPRESSANT PRESCRIPTION* ANTIPSYCHOTIC PRESCRIPTION* STIMULANT PRESCRIPTION*
PSYCHOTROPIC MEDICATION
PRESCRIPTIONS NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 851 9.1% 330 3.5% 193 2.1%
Counties We Visited
Los Angeles 3,194 267 8.4% 69 2.2% 42 1.3%
Madera 21 † † † † † †
Riverside 595 71 11.9 26 4.4 † †
Sonoma 140 25 17.9 † † † †
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’ California Medicaid Management
Information System, data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System, and matched
Medi-Cal pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* For our analysis, we considered foster children to be on more than one psychotropic medication only if they had fi lled prescriptions for more than
one psychotropic medication within the same medication classifi cation for more than 30 consecutive days.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
Ten Percent of Foster Children We Reviewed Were Authorized to Receive
More Psychotropic Medications Than State Guidelines Recommend for
Children Their Ages
Our review also found that some counties did not follow up
with prescribers to ensure that foster children only received
psychotropic medications that were appropriate for children
of their ages. As explained in the Introduction, state guidelines
recommend that children fi ve years old or younger take no more
than one psychotropic medication at a time, children aged 6 to 11
take no more than two medications, and children aged 12 to 17 take
no more than three medications.
30 California State Auditor Report 2015-131
August 2016
However, as shown in Table 6, eight (10 percent) of the 80 foster
children whose case fi les we reviewed had been authorized to
take more psychotropic medications than the state guidelines
recommended for their ages, yet the counties did not appear to have
sought additional justifi cation from the prescribers. By not questioning
providers requesting psychotropic medications beyond the guidelines,
counties cannot ensure that foster children are taking a number of
psychotropic medications that are safe and appropriate for their age.
Table 6
Cases in Which Counties Did Not Have Records That They Questioned
Prescriptions of Psychotropic Medications That Exceeded the State’s
Guidelines for Foster Children’s Ages
AT LEAST ONE INSTANCE WHERE PRESCRIPTIONS
EXCEEDED GUIDELINES FOR TOTAL NUMBER OF
PSYCHOTROPIC MEDICATIONS BY AGE
BEFORE THE STATE AFTER THE STATE
COUNTY PUBLISHED GUIDELINES PUBLISHED GUIDELINES
Los Angeles 2/20 cases 0/20 cases
Madera 0/20 0/20
Riverside 2/20 0/20
Sonoma 4/20 1/20
Totals 8/80 cases 1/80 cases*
10% 1%
Sources: California State Auditor’s analysis of records at county welfare services and behavioral
health departments.
* We identifi ed one case in which a child was prescribed psychotropic medications that exceeded
the State’s recommended guidelines both before and after the State adopted those guidelines.
Therefore, eight (10 percent) of the 80 children whose case fi les we reviewed were authorized to
take more psychotropic medications than state guidelines recommend for their ages.
Th ese eight cases all occurred before the issuance of the state
guidelines. Four of these eight cases were Sonoma County foster
children, three of whom received their parents’ approval to take these
medications. In fact, one of these Sonoma County foster children had
parental authorization to take these medications both before and after
the State issued its guidelines. After the State issued its guidelines, the
parents authorized this teenaged foster child to take fi ve psychotropic
medications at the same time, although state guidelines recommend
children that age should receive no more than three.
In two of the eight cases, Los Angeles County courts authorized
foster children to take a number of psychotropic medications
that exceeded the state guidelines for their ages. However, these
two instances occurred before the State released its guidelines,
and neither involved prescriptions that exceeded Los Angeles
County’s guidelines. In one of these cases, a young foster child
was prescribed three psychotropic medications at the same
California State Auditor Report 2015-131 31
August 2016
time. Although the state guidelines would later recommend that
foster children aged 6 to 11 only receive up to two psychotropic
medications concurrently, Los Angeles County’s guidelines allow
children aged 9 to 17 to receive up to three of these medications.
In the second case, a teenaged Los Angeles foster child was
prescribed four psychotropic medications concurrently. However,
one of the four medications was Cogentin, which Los Angeles
County’s guidelines do not count toward the maximum number of
psychotropic medications.8
Th e state data show that a signifi cant number of children statewide
also had fi lled psychotropic medication prescriptions that exceeded
the recommendations in the state guidelines for their ages. As shown In fi scal year 2014–15, 159 children
in Table 7 on the following page, the state data indicate that 29 foster in foster care aged 6 to 11 received
children aged zero to 5 received more than one fi lled psychotropic more than two fi lled psychotropic
medication prescription at the same time during fi scal year 2014–15. medication prescriptions at the
Furthermore, the state data show that 159 foster children aged 6 to 11 same time and 90 foster children
received more than two fi lled psychotropic medication prescriptions aged 12 to 17 received more than
and that 90 foster children aged 12 to 17 received more than three fi lled psychotropic medication
three fi lled psychotropic medication prescriptions at the same time. prescriptions at the same time.
Los Angeles County’s statistics, shown in Table 7 on the following
page, were lower than the corresponding statewide averages while
Riverside County’s statistics were higher. Specifi cally, less than
half a percent of Los Angeles County’s foster children aged 12 to 17
receiving psychotropic medication prescriptions had more than
three of these medications. Conversely, the rate in Riverside County
for foster children the same age was 1.8 percent, or nearly double
the statewide average. As discussed previously, Los Angeles County
uses guidelines that include age-based restrictions on psychotropic
medications that are very similar to the state guidelines, while
Riverside County does not. Th is likely explains why Los Angeles
County’s statistics compare more favorably than Riverside County’s
statistics to the statewide average.
8 According to the medical director of Los Angeles County’s Juvenile Court Mental Health Services,
the county excluded Cogentin from its standards because it is primarily used to counteract side
eff ects of antipsychotics, not to treat symptoms of a mental or behavioral disorder. The state
guidelines do not make an exception for Cogentin in determining the maximum number of
medications a child may receive.
32 California State Auditor Report 2015-131
August 2016
Table 7
Number and Proportion of Children in Foster Care With Filled Prescriptions for Psychotropic Medications That
Exceeded the State’s Recommended Guidelines for Age Groups, Statewide and for Four Counties,
Fiscal Year 2014–15
FOSTER CHILDREN AGE 611 FOSTER CHILDREN AGE 1217
WITH MORE THAN TWO WITH MORE THAN THREE
TOTAL NUMBER OF FOSTER CHILDREN AGE 05
FILLED PSYCHOTROPIC FILLED PSYCHOTROPIC
FOSTER CHILDREN WITH WITH MORE THAN ONE
MEDICATION PRESCRIPTIONS* MEDICATION PRESCRIPTIONS*
FILLED PSYCHOTROPIC FILLED PSYCHOTROPIC
MEDICATION PRESCRIPTIONS MEDICATION PRESCRIPTION* NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 29 159 1.7% 90 1.0%
Counties We Visited
Los Angeles 3,194 † 34 1.1% 14 0.4%
Madera 21 † † † † †
Riverside 595 † † † 11 1.8
Sonoma 140 † † † † †
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’ California Medicaid Management
Information System, data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System, and matched
Medi-Cal pharmacy data.
Notes: State guidelines recommend that children aged zero to 5 take no more than one psychotropic medication, children aged 6 to 11 take no more
than two psychotropics medications, and children aged 12 to 17 take no more than three psychotropic medications.
The term foster children refers to children aged zero to 17 in the foster care system.
* For our analysis, we considered foster children to be on more than one psychotropic medication only if they had fi lled prescriptions for more than
one psychotropic medication for more than 30 consecutive days.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
Nearly a Quarter of the Foster Children We Reviewed Were Authorized
to Take Larger Dosages of Psychotropic Medications Than State
Guidelines Recommend
Our review of 80 case fi les found that many foster children were
authorized to take psychotropic medications in dosages that
exceeded the state guidelines without the counties’ adequately
documenting that they had contacted the prescribers. As described
previously, when Social Services and Health Care Services created
the state guidelines, they adopted Los Angeles County’s dosage
parameters. Th ese dosage parameters established maximum daily
dosages for commonly prescribed psychotropic medications.
However, as shown in Table 8, our review of the case fi les for
80 foster children identifi ed 18 foster children (23 percent) for whom
the courts or their parents approved at least one psychotropic
medication with a maximum daily dosage that exceeded the state
guidelines. Ten of these children were authorized to take these
medications before the State issued its guidelines. One of these
10 children, along with eight more children, were all authorized to
take these medications after the State released its guidelines. We
found no evidence in any of these cases that the counties identifi ed
these prescriptions as potential problems and questioned the
prescribers about the dosages.
California State Auditor Report 2015-131 33
August 2016
Table 8
Cases in Which Counties Did Not Have Documentation That They Questioned
Providers When Prescriptions Went Beyond the State’s Recommended
Guidelines for Dosages
AT LEAST ONE PRESCRIPTION EXCEEDED GUIDELINES
FOR MAXIMUM DAILY DOSAGE
BEFORE THE STATE AFTER THE STATE
COUNTY PUBLISHED GUIDELINES PUBLISHED GUIDELINES
Los Angeles 0/20 cases 6/20 cases*
Madera 1/20 1/20
Riverside 5/20 0/20
Sonoma 4/20 2/20
Totals 10/80 cases 9/80 cases†
13% 11%
Sources: California State Auditor’s analysis of county records at welfare services and behavioral
health departments.
* Because Los Angeles County used the same parameters before the State adopted them, we consider
all Los Angeles County dosage exceptions as post-guidelines regardless of when they happened.
† Of these nine cases that exceeded the State’s recommended guidelines (state guidelines),
one case also occurred before the state guidelines. Therefore, 18 (23 percent) of the 80 foster
children whose case fi les we reviewed were authorized to take psychotropic medications with
maximum daily dosages that exceeded the state guidelines.
Although Social Services and Health Care Services consider
the state guidelines to be best practices, they are of little value if
counties do not use them. For example, six of the nine cases that
occurred after the issuance of the state guidelines involved foster
children in Los Angeles County. We fi nd this surprising since the
State adopted Los Angeles County’s preexisting dosage standards
as part of the state guidelines. In one of these instances, a physician
prescribed an antidepressant medication for a foster child with
a maximum daily dosage of 30 milligrams, which is 50 percent
higher than the state guidelines’ maximum recommended
dosage of 20 milligrams. When we asked the medical director of
LA Juvenile Court Services in Los Angeles’ County’s Department
of Mental Health why county staff did not follow up with this
provider, he explained that the county’s practice has been to only
review the actual daily dosage rather than the maximum daily
dosage. However, he stated that county staff plan to monitor each
prescription’s maximum daily dosage moving forward.
Because a prescriber may include both an actual daily dosage and a
maximum daily dosage when seeking court or parental authorization
for a prescription, we are aware that some of the foster children
we identifi ed in our review may not have taken psychotropic
medications in dosages that exceeded the state guidelines. However,
we believe counties should question prescribers when they request
maximum daily dosages that exceed the state guidelines because they
may then choose to increase the children’s dosage amounts up to the
authorized maximum amounts without receiving additional review
from the counties, the courts, or the children’s parents.
34 California State Auditor Report 2015-131
August 2016
Neither we nor the State can determine the extent statewide to
which foster children’s maximum daily dosages may exceed the
state guidelines because the State does not capture data related to
the maximum daily dosages of psychotropic medications that foster
children are authorized to take. However, we believe it would be
benefi cial for the State to capture such information and compare
it to the state guidelines. For example, such an analysis would
allow the State to identify counties in which high proportions of
foster children are being prescribed psychotropic medications
in maximum daily dosages that exceed the state guidelines. Th is
information would also allow the State to identify potentially
problematic prescribing patterns so that it could follow up with the
relevant counties. As discussed earlier, the Judicial Council recently
adopted new and revised forms to request court authorization
of psychotropic medications for foster children. Th ese forms
now require physicians to describe why they prescribed dosages
that were outside the approved range. County staff can use this
information to better ensure that foster children were properly
prescribed psychotropic medications
Because the State lacks data on foster children’s maximum authorized
daily dosages of psychotropic medications, we compared the
statewide data on prescribed daily dosages to the state guidelines’
maximum dosage parameters. Th e state data show that in
fi scal year 2014–15, 523 foster children had 2,389 prescriptions
for psychotropic medications with prescribed daily dosages
that exceeded the maximum allowable dosages in the state
guidelines. Th ese prescriptions represent nearly 2.5 percent of the
95,748 psychotropic medication prescriptions for that year. Although
these numbers are fairly small, they indicate that some foster children
received psychotropic medications in doses that exceeded the State’s
recommended maximum daily dosages, which put these children at
higher risk of potentially dangerous side eff ects.
A Signifi cant Number of the Foster Children We Reviewed Who Were
Prescribed New Psychotropic Medications Did Not Receive Timely
Follow-Up Visits With Prescribers or Other Health Care Providers
Our review of the 80 case fi les found that one-third of the foster
children who were prescribed new psychotropic medications did
not receive follow-up care with prescribers or other health care
providers in a timely manner. Specifi cally, the academy guidelines
state that providers should follow up with patients ideally within
Follow-up visits with prescribers or two weeks, but at least within a month, after they start psychotropic
other health care providers within medications. Follow-up visits within 30 days are critical because
30 days are critical because adverse adverse side eff ects from these medications are most common
side eff ects from psychotropic during the initial trial period. We excluded 13 cases from our
medications are most common analysis of follow-up visits because the foster children had been
during the initial trial period. authorized to start all of their psychotropic medications before
California State Auditor Report 2015-131 35
August 2016
the start of our audit period. However, as Table 9 shows, we
found no evidence in the county case fi les or the state data that
one-third of the remaining 67 children had follow-up visits with
their prescribers or other health care providers within 30 days of
fi lling their prescriptions for psychotropic medication or receiving
authorization to do so.9
Table 9
Cases in Which Counties Did Not Follow the American Academy of Child
and Adolescent Psychiatry’s Guidelines Regarding Follow-Up Appointments
With Providers
NO EVIDENCE THAT PROVIDERS FOLLOWED UP WITHIN 30 DAYS
COUNTY AFTER A FOSTER CHILD STARTED A PSYCHOTROPIC MEDICATION
Los Angeles 2/16 cases
Madera 8/20
Riverside 7/19
Sonoma 6/12
Total 23/67 cases
34%
Sources: California State Auditor’s analysis of county records at welfare services and behavioral health
departments, as well as data obtained from the Department of Health Care Services’ Paid Claims and
Encounters System.
Note: We excluded 13 cases from our analysis of follow-up visits because, in those cases, the foster
children were authorized to start all of their psychotropic medications before our audit period. As a
result, the foster children may have received follow-up appointments before the audit period.
One case in which a foster child did, in fact, have a follow-up
meeting with a psychiatrist within 30 days of starting a higher dose
of a psychotropic medication illustrates the importance of timely
follow-up visits. About three weeks after starting the higher dose
of the medication, the child complained of shaking hands and chest
pain; on the advice of another doctor, the child stopped taking the
medication. When the psychiatrist who had increased the medication
dosage met with the foster child within 30 days as the academy
guidelines recommend, the psychiatrist determined that the child’s
symptoms had greatly worsened since the child stopped taking
the medication. In response, the psychiatrist restarted the child’s
medication but at a lower dosage. If this follow-up visit had not
occurred or had been delayed, this child might have experienced
worsening symptoms as a result of discontinuing the medication.
9 Rather than using the ideal two-week time frame, we tested whether the foster children had a
follow-up visit with their prescriber or other health care provider within 30 days because we lacked
information about the exact dates that the children began taking the medications. Instead, we used
the dates the prescriptions were fi lled or—if we did not have that information—we used the dates
on which courts or parents authorized the medications. The 30-day time frame allows a two-week
buff er in case children did not begin taking the medication immediately after the prescriptions
were fi lled or authorized.
36 California State Auditor Report 2015-131
August 2016
Th ree of the four counties we visited off ered similar explanations
for the fact that so many foster children did not receive timely
follow-up care. For example, a division chief in Los Angeles County’s
Department of Children and Family Services indicated that the
department supports follow-up appointments with providers
within 30 days (or sooner, if indicated) for all foster children on
psychotropic medications. However, she also noted that the limited
number of child psychiatrists who accept Medi-Cal-insured
clients may explain why some foster children did not receive a
follow-up visit with their prescriber within 30 days of starting their
medication. Similarly, a division manager within Madera County
Behavioral Health Services noted that the limited number of child
and adolescent psychiatrists make it diffi cult for small counties
to schedule follow-up visits with these prescribers. Th e Sonoma
County Behavioral Health Division’s medical director also agreed
that it is reasonable for psychiatrists to arrange follow-up visits
within 30 days of foster children's starting psychotropic medications
and stated that the county is in the process of revising its policies to
adhere to the academy guidelines as closely as possible.
On the other hand, Riverside County Behavioral Health’s medical
director stated that child and adolescent psychiatrists are trained
extensively in their fi eld and that the county defers to the individual
prescriber’s discretion regarding any follow-up on a foster child’s
We believe that counties that medications. However, we believe that counties that defer to
defer to an individual prescriber’s individual providers are missing an opportunity to better protect
discretion regarding any follow-up the foster children under their care. Unless counties ensure that
on a foster child’s medications are all foster children who start new psychotropic medications receive
missing an opportunity to better follow-up visits with their prescribers within 30 days, they cannot
protect the foster children under be certain that the prescribers will monitor the children for
their care. potential adverse side eff ects.
Th e state data show that the lack of appropriate follow-up
care appears to be a statewide problem. As Table 10 illustrates,
1,881 (29 percent) of the 6,471 foster children statewide had
fi lled prescriptions for a new psychotropic medication in fi scal
year 2013–14 without a corresponding Medi-Cal claim for a
follow-up service within 30 days after the prescription was fi lled.
We acknowledge that in some of these cases, the foster child
may not have shown up for a scheduled follow-up appointment.
Th e state data show that Los Angeles County had follow-up
appointment rates that were better than the statewide statistics
by 14 percentage points. Th ey also indicate that 41 and 51 percent
of the foster children in Riverside and Sonoma counties who had
a fi lled prescription for a new psychotropic medication did not
have a corresponding Medi-Cal claim for a follow-up service
within 30 days after the prescription was fi lled. Further, although
the state data show that the rate of foster children who had a
California State Auditor Report 2015-131 37
August 2016
fi lled prescription for a new psychotropic medication without a
corresponding follow-up medication service within 30 days after
the prescription was fi lled is 29 percent throughout the state, 15 of
the counties referred to in Table A-8 beginning on page 90 in the
Appendix had rates that exceeded 50 percent. However, the state
data only cover services provided through Medi-Cal, and some
of the children may have received follow-up services outside of
Medi-Cal. We discuss this issue further in Chapter 2.
As discussed earlier, the Judicial Council recently adopted new
and revised forms to request court authorization of psychotropic
medications for foster children. Th ese forms now require county
staff to list the dates of all medication management appointments
since the last court hearing. County staff can use this information
to better ensure that foster children were properly prescribed
psychotropic medications.
Table 10
Number and Proportion of Children in Foster Care With New Psychotropic
Medication Prescriptions Filled in Fiscal Year 2013–14 Without a Corresponding
Medi-Cal Claim for a Follow-Up Medication Service Within 30 Days,
Statewide and for Four Counties
NUMBER OF FOSTER CHILDREN
WITH AT LEAST ONE FILLED PRESCRIPTION FOR A
NEW PSYCHOTROPIC MEDICATION WITHOUT A
CORRESPONDING MEDICAL CLAIM FOR
NUMBER OF FOSTER CHILDREN
FOLLOWUP MEDICATION SERVICES
WITH NEW PSYCHOTROPIC
MEDICATION PRESCRIPTIONS* NUMBER PERCENT
Statewide 6,471 1,881 29.1%
Counties We Visited
Los Angeles 2,252 334 14.8%
Madera 17 † †
Riverside 406 167 41.1
Sonoma 90 46 51.1
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care
Services’ Paid Claims and Encounters System, data obtained from the California Department
of Social Services’ Child Welfare Services/Case Management System, and matched Medi-Cal
pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* We defi ned a new prescription as any prescription for a psychotropic medication that the child had
not been prescribed in the prior 120 days and, as discussed in the Scope and Methodology section on
page 17, we applied the National Committee for Quality Assurance's methodology for follow-up care.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster
children. Such omission is in accordance with aggregate data reporting guidelines issued by the
Department of Health Care Services.
38 California State Auditor Report 2015-131
August 2016
Many of the State’s Foster Children Who Were Prescribed
Psychotropic Medications May Not Have Received Corresponding
Psychosocial Services
Both the academy and state guidelines emphasize the importance of
providing foster children with alternative treatments in addition to
psychotropic medications. Specifi cally, the academy guidelines point
out that, while many youth benefi t from psychotropic medications
used as part of a comprehensive treatment plan, this plan should
include nonmedication interventions as well, if appropriate. In
fact, the academy guidelines caution that medication may be
overprescribed when insuffi cient attention is paid to other supports
and services, such as psychosocial treatments.10 Th e academy
guidelines also state that actively pursuing alternative interventions
is especially important when the medications can have serious side
eff ects and are prescribed over an extended period of time. Similarly,
the state guidelines indicate that psychotropic medications should
be used in conjunction with psychosocial services. According to the
state guidelines, the only exception is when a health care provider
terminates a child’s psychosocial services because they have been
eff ective but the provider determines that the continued use of
medication is necessary to prevent the recurrence of symptoms.
Traditionally, psychosocial services are recommended before
pharmacological treatment. However, the academy guidelines
acknowledge that pharmacological treatments can be initiated
before, concurrent with, or after psychosocial services, depending
on the available research evidence and needs of the patient. For
example, randomized controlled trials suggest that medication
management for attention-defi cit/hyperactivity disorder should be
the fi rst-line treatment, while medication combined with behavioral
treatment may be necessary for optimal outcomes for a child with
more complex problems. Conversely, for obsessive-compulsive
disorder, the best fi rst option is either cognitive-behavioral
therapy, especially if delivered by an expert psychotherapist, or
combined treatment (i.e., therapy and medication). However,
the academy guidelines also note that although empirically
supported psychosocial treatments may be the optimal fi rst step
for many disorders, many communities lack skilled providers of
such treatments. In these communities, starting treatment with
medication may be the best intervention available.
We found that many foster children Despite the importance of psychosocial services to children’s
may not have received psychosocial overall treatment plans, we found that many foster children
services before and after starting may not have received such services before and after starting
psychotropic medications. psychotropic medications. We reviewed the case fi les of 67 foster
10 Psychosocial treatments can include behavioral health counseling and therapy, therapeutic
behavioral services, crisis intervention, and services provided in a psychiatric health facility.
California State Auditor Report 2015-131 39
August 2016
children at the four counties we visited to determine whether
they received psychosocial services before and after starting new
psychotropic medications. Because the foster children may have
received psychosocial services that the counties did not adequately
document in their case fi les, we also analyzed the State’s Medi-Cal
data for these children to determine whether the Medi-Cal program
paid for their psychosocial services. As Table 11 illustrates, our
analysis found that between 9 and 15 percent of the 67 foster
children did not receive psychosocial services six months before
starting psychotropic medications. Furthermore, this evidence also
indicates that between 4 and 7 percent of the 67 foster children
did not receive psychosocial services within six months after
starting medications.
Table 11
Cases in Which Children in Foster Care Prescribed Psychotropic Medications Did Not Receive Corresponding
Psychosocial Services
OF THOSE CASES THAT RECEIVED
PSYCHOSOCIAL SERVICES WITHIN 6 MONTHS...
NO PSYCHOSOCIAL SERVICES WITHIN 6 MONTHS... ...BEFORE, THE NUMBER THAT ...AFTER, THE NUMBER THAT
DID NOT RECEIVE THOSE SERVICES DID NOT RECEIVE THOSE SERVICES
...BEFORE STARTING AT LEAST ...AFTER STARTING AT LEAST WITHIN 30 DAYS BEFORE STARTING WITHIN 30 DAYS AFTER STARTING
ONE PSYCHOTROPIC MEDICATION, ONE PSYCHOTROPIC MEDICATION, AT LEAST ONE MEDICATION, AT LEAST ONE MEDICATION,
BASED ON COUNTY RECORDS AND BASED ON COUNTY RECORDS AND BASED ON COUNTY RECORDS AND BASED ON COUNTY RECORDS AND
COUNTY STATE DATA STATE DATA STATE DATA STATE DATA
Los Angeles 1/16–2/16 cases 0/16–1/16 cases 0/15–1/14 cases 0/16–0/15 cases
Madera 3/20–4/20 0/20 4/17–5/16 7/20–8/20
Riverside 1/19–2/19 1/19–2/19 3/18–4/17 3/18–4/17
Sonoma 1/12–2/12 2/12 4/11–3/10 4/10
Totals 6/67–10/67 cases* 3/67–5/67 cases* 11/61–13/57 cases† 14/64–16/62 cases‡
9–15 percent 4–7 percent 18–23 percent 22–26 percent
Sources: California State Auditor’s analysis of county records at welfare services and behavioral health departments, as well as data obtained from the
Department of Health Care Services’ Paid Claims and Encounters System.
Note: As described on page 41, we report a range in the number of foster children who did not receive timely psychosocial services because of diff erences
in the procedure codes used by the National Committee for Quality Assurance and the Department of Health Care Services to identify psychosocial services.
* We excluded 13 cases from these analyses because, in those cases, the foster children were authorized to start all of their psychotropic medications
before our audit period. Therefore, the services may have occurred outside the audit period and we did not review the documentation.
† We excluded a number of cases from this analysis because the foster children were either authorized to start all of their psychotropic medications
before our audit period or because the foster children did not have psychosocial services within six months before starting at least one of their
psychotropic medications.
‡ We excluded a number of cases from this analysis because the foster children were either authorized to start all of their psychotropic medications
before our audit period or because the foster children did not have psychosocial services within six months after starting at least one of their
psychotropic medications.
In addition, counties may not be ensuring that foster children
receive the optimal care if those children do not promptly receive
the necessary psychosocial services. We evaluated whether the
foster children whose fi les we reviewed received services within
30 days of starting psychotropic medications. As Table 11 shows, of
the foster children who had received psychosocial services within
40 California State Auditor Report 2015-131
August 2016
the six months before starting psychotropic medications and who
started at least one psychotropic medication within our audit
period, we found that between 18 and 23 percent did not receive
these psychosocial services within 30 days before starting their
medications. Of the foster children who received psychosocial
services within six months after starting medications and who
started at least one psychotropic medication within our audit period,
the evidence suggests that between 22 and 26 percent did not receive
those services within the fi rst 30 days of starting the medications.
When we reviewed the state data to determine the extent to which
foster children statewide who had a fi lled prescription for psychotropic
medications also received supporting psychosocial services, we found
that between 3,965 and 7,489 (41 to 77 percent) of the 9,707 foster
children with paid prescriptions for psychotropic medications in fi scal
year 2013–14 did not receive corresponding psychosocial services
through Medi-Cal both 30 days before and 30 days after receiving
psychotropic medications, as shown in Table 12.11
Table 12
Number of Children in Foster Care With Filled Prescriptions for Psychotropic
Medications Without a Corresponding Medi-Cal Claim for Psychosocial Services,
Statewide and for Four Counties, Fiscal Year 2013–14
NUMBER OF FOSTER CHILDREN
FOSTER CHILDREN WITH
WITH AT LEAST ONE INSTANCE OF NO SERVICE WITHIN...
FILLED PRESCRIPTIONS
FOR PSYCHOTROPIC ...30 DAYS BEFORE OR AFTER, ...180 DAYS BEFORE OR AFTER,
MEDICATIONS FILLING A PRESCRIPTION FILLING A PRESCRIPTION
Statewide 9,707 3,965–7,489 1,564–4,512
Counties We Visited
Los Angeles 3,267 742–2,185 204–994
Madera 23 * *
Riverside 600 385–556 146–363
Sonoma 142 98–* 56–98
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’
Paid Claims and Encounters System, data obtained from the California Department of Social Services’
Child Welfare Services/Case Management System, and matched Medi-Cal pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system. In addition,
as described on page 41, we report a range in the number of foster children who did not receive timely
psychosocial services because of diff erences in the procedure codes used by the National Committee
for Quality Assurance and the Department of Health Care Services to identify psychosocial services.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer
foster children. Such omission is in accordance with aggregate data reporting guidelines issued
by the Department of Health Care Services.
11 To determine an approximate start date for the psychotropic medications, we used the date the
medication was fi lled at the pharmacy.
California State Auditor Report 2015-131 41
August 2016
We report a range in the number of foster children who did not
receive psychosocial services because of diff erences in the way
psychosocial services are identifi ed in the state data. We based the
high estimate in our range on the defi nition of psychosocial services
contained in the Healthcare Eff ectiveness Data and Information Set
(HEDIS), a set of health care performance measures developed by the
National Committee for Quality Assurance and used by more than
90 percent of the health care plans in the United States. However,
Health Care Services uses an expanded version of the HEDIS
defi nition of psychosocial services—which includes services provided
by certain mental health professionals and billed as comprehensive
community support services or provided at federally qualifi ed health
centers or rural health clinics—which is refl ected in the low estimate
in our range. Th e chief medical information offi cer of Health Care
Services noted that the HEDIS defi nition does not count community
support services as psychosocial services. However, she stated that
mental health professionals such as psychiatrists and licensed clinical
social workers provide most of the community support services
in California and should therefore be counted as a psychosocial
service. Further, the services provided at federally qualifi ed health
centers or rural health clinics that Health Care Services includes
in its defi nition are provided by this same group of mental health
professionals. Consequently, our analysis estimates the likely range
in which foster children who took psychotropic medications also
received psychosocial services through the Medi-Cal program
based on both the HEDIS and Health Care Services' defi nition of
psychosocial services.
In addition, the state data used in our analysis only include those
services for which Medi-Cal paid and does not include services paid
for outside of Medi-Cal. Further, although children may enter and
exit the foster care system on multiple occasions over time, we did
not adjust our calculations to account for this. Information from the
California Child Welfare Indicators Project for 2013 indicated that
75 percent of foster children had lengths of stay in their last foster
care placement of 7.7 months or longer.12
Finally, as discussed earlier, the Judicial Council adopted new The Judicial Council of California
and revised forms to request court authorization of psychotropic (Judicial Council) adopted new
medications for foster children. Th ese forms place an increased and revised forms—which became
emphasis on the provision of psychosocial services to these children. eff ective in July 2016—that
For example, the forms now require prescribing physicians to providers must use to request court
provide more detailed information about the psychosocial services authorization of psychotropic
foster children previously received. In addition, the forms now medications for foster children.
require social workers and probation offi cers to identify the specifi c
12 The California Child Welfare Indicators Project is a collaborative venture between the University
of California, Berkeley School of Social Work and Social Services that makes available child
welfare administrative data to policymakers, child welfare workers, and the public on a website.
42 California State Auditor Report 2015-131
August 2016
psychosocial services that foster children received in the past
six months, as well as to indicate the types of therapeutic services
the children are enrolled in or are recommended to participate in
during the next six months.
Although the Judicial Council’s changes to the court authorization
forms place increased emphasis on the psychosocial services
provided to foster children, we believe additional steps are necessary.
Specifi cally, counties must develop and implement stronger
procedures to ensure that foster children who are prescribed
psychotropic medications consistently receive corresponding
psychosocial services. In addition, the counties must adequately
document these services so that caregivers can better monitor the
children, as we will discuss in further detail in Chapter 2.
In Violation of State Law, More Than a Third of the Foster Children We
Reviewed Received At Least One Prescription for Psychotropic
Medications Without Required Court Approval or Parental Consent
Counties do not always obtain required court
or parental approval before foster children
Information Required With Applications
receive psychotropic medications. As previously
for Court Authorization to Administer
discussed, state law requires that juvenile courts
Psychotropic Medications
either authorize the administration of psychotropic
• A description of the child’s psychiatric diagnosis to medications for foster children or delegate that
be treated with the medication. authority to the children’s parents upon fi ndings
on the record that the parents pose no danger to
• The proposed medication to be administered along
the children and have the capacity to authorize
with a maximum daily dosage and length of time for
the course of treatment. psychotropic medications. Although California
rules of court allow for the administration of
• The anticipated benefi ts and possible side eff ects
psychotropic medications without prior court
associated with using the medication.
authorization in emergency situations, even
• A list of any other drugs that the child is currently in emergency situations physicians must seek
taking and a description of any eff ect these authorization no more than two "court days" after
drugs may produce in combination with the
administering the medications.
psychotropic medication.
• A description of any other therapeutic services A physician seeking court authorization to prescribe
related to the child’s mental health status. a psychotropic medication to a foster child must
submit the application forms developed by the
• A statement that the child has been informed in
Judicial Council for that purpose. As shown in the
an age-appropriate manner of the recommended
course of treatment, the basis for it, and its text box, the application must include a number of
possible results, along with the child’s response to items to help the court decide how to adjudicate the
the information. request. A parent or guardian, or others as allowed
by the court’s rules, may fi le an opposition to the
Source: California Rules of Court, Rule 5.640, in eff ect before
July 2016 for the period covered by our testing. request with the court. Based on the information in
the application and any opposition to the request,
the court may grant authorization without a hearing.
Alternatively, it can schedule a hearing, at which it
California State Auditor Report 2015-131 43
August 2016
may grant, deny, or modify the application. At that time, it may also set
a date for review of the child’s progress and condition. A court order to
authorize a psychotropic medication is eff ective for 180 days unless the
court terminates or modifi es it sooner.
However, when we reviewed the 80 case fi les we selected, we
found that more than a third of the foster children had at least
one prescription for psychotropic medications without court
authorization or parental consent. Specifi cally, 23 (34 percent) of
the case fi les of the 67 foster children who should not have received
psychotropic medications without court approval lacked evidence
of such approval for at least one of the psychotropic medications
that the child was prescribed, as shown by Table 13. For example,
we identifi ed one foster child who was prescribed both an
antipsychotic medication and an antidepressant medication without
receiving prior court approval. Further, fi ve (38 percent) of the
case fi les for 13 foster children who should have received parental
consent before taking psychotropic medications lacked evidence of
consent for at least one of the psychotropic medications prescribed
for the child. In fact, one of these case fi les did not contain evidence
of parental consent for six of the child’s psychotropic medications.
Table 13
Counties Did Not Always Have Approvals for Psychotropic Medications Prescribed to Children in Foster Care
NO DOCUMENTATION OF NO DOCUMENTATION OF
COURT AUTHORIZATION FOR PARENTAL CONSENTS FOR LATE COURT AUTHORIZATION FOR PRESCRIPTION FOR
AT LEAST ONE PSYCHOTROPIC AT LEAST ONE PSYCHOTROPIC AT LEAST ONE PSYCHOTROPIC PSYCHOTROPIC MEDICATION
COUNTY MEDICATION PRESCRIPTION MEDICATION PRESCRIPTION MEDICATION PRESCRIPTION* FILLED PRIOR TO AUTHORIZATION
Los Angeles 8/18 cases 2/2 cases 4/18 cases 2/20 cases
Madera 6/20 0/0 6/20 3/20
Riverside 6/20 0/0 7/20 3/20
Sonoma 3/9 3/11 3/9 4/20
Totals 23/67 cases 5/13 cases 20/67 cases 12/80 cases
34% 38% 30% 15%
Sources: California State Auditor’s analysis of county records at welfare services and behavioral health departments, as well as data obtained from the
Department of Health Care Services’ Paid Claims and Encounters System.
* We defi ned late court authorizations as either counties not obtaining a renewed court authorization within 180 days for continuing psychotropic
medications, or not seeking a court authorization within two court days of the emergency administration of psychotropic medications to a foster child.
Further, we attempted to compile statewide data, however Social
Services' data is not formatted in a way that allows us to defi nitively
identify if court authorizations or parental consents are associated
with a specifi c psychotropic medication. As a result, we analyzed
the statewide data to identify the frequency with which court
authorizations or parental consents existed for any medication
and if that consent was either 180 days before or 30 days after
44 California State Auditor Report 2015-131
August 2016
the psychotropic medication prescription was fi lled. As Table 14
illustrates, more than 65 percent of the 9,317 foster children
that the state data show as having had paid prescriptions for
psychotropic medications in fi scal year 2014–15 were prescribed
at least one psychotropic medication for which Social Services’
data system lacks any record of court or parental approval. In
fact, more than 3,400 (37 percent) of these children had no court
authorization or parental consent recorded in Social Services’ data
system for any of their psychotropic medications. Th ese outcomes
were even more pronounced at the four counties we reviewed—
more than 20 percent to nearly 78 percent of the prescriptions at
these counties lacked records of consent. We acknowledge that
both the counties’ case fi les and the state data related to court
authorizations and parental consents may be incomplete; in fact, we
discuss the defi ciencies in the state data in Chapter 2. Nonetheless,
our analyses strongly suggest that a sizeable number of foster
children were prescribed psychotropic medications without prior
court authorization or parental consent.
Table 14
Number and Proportion of Children in Foster Care With Filled Prescriptions for Psychotropic Medication by Type of
Approval Recorded in Social Services’ Data, Statewide and for Four Counties, Fiscal Year 2014–15
TYPES OF CONSENT
NO COURT AUTHORIZATION
COURT AUTHORIZATION OR NO COURT AUTHORIZATION OR OR PARENTAL CONSENT
TOTAL NUMBER OF
PARENTAL CONSENT FOR ALL PARENTAL CONSENT FOR ANY FOR ONE OR MORE
FOSTER CHILDREN WITH
PSYCHOTROPIC MEDICATIONS PSYCHOTROPIC MEDICATIONS PSYCHOTROPIC MEDICATIONS
FILLED PRESCRIPTIONS FOR
PSYCHOTROPIC MEDICATIONS NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 3,232 34.7% 3,448 37.0% 6,085 65.3%
Counties We Visited
Los Angeles 3,194 920 28.8% 1,475 46.2% 2,274 71.2%
Madera 21 * * * * * *
Riverside 595 300 50.4 121 20.3 295 49.6
Sonoma 140 31 22.1 65 46.4 109 77.9
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case
Management System and matched Medi-Cal pharmacy data.
Notes: The term foster children refers to children aged zero to 17 in the foster care system.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
We also found that the counties we visited did not always obtain
court authorizations for psychotropic medications in a timely
manner. As previously mentioned, court authorizations for
psychotropic medications are only eff ective for up to 180 days. For
a foster child to continue to receive a psychotropic medication
after six months, the county must seek to renew the court’s
authorization. Furthermore, a foster child in an emergency situation
may take psychotropic medications without an authorization;
California State Auditor Report 2015-131 45
August 2016
however, the court must receive a request for authorization within
two days after the child starts the medication. If counties do not
seek court authorization within two days, the foster child is taking
psychotropic medications without proper approval. However,
our review of the case fi les for the 67 children who required court
authorization for their psychotropic medications found that
20 (30 percent) contained court authorizations that counties had
obtained from 12 days to more than seven months late. In fact,
in one case, Madera County renewed the court’s authorization
for three of a child’s medications seven months late. In this
instance, staff stated that the county opposed one of the proposed
medications, and because of delays in the process, the county
never followed up to ensure the other requested medications were
approved. When counties do not seek to obtain court approvals in
a timely manner, they deprive courts of the opportunity to assess
whether ongoing psychotropic medications are necessary and safe
for foster children to receive.
Moreover, weaknesses in the court and parental authorization
processes could lead to foster children receiving psychotropic
medications before the prescriptions are approved. For example,
as Figure 3 on the following page shows, the processes used at the
four counties we visited allow providers to write prescriptions
for psychotropic medications at the same time they request
authorization from the courts or parents. Th e caregivers of the
foster children could then take the prescriptions to pharmacies
to be fi lled. In fact, 12 (15 percent) of 80 case fi les we reviewed
contained instances in which foster children’s caregivers fi lled
their prescriptions before they were authorized. When we asked
what mechanisms prevent children from taking their medications
without the necessary authorizations, staff at three of the counties
asserted that their caregivers are responsible for ensuring that
they administer the psychotropic medications only after the
prescriptions are authorized. Alternatively, Madera County Social
Services’ deputy director stated that he believes social workers are
ultimately responsible for ensuring that foster children do not take
psychotropic medications that are not yet approved.
Given the results of our case fi le review, we believe that better Better safeguards are necessary
safeguards are necessary to prevent children from taking to prevent children from taking
psychotropic medications without the legally required approvals. psychotropic medications without
For example, counties could create a process in which the caregiver the legally required approvals.
notifi es a foster child’s social worker or public health nurse when
the child is ready to start a psychotropic medication. Th e social
worker or public health nurse could then determine whether court
or parental authorizations exist for the medication, and inform the
caregiver about whether the foster child can start the psychotropic
medication. Th is process would also allow counties to obtain
more accurate medication start dates, an issue that we discuss in
46 California State Auditor Report 2015-131
August 2016
Chapter 2. By ensuring that caregivers know when to properly
administer psychotropic medications to their foster children,
counties can gain better assurance that foster children do not take
psychotropic medications before those prescriptions are approved.
Figure 3
Psychotropic Medication Oversight of Children in Foster Care
Child
Court Authorization Request Process*
Request to administer
psychotropic medication
Child Welfare Services
Worker / Public County Approval
Health Nurse
Caregiver Physician Coordinators† Courts
Treatment Authorization Request Process
Request treatment authorization
(if applicable)
Approval
Department of
Pharmacist
Health Care Services
sretsinimdA noitacidem
Coordinate
health care
sesnepsiD noitacidem
C
o
or
dinate
health
care M
edical
a
p
p
o
in
tm
e n
t
Paper
prescription
Court authorization
n
o
pti
escri
pr
nic
Electro
Sources: California State Auditor’s analysis of state laws and regulations, county policies and procedures, and interviews with county offi cials at
Los Angeles, Madera, Riverside, and Sonoma counties.
Note: We use the term foster children to refer to children aged zero to 17 in the foster care system.
* The court may delegate its authority to administer psychotropic medications to a foster child’s parents, which removes the court authorization process.
† County coordinators include social workers, probation offi cers, public health nurses, and other county staff who coordinate gathering the court
authorization request documents to provide to the courts.
Because most counties we visited identifi ed the caregiver as the
point of control in the administration of psychotropic medications
to foster children, the entity that oversees the caregivers should
logically be responsible for providing instructions related to those
medications’ authorization. Social Services’ Community Care
Licensing Division—specifi cally, its Children’s Residential Licensing
California State Auditor Report 2015-131 47
August 2016
Program (Licensing Program)—issues licenses to homes and
facilities that house foster children and performs inspections of
those homes to ensure they provide a safe and healthy environment.
Th e Licensing Program created a medications guide specifi c
to group homes that includes detailed information concerning
psychotropic medication use and explains the court authorization
process. According to a program manager, the Licensing Program
posted this medication guide on its website on December 31, 2015.
She indicated that the Licensing Program is currently creating a
similar guide for foster family agencies and homes. By issuing clear,
detailed instructions to caregivers in all types of facilities, the State
can better ensure that foster children do not receive psychotropic
medications without or before approval.
Two of the counties we reviewed also recently implemented
processes that may help mitigate the issues we found related to
missing or late court authorizations. Specifi cally, in July 2015,
Riverside County hired a public health nurse whose primary
responsibility is to monitor and ensure compliance with the court
authorization process at both a case level and a systemic level.
Th e public health nurse produces a monthly report for Riverside
County’s Department of Social Services summarizing the number
of court authorizations that have lapsed without renewals. Similarly,
in November 2015 Sonoma County started to track expiring court
authorizations and parental consents to help ensure foster children
have current approvals for psychotropic medications. A program
development manager from Sonoma County Family, Youth and
Children Division creates monthly summary reports of foster
children prescribed psychotropic medications from Social Services’
Child Welfare Service Case Management System and provides
the reports to social worker supervisors and their managers for
follow up.
Despite Sonoma County’s recent positive steps, we remain
concerned about its problematic practices for obtaining parental
consent for psychotropic medications. As mentioned earlier,
Sonoma County used parental consent far more frequently than
most other counties in fi scal year 2014–15. Sonoma County told us
that its use of parental consent is in line with its local legal culture
to keep parents involved in their children’s lives. Consequently,
its social workers generally advocate to the court to delegate
authorization of psychotropic medications to the parents. As a Most counties recorded parental
result, Social Services’ data show that most counties recorded consent for 1 percent or less of their
parental consent for 1 percent or less of their foster children, foster children, whereas Sonoma
whereas Sonoma County recorded parental consent for more than County recorded parental consent
20 percent. for more than 20 percent.
48 California State Auditor Report 2015-131
August 2016
According to a deputy director at Social Services, a county may
have valid reasons for having parents consent for a foster child’s
psychotropic medications. However, Sonoma County currently
does not follow its policy related to obtaining parental consent
for psychotropic medications. Specifi cally, the Sonoma County
Family, Youth and Children Division purportedly operates under
a 16-year-old policy related to parental consent, fi rst adopted in
response to the statutes that established the requirement. Among
other things, the policy states that social workers will mail parents
copies of physician recommendations for medications along with
consent forms—a process that would clearly document the request
for medications and the parents’ consent. However, according to
a Sonoma County division director, the county does not follow
this policy. Instead, prescribing physicians must work with the
parents directly to obtain their informed consent. Th is process
seems problematic, since it is unclear how physicians would know
whom to contact if caregivers bring the children to appointments.
Contrary to what the department director indicated, a program
manager stated the county’s practice is that social workers obtain
parental consent, verbal or otherwise, and then record the consent
into Social Services’ data system every six months.
Recommendations
Counties
To better ensure that foster children only receive psychotropic
medications that are appropriate and medically necessary, counties
should take the following actions:
• Implement procedures to more closely monitor requests for
authorizations for foster children's psychotropic medications that
exceed the state guidelines for multiple prescriptions, specifi c
age groups, or dosage amounts. When prescribers request
authorizations for prescriptions that exceed the state guidelines,
counties should ensure the new court authorization forms
contain all required information and, when necessary, follow up
with prescribers about the medical necessity of the prescriptions.
Counties should also document their follow-up monitoring in
the foster children’s case fi les. In instances in which counties
do not believe that prescribers have adequate justifi cation for
exceeding the state guidelines, the counties should relay their
concerns and related recommendations to the courts or parents.
• Ensure that all foster children are scheduled to receive a
follow-up appointment within 30 days of starting a new
psychotropic medication.
California State Auditor Report 2015-131 49
August 2016
• Implement processes to ensure that foster children receive
any needed mental health, psychosocial, behavioral health, or
substance abuse services before and concurrently with receiving
psychotropic medications.
• Implement a systemic process for ensuring that court authorizations
or parental consents are obtained and documented before
foster children receive psychotropic medications and that court
authorizations for psychotropic medications are renewed within
180 days as state law requires. Th e process should also ensure that
the counties better document the court authorizations and parental
consents in the foster children’s case fi les.
• Develop and implement a process for county staff and caregivers
to work together to ensure the psychotropic medications are
authorized before being provided to foster children. Th is process
should also ensure that the counties obtain accurate medication
start dates from caregivers.
Riverside County
To improve its oversight of foster children who are prescribed
psychotropic medications, Riverside County should take the
following actions:
• Immediately adopt the state guidelines for its physicians’ use
when prescribing psychotropic medications and for the county's
use when reviewing court authorization requests.
• Continue to use its new tracking process to better ensure that
court authorizations are renewed within 180 days.
Sonoma County
To improve its oversight of foster children prescribed psychotropic
medications, Sonoma County should take the following actions:
• Immediately adopt the state guidelines for its physicians’ use
when prescribing psychotropic medications and the county’s
use when reviewing court authorization requests.
• Within six months, implement a process to review psychotropic
medications that receive parental consent rather than
court authorization.
• Update its policies to describe methods for obtaining and
documenting in the foster children's case fi les parental consents
for psychotropic medications.
50 California State Auditor Report 2015-131
August 2016
California Department of Social Services
To better ensure that counties only use parental consent in place of
court authorization when it is appropriate, Social Services should
assess Sonoma County’s practice of advocating to the juvenile court
that it delegate to parents the authority to administer psychotropic
medications to foster children.
To better ensure that all caregivers are informed and educated
regarding the use of psychotropic medications and the court
authorization process, Social Services should develop instructions
regarding these topics and provide them to caregivers, such as
foster family agencies, that do not operate group homes.
California State Auditor Report 2015-131 51
August 2016
Chapter 2
FRAGMENTED OVERSIGHT AND POOR DATA HAVE
HAMPERED STATE AND COUNTY EFFORTS TO ENSURE
THE APPROPRIATE PRESCRIBING OF PSYCHOTROPIC
MEDICATIONS TO CHILDREN IN FOSTER CARE
Chapter Summary
As described in the Introduction, California’s current government
structure for overseeing psychotropic medications prescribed to
children in foster care (foster children) is fragmented, with state
and local executive and judicial branch entities performing various
functions. Although these entities have made some eff orts to
collaborate, the State’s approach provides little system-level oversight
to help ensure that the entities’ eff orts actually work as intended.
Further, the State has not developed a comprehensive oversight
plan that identifi es each of its various oversight mechanisms and
describes how these mechanisms should work together.
Th e State’s fragmented oversight structure has contributed to
the problems we identifi ed in Chapter 1 and has led to other
weaknesses in the monitoring of foster children’s psychotropic
medications as well. For instance, at the four counties we visited,
many foster children’s Health and Education Passports—critical
health summary documents that follow foster children should
their placement change—contained omissions and errors in their
health information. Specifi cally, the Health and Education Passports
for all 80 of the foster children whose case fi les we reviewed
had incorrect start dates for psychotropic medications. Further,
many of these Health and Education Passports did not identify
all the psychotropic medications that the courts authorized, and
none contained complete summaries of the psychosocial services
that the foster children had received. When Health and Education
Passports contain inaccurate and incomplete health information,
health care providers and caregivers may not have critical
information that they need to make sound health care decisions for
the foster children in their care. Further, inaccurate and incomplete
information hampers the State’s and counties’ oversight eff orts.
We also found weaknesses in the State’s oversight of the counties,
physicians, and pharmacists who are involved with foster children’s
mental health care. Th e California Department of Social Services
(Social Services) only recently began examining psychotropic
medications prescribed to foster children through its California
Child and Family Services Reviews (California reviews) of the
counties. Further, the Medical Board of California (Medical
Board) does not currently take steps to proactively identify
52 California State Auditor Report 2015-131
August 2016
physicians for further investigation who might have inappropriately
prescribed psychotropic medications to foster children. Finally, the
Department of Health Care Services (Health Care Services) has not
programmed its claims system to prompt pharmacists to submit
treatment authorization requests for psychotropic medications
that are prescribed for off -label use—a use that has not been
approved by the U.S. Food and Drug Administration—to ensure the
prescriptions’ medical necessity. Due to its insuffi cient oversight,
the State has reduced assurance that health care providers are
reasonably prescribing psychotropic medications to foster children.
The Fragmented Structure of California’s Child Welfare System Has
Contributed to Weaknesses in the Oversight of the Prescription of
Psychotropic Medications to Foster Children
We believe that the fragmented structure of California’s child
welfare system lessens the State’s assurance that psychotropic
medications are appropriately prescribed to foster children. As
the Introduction explains, oversight of psychotropic medications
prescribed to foster children is diff used among multiple
government levels and branches. Consequently, executive
and judicial branch agencies at the state and local levels share
responsibilities for administering and overseeing diff erent aspects
of the provision of psychotropic medications to foster children.
However, by increasing their current levels of collaboration, the
various government agencies involved in child welfare services
could improve their oversight and better address many of the
problems we discuss later in this chapter and in Chapter 1.
Given the splintered nature of California’s administration of
foster care and oversight of psychotropic medications for foster
children, we expected to fi nd that the State had a comprehensive
oversight plan. Ideally, this plan would describe the State’s
various oversight mechanisms, the public entities responsible for
California’s oversight approach for employing those mechanisms, and the tools in place to ensure
its administration of foster care that these entities work individually and collectively to ensure that
and monitoring of psychotropic psychotropic medications are prescribed properly to foster children.
medications appears to be However, we found no such plan. Despite some collaborative eff orts
piecemeal with little system-level of the public entities involved, California’s oversight approach to
oversight to help ensure that the date appears to be piecemeal with little system-level oversight
collective oversight eff orts produce to help ensure that the collective oversight eff orts produce
measureable, desirable results. measureable, desirable results.
Social Services created the closest thing to a comprehensive
plan that we were able to identify. Specifi cally, Social Services
summarized certain existing eff orts to oversee the prescription
of psychotropic medications to foster children as part of its
2015–2019 Child and Family Services Plan (state plan) required
California State Auditor Report 2015-131 53
August 2016
by the federal government. Within this state plan, Social Services
included a section covering the oversight of prescription
medicines, including psychotropic medications. Social Services
identifi ed four critical components of the State’s oversight of
prescription medicines:
• Public health nurses, who are responsible for ensuring that foster
children have current records of their prescribed medications
and that their medication information is documented in their
Health and Education Passports and in Social Services’ Child
Welfare Services/Case Management System (Social Services’ data
system), as we will discuss later in this chapter.
• Juvenile courts, which are responsible for authorizing
prescriptions for psychotropic medications for foster children.
• Th e Quality Improvement Project, which began in 2012 and whose
goals include reducing the inappropriate prescribing of multiple
psychotropic medications to foster children and supporting the
use of psychosocial services in lieu of medications.
• Outcome Measure 5F, which uses information recorded in Social
Services’ data system to track the proportion of foster children
for whom the courts have authorized psychotropic medications.
Although these components may play a role in the oversight of the
prescription of psychotropic medications to foster children, they
do not as a whole represent the sort of comprehensive, systemwide
eff ort that could best ensure that children do not receive these
medications unnecessarily.
Other states have taken more streamlined approaches to their
oversight of psychotropic medications prescribed to foster children.
According to its 2015–2019 Child and Family Services Plan, Texas
has dedicated specialized staff within its Department of Family
and Protective Services to coordinate and oversee health care
services for foster children, including a medical director who is
a child and adolescent psychiatrist and who coordinates with
Texas’ health care plan to ensure the appropriate prescribing of
psychotropic medications. In contrast to California, which provides In contrast to California, which
psychosocial services through multiple Medi-Cal mental health provides psychosocial services
plans, various Medi-Cal managed care plans, and fee-for-service through multiple Medi-Cal mental
providers, its Child and Family Services Plan states that Texas health plans, managed care plans,
contracts with a single health plan in which all Texas foster and fee-for-service providers, Texas
children are enrolled. Further, Texas requires the health plan to contracts with a single health plan
oversee the administration of psychotropic medications to foster for all foster children.
children to ensure compliance with that state’s requirements. Th ese
requirements identify utilization parameters, maximum dosage
amounts, warnings about side eff ects, and nine criteria that trigger
54 California State Auditor Report 2015-131
August 2016
further review of children’s clinical status and care. Further, Texas’
health plan also includes a psychotropic medications utilization
review process that allows it to identify and investigate physicians
who consistently prescribe outside the state’s utilization parameters.
Another state with a single public entity responsible for oversight
is Illinois. By law, the Illinois Department of Children and Family
Services (department) is responsible for consenting to the medical,
surgical, and psychiatric care for children and adolescents in its
custody. To meet these responsibilities related to the prescription
of psychotropic medications, the department established a
medication consent program. To support the consent process, the
department contracted with a university to independently review
all consent requests from clinicians to prescribe psychotropic
medications to children in their care. Furthermore, Illinois includes
in its Administrative Code—the equivalent of the California Code
of Regulations—guidelines regarding the use of psychotropic
medications for children in foster care. Th e Illinois guidelines
contain similar clinical parameters to those in the California
Guidelines for the Use of Psychotropic Medication with Children
and Youth in Foster Care (state guidelines). However, while Illinois’
guidelines are an appendix in its state regulations that specifi cally
direct Illinois’ child welfare department to oversee administration
of psychotropic medications, California simply makes its guidelines
available to counties for their use.
Foster Children’s Health and Education Passports Contained
Incomplete and Inaccurate Mental Health Data
Health and Education Passports are critical documents that
summarize health and education information for foster children.
Nonetheless, our review of 80 case fi les at the four counties we
visited—Los Angeles, Madera, Riverside, and Sonoma—found that
many children’s Health and Education Passports were incomplete
We found that many Health and inaccurate. For example, many of these Health and Education
and Education Passports did Passports did not include foster children’s psychosocial services
not include foster children's or authorized psychotropic medications. As a result, individuals
psychosocial services or authorized and agencies involved with the foster children may be unaware of
psychotropic medications. important components of their mental health histories. Absent
such information, caregivers, health care providers, judicial offi cers,
or county staff could make inappropriate or harmful health care
decisions, such as prescribing new psychotropic medications that
could interact harmfully with those a child is already receiving.
Furthermore, inaccurate and incomplete data hamper the State’s
ability to ensure that foster children only receive medications that
are safe and medically necessary.
California State Auditor Report 2015-131 55
August 2016
Counties Often Did Not Adequately or Accurately Record Information About
Foster Children’s Psychotropic Medications in Social Services’ Data System
State law requires that every foster child’s case plan
include a summary of his or her health and Health and Education Passport Information
education information, as shown in the text box.
State law specifi es the contents of a Health and Education
According to state law, county staff must provide the
Passport or summary required for each foster child. The
summary to the foster child’s caregivers within
relevant health information includes the following:
30 days of placement and update the summary
before each court date or within 48 hours of a change • Names and addresses for the child’s health care
in placement. Although state law allows counties to providers, including mental health care providers.
maintain the summary in the form of a Health and • Immunizations and allergies.
Education Passport, it does not require it; however,
• Known medical problems.
the four counties we visited all use Health and
Education Passports. According to Social Services, it • Current medications.
designed the Health and Education Passport to meet
• Past health problems and hospitalizations.
the State’s requirements. Social Services also stated
• Relevant mental health history.
that information in the Health and Education
Passports is for use by caregivers, social workers, • Known mental health conditions and medications.
probation offi cers, the courts, medical professionals,
• Any other relevant mental health information
and foster children.
concerning the child determined to be appropriate
by the director of the California Department of
Social Services issued an information notice to
Social Services.
all county welfare directors and chief probation
Source: California Welfare and Institution Code, Section 16010(a).
offi cers in March 2008 that included specifi c
requirements and instructions for properly entering
the necessary information into its data system, which
then populates the Health and Education Passports. Social Services
also established a process for updating the Health and Education
Passports, as Figure 4 on the following page shows. Specifi cally,
each printed Health and Education Passport instructs a caregiver
to bring it to all the foster child’s health visits and to remind health
care providers to add or correct information on it. It also instructs
the caregiver to give the updated or corrected Health and Education
Passport to the foster child’s social worker or probation offi cer during
his or her next visit. Th e social worker or probation offi cer should
then forward the updated or corrected information to a public
health nurse and then work with the public health nurse to enter the
information into Social Services’ data system.
Nonetheless, our review of the Health and Education Passports
for 80 foster children at the four counties we visited found that the
mental health information they contained—including psychotropic
medications and psychosocial services—was frequently incomplete
and inaccurate. Table 15 on page 57 summarizes the nature and
extent of the concerns we identifi ed. It shows that all 80 Health
and Education Passports we reviewed were missing information
about the corresponding psychosocial services the children should
have received for at least one psychotropic medication, as we
56 California State Auditor Report 2015-131
August 2016
describe in Chapter 1. Table 15 also shows that the Health and
Education Passports for 13 (16 percent) of these foster children
were missing at least one prescribed psychotropic medication that
the courts or parents had authorized. Ten of these 13 Health and
Education Passports were for foster children from two counties—
Los Angeles and Sonoma. In fact, the Health and Education Passport
for one of these foster children was missing three authorized
psychotropic medications.
Figure 4
Flow of Information to Update the California Department of Social Services’ Child Welfare Services/Case Management
System and to Populate Health and Education Passports for Children in Foster Care
Sources: California State Auditor’s review of the California Department of Social Services’ Child Welfare Services/Case Management System training
instructions, the Department of Health Care Services’ Plan and Fiscal Guidelines for the Health Care Program for Children in Foster Care, and Health and
Education Passports.
Note: The documents we examined do not specifi cally identify the persons who provide the Health and Education Passports to the caregivers.
In addition, 12 of the 80 Health and Education Passports were
missing at least one prescription for a psychotropic medication
that had been fi lled for the child but did not appear to have
been authorized by the courts or parents. In these instances,
the caregivers were apparently in possession of the prescribed
psychotropic medications, but the counties never obtained
court authorizations or parental consents. In fact, we identifi ed
California State Auditor Report 2015-131 57
August 2016
one instance in which a court denied a request to prescribe an
antidepressant to a foster child, but the pharmacist fi lled the
prescription for that medication shortly thereafter.
Table 15
Errors and Omissions in the Health and Education Passports for Children in Foster Care
FOSTER CHILDREN’S HEALTH AND EDUCATION PASSPORTS…
…WERE MISSING… …CONTAINED INACCURACIES SUCH AS…
…CORRESPONDING …AT LEAST ONE …AT LEAST ONE …INCORRECT COURT …LESS RECENT
PSYCHOSOCIAL AUTHORIZED FILLED PRESCRIPTION …INCORRECT START AUTHORIZATION INFORMATION THAN
SERVICES FOR AT LEAST PRESCRIBED FOR PSYCHOTROPIC DATES FOR AT LEAST DATES FOR AT LEAST CONTAINED IN THE CHILD
ONE PSYCHOTROPIC PSYCHOTROPIC MEDICATIONS THAT WERE ONE PSYCHOTROPIC ONE PSYCHOTROPIC WELFARE SERVICES/CASE
COUNTY MEDICATION MEDICATION NOT AUTHORIZED MEDICATION MEDICATION* MANAGEMENT SYSTEM
Los Angeles 20/20 6/20 3/20 20/20 6/18 1/20
Madera 20/20 0/20 2/20 20/20 4/20 0/20
Riverside 20/20 3/20 3/20 20/20 2/20 0/20
Sonoma 20/20 4/20 4/20 20/20 7/9 6/20
Totals 80/80 13/80 12/80 80/80 19/67 7/80
100% 16% 15% 100% 28% 9%
Sources: California State Auditor’s analysis of selected foster care case fi les at each of the counties’ welfare services departments and data obtained
from the Department of Health Care Services’ Paid Claims and Encounters System, the California Department of Social Services’ Child Welfare Services/
Case Management System, and matched Medi-Cal pharmacy data.
* Unless noted otherwise in the Table, we reviewed the case fi les for 20 foster children at each of the four counties, for a total of 80 foster children. For
two counties, we reviewed fewer than 20 case fi les because the courts had delegated authority to administer psychotropic medications to some
foster children’s parents, and therefore, this column is not applicable for these children.
Besides missing certain information, all 80 Health and Education
Passports we reviewed included inaccurate dates showing when
the foster children started taking psychotropic medications, as
shown in Table 15. In its 2008 information notice, Social Services
instructed counties to enter into its data system the actual date
that a foster child started taking a psychotropic medication.
However, instead of entering this date, the four counties we
visited entered the dates that prescribers saw children, the dates
that court authorizations were fi led, or the dates on which courts
authorized prescriptions. Moreover, the Health and Education
Passports for 19 (28 percent) of the 67 foster children for whom the
court authorized psychotropic medications had inaccurate court
authorization dates.
Table 15 also shows that seven foster children’s Health and
Education Passports were missing authorized psychotropic
medications even though Social Services’ data system included this
information. Six of these seven children were from Sonoma County.
For example, Social Services’ data system showed that one foster
child had two authorized psychotropic medications, both of which
were antipsychotics; however, the child’s Health and Education
Passport did not refl ect this information. We determined that
although Sonoma County staff had entered information about the
58 California State Auditor Report 2015-131
August 2016
six foster children’s psychotropic medications into Social Services’
data system, they did not follow Social Services’ instructions to
have the data system update the children’s Health and Education
Passports. In fact, in the above example, Sonoma County had not
updated the foster child’s Health and Education Passport in more
than 10 years. In contrast, Riverside County, which had no such
errors, provides written instructions to its staff on how to properly
update Health and Education Passports after entering new medical
information into Social Services’ data system.
Finally, Social Services’ data system includes a fi eld for county staff
to log the date when they provide the Health and Education
Passports to caregivers. Th is fi eld was blank in the records for
49 (61 percent) of the 80 foster children we examined. It is therefore
unclear whether county staff actually provided the Health and
Education Passports to these caregivers. We noted that Los Angeles
and Riverside counties were responsible for 37 of the 49 case fi les
with blank fi elds. Without these completed fi elds in Social Services’
data system, the State lacks information to ensure that counties
provided caregivers with critical information about foster
children’s health.
Selected Responsibilities of Two General Factors Appear to Have Consistently
Foster Care Public Health Nurses Contributed to Foster Children’s Incomplete Health
and Education Passports
• Work with child welfare case workers to coordinate health
care services, including psychosocial services.
We determined that two general factors may
• Serve as a liaison with health care professionals. have contributed to foster children’s incomplete
Health and Education Passports: the counties’
• Document that each child receives initial and follow-up
health screenings that meet reasonable standards of insuffi cient number of public health nurses and
medical practice. a lack of information sharing among county
departments. As described earlier, public health
• Collect health information and other relevant data on each
nurses work with social workers and probation
foster child as available, including mental health services.
offi cers to enter and update foster children’s
• Participate in medical care planning and coordinating health and medical information in Social Services’
for each foster child, which may include facilitating the
data system. Th e public health nurses are part
acquisition of any necessary court authorizations for
of the Health Care Program for Children in
procedures or medications, as well as monitoring and
Foster Care (Health Program), a public health
providing oversight of psychotropic medications.
nursing program that is located in county child
• Provide follow-up contact to assess each foster child’s welfare services agencies and county probation
progress in meeting treatment goals. departments. Th e Health Program provides
• Assist nonminor dependents in making informed decisions public health nursing expertise in meeting the
about their health care, specifi cally helping them assume medical, dental, behavioral, and developmental
responsibility for their ongoing health care management health needs of children in out-of-home
while transitioning out of foster care. placements or foster care. State law identifi es the
public health nurses’ responsibilities, as shown in
Source: Welfare and Institutions Code, Section 16501.3.
the text box.
California State Auditor Report 2015-131 59
August 2016
Social Services’ inclusion of public health nurses and the
Health Program in its state plan for 2015–2019 demonstrates
the signifi cance the State places on their role in overseeing
psychotropic medications prescribed to foster children. In this
federally required plan—which we describe in the Introduction—
Social Services stated that public health nurses, in consultation and
collaboration with others, are responsible for ensuring that every
foster child has a current record of prescribed medications and for
documenting medication information in the Health and Education
Passports. Social Services also stated that the Health Program
provides assurance that counties continue to identify and address
foster children’s physical and mental health needs.
However, the public health nurses at the four counties we visited Limited staff resources and the need
indicated that limited staff resources and the need to address to address foster children’s serious
foster children’s serious medical conditions constrain their ability medical conditions are asserted
to maintain accurate and complete data in Social Services’ data to be two reasons that constrain
system, which is then refl ected in inaccurate and incomplete Health public health nurses' ability to
and Education Passports. For example, one public health nurse maintain accurate and complete
explained that she spent an estimated eight hours just to arrange an data in Social Services’ data system.
emergency root canal surgery for one foster child. She stated that
foster children with threatening or serious medical conditions take
precedence over basic medical data entries to update the Health
and Education Passports.
Th e statements from the public health nurses are consistent with the
ratio of public health nurses to foster children within each county.
Documents issued by both Social Services and Health Care Services
from around the time of the Health Program’s original implementation
in 2000 indicate that it intended to maintain an ideal ratio of one
public health nurse per 200 foster children. However, Health Care
Services’ information from February 2016 showed that only 13 of
California’s 58 counties had public health nurse-to-foster-children
ratios at or below 1-to-200. Further, the ratios for the four counties we
visited ranged from 1-to-252 to 1-to-413.
Counties could improve these caseload ratios by funding additional
public health nurses. Federal law states that the federal government
will cover 75 percent of the costs for skilled professional medical
personnel, such as public health nurses, as well as 75 percent of
the cost for the medical personnel’s necessary support staff . Th ese
support staff could enter information into the Health and Education
Passports, freeing the public health nurses to oversee the support
staff ’s work and to perform their other, more pressing responsibilities.
However, counties may not be obligated to implement Social
Services’ directives to address inaccurate and incomplete mental
health information in Social Services’ data system by taking actions
such as hiring additional Health Program staff . As discussed in the
60 California State Auditor Report 2015-131
August 2016
Introduction, realignment laws enacted in 2011 and 2012 moved
program and fi scal responsibility for foster care to the counties,
leaving Social Services with the role of providing oversight, training,
and technical assistance to the counties. Around the same time,
California voters enacted Proposition 30, which states that the
counties are not obligated to implement new state laws, regulations,
or administrative directives that increase local costs to administer
child welfare services that were transferred to them as a result of
the realignment laws, unless the State provides additional annual
funding to pay for the increased costs. As a result, Social Services
cannot simply issue directions and expect the counties to take steps
to correct the data in its data system; instead, Social Services and
the counties must reach agreement on a plan to improve the health
information in Social Services’ data system and on acceptable
funding sources—likely from both the counties and the State—if
that plan results in additional costs for the counties.
Another reason for incomplete Health and Education Passports
is a lack of information sharing among the diff erent county
departments involved with foster children who receive psychosocial
Although the counties appear services, including psychotropic medications. Although the
to maintain records pertaining counties appear to maintain records pertaining to foster children’s
to foster children’s psychosocial psychosocial services, that information is split among separate
services, that information is county departments, which do not always share information
split among separate county with each other. For instance, staff at two of the four counties we
departments, which do not always visited cited concerns over health information privacy laws as an
share information with each other. impediment to the sharing of information about foster children’s
psychosocial services by county departments of mental health
with county child welfare departments. In fact, according to the
medical director of Sonoma County’s Division of Behavioral
Health, clearer guidance from the State as to what psychosocial
services information can or cannot be shared is necessary; he stated
that federal and state laws governing such information sharing
are subject to interpretation and the California courts take very
seriously the right to confi dentiality and privacy of psychosocial
services information.
However, according to a deputy director at Social Services and
the chief medical information offi cer at Health Care Services, the
federal Health Insurance Portability and Accountability Act
(HIPAA), California’s Confi dentiality of Medical Information Act,
and other state medical privacy laws do not prevent entities from
sharing certain summary level information about foster children’s
psychosocial services for purposes of care coordination. Both
the chief medical information offi cer at Health Care Services
and the deputy director at Social Services stated that they would
be amenable to issuing guidance to counties regarding the
sharing of information to help ensure more complete Health and
Education Passports.
California State Auditor Report 2015-131 61
August 2016
As we mentioned in Chapter 1, the Judicial Council of California
(Judicial Council) adopted new and revised forms—which became
eff ective in July 2016—to be used in the court authorization process
for foster children’s psychotropic medications. Th e Judicial Council
also revised its court rules to allow counties to develop their own
processes to share information from the new forms with public
health nurses. As a result, the use of the new forms may help
the public health nurses obtain information on foster children’s
psychosocial services, which they or support staff can then include
in Social Services’ data system and in foster children’s Health and
Education Passports. Such changes could mitigate some of the
problems that the lack of information sharing has likely caused in
the past.
The State’s and Counties’ Lack of Reliable Data Has Impeded Their
Oversight of Psychotropic Medications for Foster Children
As discussed previously, Social Services’ data system contains Social Services’ data system does
incomplete and inaccurate mental health information related not accurately record whether
to foster children. It does not accurately record whether foster foster children have been prescribed
children have been prescribed psychotropic medications, how psychotropic medications, how
many psychotropic medications they were prescribed, or whether many medications were prescribed,
maximum daily dosages were within acceptable limits. Further, or whether maximum daily dosages
using the data system, we were unable to determine whether foster were within acceptable limits.
children had follow-up visits with their prescribers or other health
care providers within 30 days after starting new psychotropic
medications and whether they received psychosocial services before
or concurrent with their psychotropic medications. Finally, the
data system does not accurately and consistently record whether
counties obtained court or parental authorizations before foster
children received psychotropic medications.
Th ese incomplete and inaccurate data can hinder county and state
oversight of psychotropic medications prescribed to foster children.
Social workers, probation offi cers, caregivers, public health nurses,
health care providers, and others at the county level use the health
information in Social Services’ data system and in the foster
children’s Health and Education Passports to assist in the provision
of appropriate mental health care to foster children. If this health
information is inaccurate or incomplete, these individuals could
make decisions that are less than optimal or that could even result
in harm to these children.
In addition to potentially hampering county-level coordination and
oversight of foster children’s mental health care, inaccurate
and incomplete information in Social Services’ data system may
also impede the State’s ability to oversee psychotropic medications
prescribed to foster children. Social Services uses information
from its data system for several purposes. For instance, it provides
62 California State Auditor Report 2015-131
August 2016
data from its system to the California Child Welfare Indicators
Project to allow policymakers, child welfare workers, researchers,
and the public access to information on California’s child welfare
system.13 However, users could draw inaccurate conclusions if they
relied only on this information. For example, Measure 5F—which
captures the number of foster children authorized for psychotropic
medications recorded in Social Services’ data system—does not
accurately refl ect the number of foster children with prescriptions
for psychotropic medications because county staff have not entered
all court or parental authorization information into the data system.
Th e State’s ability to identify foster children who receive
psychotropic medication prescriptions has improved since
various state agencies and other government entities—including
some counties—entered a data-sharing agreement in April 2015.
Among other things, this data-sharing agreement between Health
Care Services, Social Services, and other government entities
allows them to share confi dential data about foster children’s
psychosocial services and prescriptions. For example, Health Care
Services used this agreement to share Medi-Cal pharmacy data
about psychotropic medications with Social Services so Social
Services could identify which foster children have prescriptions for
psychotropic medications. Because this data-sharing agreement is
still relatively new, Social Services and Health Care Services are still
working to improve the links between their diff erent data systems.
However, even with these improvements, county and state
stakeholders are likely to continue to lack the accurate, complete
information they need to make decisions or to analyze whether
improvements occur over time. As discussed, Social Services’ data are
Health Care Services’ data do not inaccurate and incomplete. However, Health Care Services’ data also
refl ect psychosocial services or cannot paint a complete picture of foster children’s psychosocial
psychotropic medications for foster services and medications because, as shown in Figure 5, the data do
children for which Medi-Cal did not refl ect those psychosocial services or psychotropic medications
not pay. for which Medi-Cal did not pay and, as mentioned in Chapter 1,
Health Care Services' procedure codes do not capture precisely the
extent to which psychosocial services are provided to foster children.
For example, a program manager at Sonoma County’s Family, Youth
and Children Division stated that the county paid for therapy services
for three of the 20 foster children whose case fi les we reviewed;
thus, Health Care Services’ data did not refl ect these services.
Because neither Social Services nor Health Care Services has
complete information on foster children’s psychosocial services and
psychotropic medications, combining their data will likely continue
to result in an inaccurate summary. Consequently, state and county
oversight of psychotropic medications administered to foster children
13 The California Child Welfare Indicators Project is a collaborative venture between the University of
California, Berkeley School of Social Work and Social Services that makes available child welfare
administrative data to policymakers, child welfare workers, and the public on a website.
California State Auditor Report 2015-131 63
August 2016
is likely to continue to be limited by weaknesses in the available data
until Social Services successfully works with the counties to improve
its data system.
Figure 5
Gaps in the State’s Data Related to the Prescription of Psychotropic Medications to Children in Foster Care
State Data for Foster Care Medications and Services
Other Health Care Providers
California Department of Department of
Social Services’ Health Care Services’ Non-Medi-Cal-Reimbursed
(Social Services) (Health Care Services) Services
Source Child Welfare Services / Medi-Cal Data Systems
Case Management System
• Psychotropic medication
• Psychotropic medication prescriptions
• Court authorization or prescriptions
parental consent for the use • Psychosocial services
• Psychosocial services
of psychotropic medications
• Medication management
Information • Psychiatric diagnoses • Medication management services
services
FOSTER CHILDREN’S HEALTH CARE INFORMATION
Incomplete Other psychosocial services,
psychotropic medications,
information on
and medication
foster children
management services
Result
Sources: California State Auditor’s analysis of the Social Services’ Child Welfare Services/Case Management System, Health Care Services’ Medi-Cal data,
and interviews with county offi cials.
Until Recently, the State’s County-Level Reviews Included Only Minimal
Examination of Psychotropic Medications Prescribed to Foster Children
As discussed in the Introduction, Social Services and Health
Care Services took steps starting in 2012 to address the issue of
psychotropic medications prescribed to foster children. However,
the eff ectiveness of the practices that the two departments
developed are largely dependent upon the counties’ willingness
to implement those practices—which many counties have not yet
done. Further, neither Social Services nor Health Care Services
included examinations of the prescription of psychotropic
medications to foster children as part of their periodic reviews at
the county level until recently. Consequently, the State has lacked
assurance that the counties’ monitoring of this issue adequately
protects the best interests of foster children.
64 California State Auditor Report 2015-131
August 2016
In response to heightened national awareness
regarding psychotropic medications prescribed to
Quality Improvement Project
foster children, Social Services and Health Care
Educational and Informational Materials
Services established the Quality Improvement
California Guidelines for the Use of Psychotropic Project in 2012. Although it does not have offi cial
Medication with Children and Youth in Foster Care: monitoring duties, the Quality Improvement
Released jointly by the California Department of Social Project has since produced educational and
Services and the Department of Health Care Services,
informational materials—as shown in the text
the document describes best practices for the treatment
box—to help assure the safe and appropriate
of children in out-of-home care who may require
prescribing and monitoring of psychotropic
psychotropic medications.
medications prescribed to foster children.
Questions to Ask About Medications: A document to help
foster children, parents, and caregivers to improve their skills Additionally, the Quality Improvement Project
and knowledge about side eff ects and adverse symptoms
devised ways in which the two departments and
related to medications.
counties, under their data-sharing agreement,
Foster Youth Mental Health Bill of Rights: A document could use data results to aid in the oversight
to educate foster children, parents, and caregivers of psychotropic medications prescribed to
about the rights of foster children as they pertain to foster children. For instance, since May 2015,
psychotropic medications. Social Services has distributed to counties
quarterly reconciliation reports that included case
Sources: California Department of Social Services’ All County
Information Notice I-36-15—issued May 2015—and website. numbers of foster children who had paid Medi-Cal
claims for psychotropic medications but no prior
or concurrent authorizations recorded in Social
Service’s data system. Our review of these reports
for the four counties we visited indicated that the counties used them
to resolve possible discrepancies. For example, Los Angeles County’s
fi rst reconciliation report identifi ed 558 possible discrepancies.
Its reconciliation report two quarters later listed only 240, a
reduction of 318. Also, Social Services will provide more detailed
case information, including foster children’s names, identifi cation
numbers, medication names and dates, and placement types to those
counties that sign on to the data-sharing agreement.
Although these and other practices we examined can help
counties to ensure that providers properly prescribe psychotropic
medications to foster children, the counties do not universally use
them. For example, we found that counties did not always use the
educational and informational materials the Quality Improvement
Project produced. Furthermore, Social Services told us in May 2016
that only 19 of California’s 58 counties—including Madera
and Sonoma—had signed on to the data-sharing agreement.
Consequently, the Quality Improvement Project’s eff orts to date
have not resulted in widespread assurance that the State’s and
counties’ collective oversight and monitoring mechanisms actually
produce measureable, desirable results.
Until recently, the State’s actual monitoring mechanisms for overseeing
child welfare systems and the provision of health care services at the
county level included only minimal examinations of psychotropic
California State Auditor Report 2015-131 65
August 2016
medications prescribed to foster children. Social Services and Health
Care Services conduct at least three diff erent types of periodic reviews
at the county level to examine diff erent aspects of each county’s child
welfare system or health care and mental health service operations. We
summarize these reviews in Table 16. Because the two departments
have not included substantive examinations of the provision of
psychotropic medications to foster children as part of these periodic
reviews in the past, they missed opportunities to obtain critical
information from more in-depth, county-by-county reviews of this
issue. However, as of March 2016, Social Services and Health Care
Services began collecting from the counties certain information about
the provision of these medications.
Table 16
Types of County Reviews
PSYCHOTROPIC
CASE FILE MEDICATIONS AND
ENTITIES PERFORMING ENTITIES PURPOSE FREQUENCY REVIEW FOSTER CARE INCLUDED
REVIEW TYPE THE REVIEW REVIEWED OF REVIEW OF REVIEW INCLUDED AS PART OF REVIEW RESULTS OF REVIEW
California Child Collaboration County child To strengthen the Ongoing. Yes, Yes, starting County
and Family between the welfare accountability However, counties starting in 2008 and self-assessments,
Services Review California departments system used are to prepare in 2015. expanded in 2014. system improvement
Department of and probation in the State to and submit plans, and annual
Social Services placement monitor and assess self-assessments progress reports
(Social Services) agencies. the quality of and system linked on Social
and county services provided improvement Services’ website.
child welfare on behalf of plans every
departments maltreated children. fi ve years and
and probation progress reports
placement annually.
agencies.
Program Department County Medi-Cal Verify that county Triennial. Yes. Yes, starting in County Medi-Cal
Oversight and of Health Care mental health Medi-Cal mental fi scal year 2015–16. mental health plans’
Compliance Services (Health plans. health plans submissions to
Review Care Services). provided medically Health Care Services
necessary services of plans of correction
in compliance with for any items out of
state regulations complance.
and the contract
between Health
Care Services and
the plan.
External Quality Health Care County Medi-Cal To evaluate the Annual. No. Not substantively. Annual reports
Reviews Services, via managed care quality, access, linked on Health Care
contracts with plans and county and timeliness of Services’ website.
private vendors. Medi-Cal mental health care services
health plans. off ered to Medi-Cal
benefi ciaries
through Medi-Cal
plans.
Sources: Federal and state laws and regulations, documents obtained from Social Services and Health Care Services, and interviews with staff of Social Services.
66 California State Auditor Report 2015-131
August 2016
One of the State’s oversight mechanisms is Social Services’
California Child and Family Services Review (California review).
Social Services implemented the California review in 2004 in
response to a state law requiring it to monitor county child welfare
systems’ performance, including foster care. According to Social
Services, this review is an enhanced version of the federal Child
and Family Services Review, through which the U.S. Department
of Health and Human Services reviews each state’s child welfare
system to ensure that it provides quality services to children and
families. Th e California review contains more measures than
the federal review and has a primary focus on measuring each
county child welfare system’s performance in the areas of safety,
permanence, and family well-being. Th e State’s goal for the
California review is to strengthen the accountability system it uses
to monitor and assess the quality of services provided to maltreated
children. According to Social Services, the review establishes core
outcomes that are central to maintaining an eff ective system of
child welfare services.
Th e California review is an ongoing, cyclical process that requires
counties every fi ve years to submit self-assessments in which they
review their child welfare and probation offi ce placement programs to
determine the eff ectiveness of their current practices, programs, and
resources. Th ey must also submit system improvement plans every
fi ve years, which are operational agreements between the counties and
Social Services that outline how counties plan to improve their system
of care for children and families and address priority needs within
the child welfare services system. Finally, the counties must prepare
and submit annual progress reports to Social Services that provide a
written analysis assessing whether their system improvement plans
are achieving the desired results.
As part of the California review, the California Child Welfare
Indicators Project publishes on its website data on all 58 counties’
child welfare systems’ performance related to specifi ed outcome
measures. Social Services also makes the data available on its
website. With these measures, counties can identify areas in which
they could improve performance. Currently, only one measure—
Measure 5F—addresses the number of foster children authorized to
receive psychotropic medications. As previously discussed, we found
a number of weaknesses in the information this measure provides.
As of January 2014, Social
Services expanded the county Further, until 2014, the county self-assessment component of
self-assessment reporting Social Services’ California reviews did not specifi cally address
requirements to include a psychotropic medications prescribed to foster children other than
description and analysis of how the what was required for Measure 5F. As of January 2014, Social Services
counties monitor the administration expanded the self-assessment reporting requirements to include a
of prescription drugs, including description and analysis of how the counties monitor the appropriate
psychotropic medications. administration of prescription medications, including psychotropic
California State Auditor Report 2015-131 67
August 2016
medications for foster children. Th e most recent self-assessment
reports for the four counties we visited are all dated before 2014,
before implementation of the new requirement. Although the
four counties have yet to fulfi ll this specifi c requirement, all have
written procedures associated with the court’s consideration of
requests to authorize prescriptions of psychotropic medications to
foster children.
In addition, Sonoma County was the only county of the four to address Sonoma County was the only
psychotropic medications as an area of needed improvement in its county of the four to address
most recent system improvement plan for 2014 to 2019. In the plan, psychotropic medications as an
Sonoma noted that, with the exception of two counties with very small area of needed improvement in its
populations of foster children, it had the highest rate of foster children most recent system improvement
authorized for psychotropic medications: more than 24 percent in the plan for 2014 to 2019.
fourth quarter of 2012, or nearly double the statewide rate at that time.
Consequently, the plan stated that Sonoma’s child welfare department
would identify the causes of the high rate and develop monitoring
processes to reduce by 5 percent the number of youth authorized for
psychotropic medications. Although a subsequent annual progress
report did not identify the causes for its high rate, it mentioned that
Sonoma was implementing a number of steps to reduce the number
of foster children prescribed psychotropic medications. Th ese steps
included engaging county partners in conversation about the problem,
implementing an internal review process for court authorization
requests for psychotropic prescriptions, and providing training on the
issue for all its social workers.
Th e State also monitors county mental health care plans (Medi-Cal
mental health plans) through triennial program oversight and
compliance reviews. Health Care Services conducts these triennial
reviews, which verify that the Medi-Cal mental health plans
provide medically necessary services to benefi ciaries in compliance
both with the terms of their contracts with Health Care Services
and with state and federal laws and regulations. However, the
review protocol for fi scal year 2014–15—which was essentially
a checklist more than 90 pages long containing questions for
which Health Care Services seeks answers—did not include any
questions regarding psychotropic medications for foster children.
Health Care Services recently took a step toward ensuring that its
triennial reviews better address this issue in the future. Specifi cally,
its review protocol for fi scal year 2015–16 includes three questions
on the prescription of psychotropic medications to foster children.
A third state mechanism for monitoring counties’ provision of
health care is Health Care Services’ annual external quality review
(external review) of local Medi-Cal health plans. In accordance
with federal law and regulations, Health Care Services must
contract with third-party vendors to conduct external reviews
that examine Medi-Cal benefi ciaries’ access to timely health care
68 California State Auditor Report 2015-131
August 2016
services as well as the quality of their outcomes under county
mental health care plans and county Medi-Cal managed care plans
(Medi-Cal managed care plans). Health Care Services contracts
with two organizations to conduct these external reviews and
includes links to the organizations’ reports on its website. However,
the reports for the most recent annual external reviews for the
Medi-Cal mental health plans and Medi-Cal managed care plans for
the four counties we visited did not include substantive information
regarding psychotropic medications prescribed to foster children.
Although external reviews annually examine the counties’ Medi-Cal
mental health plans and Medi-Cal managed care plans, the assistant
chief of the Medical Review Branch within Health Care Services’
Audits and Investigations Division indicated that the State has
no similar oversight mechanism in place for health professionals
who provide psychosocial services and then bill Medi-Cal via the
fee-for-service approach. While more Medi-Cal benefi ciaries are
enrolling in managed care plans, foster children have the option to
receive health care services from fee-for-service providers instead.
Health Care Services is responsible for signing up and screening
these providers. However, according to the assistant chief of the
Medical Review Branch, the only oversight Health Care Services
performs related to this type of provider involves identifying
appropriate billing based on medical necessity criteria and federal
and state reimbursement guidelines.
The three types of county-level Th e three types of county-level reviews that Social Services and
reviews that Social Services and Health Care Services perform present an opportunity for the
Health Care Services perform departments to gather fi rst-hand information regarding the counties’
present an opportunity to gather administration of psychotropic medications to foster children. Th ese
fi rst-hand information regarding reviews could allow Social Services and Health Care Services to
the counties’ administration identify relevant defi ciencies in this area and work with counties
of psychotropic medications to to resolve those defi ciencies. Further, using the relevant results of
foster children. these reviews in conjunction with complete and accurate state data,
Social Services, Health Care Services, and their county partners
could consider whether to modify their oversight structures to better
ensure that providers only prescribe psychotropic medications to
foster children when reasonably necessary.
The State Has Not Proactively Overseen Physicians Who Prescribe
Psychotropic Medications for Foster Children
Although the State has mechanisms in place for reacting to
complaints about physicians who may have inappropriately
prescribed psychotropic medications to foster children, it does
not currently take routine proactive steps to identify and correct
inappropriate prescribing practices. Th e State oversees physicians
through the Medical Board, which is responsible for issuing
California State Auditor Report 2015-131 69
August 2016
physicians’ licenses, investigating complaints, and imposing
discipline. Its disciplinary actions may include administrative
citations, fi nes, or license revocation. However, as of February 2016,
its executive director stated that the Medical Board had not
received any complaints against physicians for inappropriately
prescribing psychotropic medications to foster children. Given the
nature and extent of the issues we identifi ed in Chapter 1 related to
psychotropic medications, we believe that the lack of complaints
to the Medical Board may suggest that this reactive approach alone
is not suffi cient to help ensure that physicians properly prescribe
psychotropic medications to foster children.
Although the State also has other reactive methods through which
it can monitor physicians who prescribe psychotropic medications
to foster children, it is unclear whether these methods provide
adequate oversight. For instance, state law requires Social Services
to establish a foster care ombudsman’s offi ce to disseminate
information on the rights of foster children and to investigate
and attempt to resolve complaints made by or on behalf of foster
children related to their care, placement, or services. Nonetheless,
according to a consultant in the foster care ombudsman’s offi ce,
a review of a sample of child welfare complaints over a four-year
period showed that the offi ce had not received complaints
regarding children being overprescribed psychotropic medications.
Similarly, state regulations allow Health Care Services to designate
a Medi-Cal managed care ombudsman to investigate and resolve
complaints between Medi-Cal benefi ciaries and their managed
care health plans. However, the chief of Health Care Services’
Managed Care Operations Division told us that the managed care
ombudsman’s offi ce does not investigate complaints regarding
inappropriate prescribing of psychotropic medications to foster
children and would refer any such complainants to another
appropriate program.
Consequently, we believe that the State’s reactive approach for We believe the State’s reactive
overseeing physicians should be supplemented by more proactive approach for overseeing physicians
steps to better ensure that physicians who prescribe psychotropic should be supplemented by more
medications to foster children adhere to applicable guidelines. proactive steps to better ensure
Although the Medical Board is trying to take proactive steps, its that physicians who prescribe
progress has been slow. Specifi cally, in April 2015 the Medical psychotropic medications
Board entered into an agreement with Health Care Services to foster children adhere to
and Social Services to obtain pharmacy claims data for all foster applicable guidelines.
children who were or had been on three or more psychotropic
medications for 90 days or longer. Th e Medical Board’s executive
director stated that her staff had planned to analyze these data and
investigate those physicians who exhibited inappropriate patterns of
prescribing psychotropic medications to foster children. However,
even though the Medical Board received these data in May 2015,
70 California State Auditor Report 2015-131
August 2016
the executive director explained in February 2016 that the board
had not yet been able to use it to identify physicians with potentially
inappropriate prescribing habits.
Th e executive director attributed the delay to a number of causes.
Specifi cally, she stated that the Medical Board was unable to
contract with a consultant to analyze the data until November 2015
because it took longer than expected to identify an appropriate,
available expert in the Sacramento area. She further stated that in
late January 2016, the consultant reported to the Medical Board that
the data were inadequate to perform the desired assessment. Th e
consultant presented a list of additional information necessary to
perform the desired analysis, such as each child’s targeted diagnosis
and weight, and each medication’s dosage and frequency. In
February 2016, the Medical Board met with Health Care Services
and Social Services to request the additional information. Health
Care Services responded in March 2016, stating that its claims
system does not capture data for the targeted diagnoses, dosages, or
frequency of the medications but that it could provide other data
fi elds as substitutes. Health Care Services also said that Social
Services could provide each child’s weight to the extent its data
system captured that information. Th e Medical Board requested
these substitute data fi elds but, according to the executive director,
was still waiting as of April 2016 to hear from the
two departments.
Off -label Use of
Because the Medical Board has not yet received
Prescription Medications by Children
the necessary information from Health Care
According to studies and other documents that we Services and Social Services, it does not know
examined, physicians may prescribe medications for when it will be able to complete this project.
off -label uses, which are any uses that are not indicated on However, its executive director asserted that if this
the medications’ approved drug labels. Federal regulations project is successful in identifying physicians who
state that any prescription medication approved by the may have inappropriately prescribed psychotropic
U.S. Food and Drug Administration (FDA) must contain medications to foster children, the Medical Board
a drug label that identifi es its approved uses, including
will continue working with Health Care Services
the target population, diagnosis, dosages, and method
and Social Services to review their data on a
of administration. According to the FDA, most medicines
regular basis.
prescribed for children have not been tested in children and,
by necessity, doctors have routinely prescribed medications
for off -label use in children. However, the safety and
Health Care Services Does Not Ensure That
eff ectiveness of a medication may or may not extend to all
Pharmacists Obtain Its Approval Before They
age groups or diagnoses that were not tested, which could
pose additional risks to a patient prescribed a medication for Dispense Psychotropic Medications to Foster
off -label purposes. Nevertheless, according to the American Children for Off -Label Uses
Academy of Child and Adolescent Psychiatry, it is ethical,
appropriate, and consistent with general medical practice to Health Care Services has not consistently ensured
prescribe medication off -label when clinically indicated. that pharmacists obtain its approval before they
dispense psychotropic medications to foster
Sources: California State Auditor’s review of the FDA’s regulations
and website and of studies and other documents related to children for purposes other than those indicated
off -label use of medications.
on the medications’ product labels. As the text box
describes, such uses of prescription medications
California State Auditor Report 2015-131 71
August 2016
are considered off -label because they do not have the approval of
the U.S. Food and Drug Administration (FDA). State regulations
require pharmacists to obtain approved treatment authorization
requests (TARs) before dispensing any medication, including
psychotropic medications, to be used for off -label purposes, except
in cases of emergency. According to an American Bar Association
2011 Practice and Policy Brief, more than 75 percent of psychotropic
medication use by children and adolescents is likely prescribed for
off -label purposes. However, our review found that few pharmacists
had obtained TARs when dispensing these medications to
foster children.
Health Care Services’ staff pharmacists review and adjudicate TARs,
either approving the requests, denying them, or deferring them in
order to gather more information from the health care providers—
including the prescribing physicians—before making decisions.
According to the chief of its Clinical Assurance and Administrative
Support Division, Health Care Services’ staff pharmacists look at the
type of medication and the child’s diagnosis, and then evaluate
the following questions as part of each TAR review:
• Whether the intended use is FDA-approved.
• Whether the usage is age-appropriate.
• Whether the regular and daily dosage amounts are appropriate
for a child’s age and size.
• Whether the medication is medically necessary.
• Whether the medication is in the same pharmaceutical class as
any other medications the child is receiving.
• In the case of antipsychotic medications, whether the child is
receiving metabolic monitoring as part of monitoring side eff ects.
State regulations allow Health Care Services to authorize the State regulations allow Health Care
off -label use of medications when that use represents reasonable Services to authorize the off -label
and current prescribing practice. For example, our review of the use of medications when that use
case fi les for 80 foster children at the four counties we visited represents a reasonable and current
showed that a number of physicians prescribed trazodone—an prescribing practice.
antidepressant—to treat insomnia. Although this usage is not
indicated on the medication’s FDA-approved label, a 2010 survey
of the members of the American Academy of Child and Adolescent
Psychiatry found that trazodone was the most commonly
prescribed insomnia medication for children with anxiety
disorders.14 Th e results of this survey suggest that prescribing
trazodone for insomnia is a reasonable off -label use.
14 The FDA-approved label for trazodone lists somnolence, or sleepiness, as an adverse reaction.
72 California State Auditor Report 2015-131
August 2016
Although the TARs review process provides an opportunity for
the State to ensure that foster children only receive psychotropic
medications for appropriate off -label purposes, our review found
that pharmacists rarely obtained approved TARs before dispensing
these medications. Specifi cally, when we reviewed the case fi les for
the 80 foster children, we identifi ed 45 children to whom physicians
prescribed at least one psychotropic medication for an off -label use.
However, when we asked Health Care Services to provide approved
TARs for the medications prescribed for these 45 foster children, it
Pharmacists failed to submit TARs, could not do so for 44 of them—even though some of the children
as state regulations require, in were receiving multiple psychotropic medications for off -label
nearly all instances of off -label use purposes. In other words, pharmacists failed to submit TARs, as
we reviewed. state regulations require, in nearly all instances of off -label use.
When it does not receive, review, and approve TARs for psychotropic
medications prescribed for off -label use by foster children, Health Care
Services has less assurance that physicians have properly prescribed
these medications. For example, in April 2014 a physician prescribed
Seroquel—an antipsychotic medication that the FDA approved to treat
symptoms of bipolar disorder in patients 10 and older or schizophrenia
in patients 13 and older—to a 15-year-old foster child. However, the
physician prescribed Seroquel to treat “mood dysregulation” with
symptoms of moodiness, irritability, anger problems, and arguing.
Although we concluded that this was an off -label use because the
documents did not mention bipolar disorder or schizophrenia, Health
Care Services could not provide an approved TAR.
Pharmacists rarely submitted TARs for off -label prescriptions in part
because Health Care Services has not programmed its claims system
to identify medications prescribed for off -label use in order to prompt
pharmacists to submit TARs. According to a section chief in its Clinical
Assurance and Administrative Services Division (section chief), Health
Care Services relies on pharmacists to voluntarily identify when
medications are prescribed for off -label uses. However, the section
chief acknowledged that few dispensing pharmacists devote the time
or have the information necessary to determine whether psychotropic
medications are prescribed for off -label purposes.
Th e chief of Health Care Services’ Pharmacy Benefi ts Division
(chief of pharmacy benefi ts) indicated that Health Care Services has
not programmed its claims system to identify off -label prescriptions
of psychotropic medications using children’s diagnoses because
prescriptions do not always include reliable diagnoses that indicate
the purposes of the medications. Without a diagnosis, the system
cannot determine whether a medication is being prescribed for
an off -label purpose. Th e chief of pharmacy benefi ts also stated
that for Health Care Services to use diagnoses to enforce the TAR
requirement for off -label purposes through its claims system,
California State Auditor Report 2015-131 73
August 2016
it would need to require TARs for all psychotropic medication
prescriptions, which would result in the submission of unnecessary
TARs and impede foster children’s access to medications they need.
However, even if Health Care Services cannot reasonably program Health Care Services' claims
its claims system to detect prescriptions for off -label uses based on system could better oversee the
diagnoses, the claims system could still trigger a TAR requirement for appropriateness of off -label use for
off -label use for psychotropic medications based on children’s ages, psychotropic medications by creating
just as it currently does for antipsychotic medications. Specifi cally, for a TAR process based on children’s ages.
service dates on or after October 1, 2014, Health Care Services began
requiring TARs for antipsychotic medications prescribed to Medi-Cal
benefi ciaries under age 18, including foster children. According to
the chief of pharmacy benefi ts, Health Care Services enacted this
TAR requirement to ensure the safe and appropriate use of these
medications by children given their severe and potentially irreversible
side eff ects. Health Care Services enforces this TAR requirement by
having its claims system automatically prompt pharmacists to submit
TARs whenever they submit claims for antipsychotic medications
prescribed to Medi-Cal benefi ciaries under 18 years old. Health Care
Services appears to properly enforce this TAR requirement; it provided
approved TARs for the 27 foster children we reviewed who had
prescriptions for antipsychotic medications fi lled after October 1, 2014.
Th e section chief noted that since implementing the TAR
requirement in October 2014, Health Care Services has denied some
TARs for antipsychotics that it deemed were medically inappropriate
for various reasons, including for too-high dosages, concurrent use
of multiple psychotropic medications, and off -label uses that were
not medically justifi ed. In fact, in April 2015 Health Care Services
denied a TAR for the foster child we mentioned previously who
had been prescribed Seroquel—an antipsychotic medication—for
an off -label use. According to the section chief, the claims system
required the TAR because of the patient’s age, which allowed Health
Care Services to request additional information—including the
child’s specifi c diagnosis, the clinical justifi cation for the medication,
and evidence of metabolic monitoring—to assess the medication’s
appropriateness. According to the section chief, the pharmacist did
not provide the requested information within 30 business days, so
Health Care Services automatically denied the TAR.
Although Health Care Services may not be able to ensure that it
reviews all off -label uses of psychotropic medications by foster
children, we believe it can better oversee the appropriateness of
some of these medications by creating a TAR process similar to the
one it uses to for antipsychotic medications but focused specifi cally
on children’s ages. Of the 45 psychotropic medications we identifi ed
from the case fi les we reviewed, 19—or 42 percent—were not
FDA-approved for any use by patients under age 18 as of March 2016.
74 California State Auditor Report 2015-131
August 2016
Th e chief of pharmacy benefi ts agreed that Health Care Services
should consider programming its claims system to trigger TAR
requirements for these psychotropic medications based on the
patients’ ages. He also stated that Health Care Services should
evaluate alternative tools and procedures to identify off -label use of
medications and better enforce compliance with TAR requirements.
For example, he stated Health Care Services could consider
developing a process through which its Audits and Investigations
Division could include off -label TARs in its retail pharmacy audits.
Finally, as discussed earlier, the Judicial Council recently
adopted new and revised forms to request court authorization
of psychotropic medications prescribed to foster children. Th ese
forms now require physicians to describe why they prescribed
psychotropic medications not approved for a child this age. County
staff can use this information to better ensure that foster children
were properly prescribed psychotropic medications.
Recommendations
Legislature
To improve the State’s and counties’ oversight of psychotropic
medications prescribed to foster children, the Legislature should
require Social Services to collaborate with its county partners and
other relevant stakeholders to develop and implement a reasonable
oversight structure that addresses, at a minimum, the concerns
identifi ed in this audit report.
To improve the State’s oversight of physicians who prescribe
psychotropic medications to foster children, the Legislature
should require the Medical Board to analyze Health Care Services’
and Social Services data in order to identify physicians who may
have inappropriately prescribed psychotropic medications to
foster children. If this initial analysis successfully identifi es such
physicians, the Legislature should require the Medical Board to
periodically perform the same or similar analyses in the future.
Further, the Legislature should require Health Care Services and
Social Services to provide periodically to the Medical Board the
data necessary to perform these analyses.
California Department of Social Services
To improve the oversight of psychotropic medications prescribed to
foster children, Social Services should collaborate with the counties
and other relevant stakeholders—including Health Care Services, as
California State Auditor Report 2015-131 75
August 2016
necessary—to develop and implement a reasonable oversight structure
that ensures the coordination of the State’s and counties’ various
oversight mechanisms as well as the accuracy and completeness of
the information in Social Services’ data system. Th is structure should
include at least the following items:
• Identifi cation of the specifi c oversight responsibilities to be
performed by the various state and local government agencies.
• An agreement on how county staff such as social workers, probation
offi cers, and public health nurses will use printed Health and
Education Passports to obtain foster children’s necessary mental
health information—including psychotropic medications and
psychosocial services—for inclusion in Social Services’ data system.
• A plan to ensure that counties have suffi cient staff available to
enter foster children’s mental health information into Social
Services’ data system and the resources to pay for those staff .
• An agreement on the specifi c information related to psychotropic
medication—including but not limited to the medication name,
maximum daily dosage, and court authorization date—and
psychosocial services and medication follow-up appointment
information that county staff must enter into Social Services’
data system for inclusion in foster children’s Health and
Education Passports.
• Specifi c directions from Social Services regarding the correct
medication start dates and court authorization dates counties
should include in its data system and foster children’s Health and
Education Passports.
• An agreement on the training or guidance Social Services should
provide to county staff members working with Social Services’
data system to ensure that they know how to completely and
accurately update foster children’s Health and Education Passports.
• An agreement on how the counties will use information on the
new authorization forms that the Judicial Council approved
to better oversee the prescription of psychotropic medications to
foster children.
• An agreement regarding how counties will implement, use,
or disseminate the educational and informational materials
the Quality Improvement Project has produced, including the
California Guidelines for the Use of Psychotropic Medication
with Children and Youth in Foster Care, Questions to Ask About
Medications, and the Foster Youth Mental Health Bill of Rights.
76 California State Auditor Report 2015-131
August 2016
• An agreement on the specifi c measures and the best available
sources of data the State and counties will use to oversee foster
children prescribed psychotropic medications, including
psychosocial services and medication follow-up appointments.
• An agreement on how the State and counties will oversee
psychotropic medications prescribed to foster children by
fee-for-service providers who are not affi liated with county
Medi-Cal mental health plans.
• An agreement on the extent of information related to psychotropic
medications prescribed to foster children that counties will include
in the self-assessments, system improvement plans, and annual
progress reports they develop as part of Social Services’ California
Child and Family Services Reviews.
• An agreement on the extent of the information related to
psychotropic medications prescribed to foster children that
counties will include in their responses to Health Care Services’
reviews, including its county Medi-Cal mental health plan
compliance reviews and external quality reviews.
California Department of Social Services and the Department of
Health Care Services
To ensure that the Medical Board can promptly complete its
analysis to identify physicians who may have inappropriately
prescribed psychotropic medications to foster children,
Social Services and Health Care Services should continue to work
with the Medical Board and its consultant to meet their data needs.
If the Medical Board’s analysis is able to identify these physicians,
Social Services and Health Care Services should enter into an
agreement with the Medical Board to provide the information the
Medical Board needs to perform similar analyses in the future.
Department of Health Care Services
To increase the State’s assurance that foster children do not
receive medically inappropriate or unnecessary psychotropic
medications, Health Care Services should devise and implement
within six months methods to better enforce its prior authorization
requirement for the off -label use of psychotropic medications.
For example, Health Care Services should revise its claims
system to automatically prompt pharmacists to submit treatment
authorization requests when fi lling prescriptions for Medi-Cal
benefi ciaries under age 18 when the prescribed psychotropic
medications have no FDA-approved pediatric uses. Furthermore,
California State Auditor Report 2015-131 77
August 2016
as part of its collaboration with Social Services and the counties to
develop and implement a reasonable oversight structure, Health
Care Services should determine whether information from the
Judicial Council’s revised court authorization forms would help it
better enforce its prior authorization requirements.
Medical Board of California
To ensure that physicians do not inappropriately prescribe
psychotropic medications to foster children, the Medical Board
should take the following steps:
• Within 60 days, obtain and analyze the data from Health Care
Services and Social Services to identify physicians who may
have inappropriately prescribed psychotropic medications for
foster children.
• Following the completion of this analysis, take the appropriate
follow-up actions that it deems necessary, including the
investigation of physicians identifi ed in its analysis.
• To the extent that its analysis is able to identify physicians who
may have inappropriately prescribed psychotropic medications
to foster children, the Medical Board should enter into an
agreement with Health Care Services and Social Services within
six months of completing its initial review to periodically obtain
the data necessary to perform the same or similar analyses.
78 California State Auditor Report 2015-131
August 2016
We conducted this audit under the authority vested in the California State Auditor by Section 8543
et seq. of the California Government Code and according to generally accepted government auditing
standards. Th ose standards require that we plan and perform the audit to obtain suffi cient, appropriate
evidence to provide a reasonable basis for our fi ndings and conclusions based on our audit objectives
specifi ed in the Scope and Methodology section of the report. We believe that the evidence obtained
provides a reasonable basis for our fi ndings and conclusions based on our audit objectives.
Respectfully submitted,
ELAINE M. HOWLE, CPA
State Auditor
Date: August 23, 2016
Staff : Mike Tilden, CPA, Audit Principal
Dale A. Carlson, MPA, CGFM
Michelle J. Sanders
Oswin Chan, MPP, CIA
Nisha Chandra
Molly Hogan, MPP
Hunter Wang
IT Audits: Michelle J. Baur, CISA, Audit Principal
Lindsay M. Harris, MBA, CISA
Richard W. Fry, MPA, ACDA
Legal Counsel: J. Christopher Dawson, Sr. Staff Counsel
For questions regarding the contents of this report, please contact
Margarita Fernández, Chief of Public Aff airs, at 916.445.0255.
California State Auditor Report 2015-131 79
August 2016
Appendix
SUMMARY TABLES SHOWING STATEWIDE AND COUNTY
DATA REGARDING PSYCHOTROPIC MEDICATIONS
PRESCRIBED TO FOSTER CHILDREN
As part of our review of psychotropic medications prescribed to
children in foster care (foster children), we analyzed data obtained
from the California Department of Social Services’ (Social Services)
Child Welfare Services/Case Management System and Medi-Cal
pharmacy data from the Department of Health Care Services
(Health Care Services). We present the results of our analysis that
pertain to the four counties we visited in Chapter 1 and Chapter 2.
Th e following tables summarize the results of our analysis for the
State as a whole and for each of California’s 58 counties. To protect
individual privacy, we omitted results of 10 foster children or fewer.
Table A-1, beginning on the following page, shows the number of
foster children in California and the number and proportion
of those foster children with fi lled prescriptions for psychotropic
medications for three fi scal years. As this Table shows, the number
of foster children in California increased from fi scal year 2012–13
through 2014–15, while the number of foster children with fi lled
prescriptions for psychotropic medications decreased over the
same time period. Data for the counties included in the Table
showed varying trends.
August
2016
80
California
State
Auditor
Report
2015-131
Table A-1
Number and Proportion of Children in Foster Care With Filled Psychotropic Medication Prescriptions During Fiscal Years 2012–13 Through 2014–15,
Statewide and by County
FOSTER CHILDREN FOSTER CHILDREN WITH FILLED PRESCRIPTIONS FOR PSYCHOTROPIC MEDICATIONS
FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415 FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415
PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF
FOSTER CHILDREN FOSTER CHILDREN FOSTER CHILDREN FOSTER CHILDREN IN FOSTER CHILDREN IN FOSTER CHILDREN IN
NUMBER STATEWIDE NUMBER STATEWIDE NUMBER STATEWIDE NUMBER THE STATE/COUNTY NUMBER THE STATE/COUNTY NUMBER THE STATE/COUNTY
Statewide 77,043 100.0% 78,859 100.0% 79,166 100.0% 10,048 13.0% 9,707 12.3% 9,317 11.8%
Counties
Alameda 2,048 2.7% 2,001 2.5% 1,939 2.4% 384 18.8% 323 16.1% 298 15.4%
Amador 64 0.1 75 0.1 90 0.1 12 18.8 12 16.0 17 18.9
Butte 647 0.8 610 0.8 643 0.8 111 17.2 85 13.9 76 11.8
Calaveras 140 0.2 205 0.3 190 0.2 * * 22 10.7 26 13.7
Contra Costa 1,435 1.9 1,450 1.8 1,454 1.8 236 16.4 221 15.2 215 14.8
Del Norte 136 0.2 144 0.2 137 0.2 18 13.2 16 11.1 14 10.2
El Dorado 428 0.6 418 0.5 398 0.5 59 13.8 64 15.3 69 17.3
Fresno 2,258 2.9 2,408 3.1 2,534 3.2 225 10.0 234 9.7 246 9.7
Glenn 88 0.1 119 0.2 95 0.1 11 12.5 17 14.3 12 12.6
Humboldt 330 0.4 366 0.5 444 0.6 43 13.0 38 10.4 43 9.7
Imperial 403 0.5 452 0.6 517 0.7 50 12.4 68 15.0 75 14.5
Kern 2,185 2.8 2,105 2.7 2,190 2.8 251 11.5 253 12.0 249 11.4
Kings 582 0.8 611 0.8 761 1.0 51 8.8 46 7.5 51 6.7
Lake 165 0.2 164 0.2 186 0.2 32 19.4 34 20.7 33 17.7
Lassen 111 0.1 129 0.2 113 0.1 * * 18 14.0 17 15.0
Los Angeles 27,100 35.2 27,577 35.0 27,466 34.7 3,487 12.9 3,267 11.8 3,194 11.6
Madera 393 0.5 443 0.6 427 0.5 24 6.1 23 5.2 21 4.9
Marin 150 0.2 137 0.2 142 0.2 18 12.0 14 10.2 20 14.1
Mariposa 43 0.1 33 0.0 14 0.0 11 25.6 * * * *
Mendocino 327 0.4 354 0.4 343 0.4 52 15.9 55 15.5 48 14.0
Merced 845 1.1 883 1.1 788 1.0 90 10.7 85 9.6 81 10.3
Monterey 495 0.6 520 0.7 573 0.7 107 21.6 116 22.3 94 16.4
Napa 181 0.2 196 0.2 208 0.3 34 18.8 36 18.4 30 14.4
Nevada 145 0.2 129 0.2 118 0.1 30 20.7 16 12.4 18 15.3
continued on next page . . .
August
2016
California
State
Auditor
Report
2015-131
81
FOSTER CHILDREN FOSTER CHILDREN WITH FILLED PRESCRIPTIONS FOR PSYCHOTROPIC MEDICATIONS
FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415 FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415
PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF
FOSTER CHILDREN FOSTER CHILDREN FOSTER CHILDREN FOSTER CHILDREN IN FOSTER CHILDREN IN FOSTER CHILDREN IN
NUMBER STATEWIDE NUMBER STATEWIDE NUMBER STATEWIDE NUMBER THE STATE/COUNTY NUMBER THE STATE/COUNTY NUMBER THE STATE/COUNTY
Orange 3,126 4.1% 3,024 3.8% 2,923 3.7% 322 10.3% 301 10.0% 257 8.8%
Placer 406 0.5 445 0.6 424 0.5 51 12.6 57 12.8 56 13.2
Plumas 91 0.1 71 0.1 79 0.1 * * * * 12 15.2
Riverside 5,673 7.4 6,093 7.7 6,191 7.8 558 9.8 600 9.8 595 9.6
Sacramento 3,062 4.0 3,394 4.3 3,436 4.3 442 14.4 456 13.4 424 12.3
San Bernardino 5,457 7.1 5,789 7.3 6,378 8.1 695 12.7 680 11.7 660 10.3
San Diego 4,662 6.1 4,412 5.6 4,239 5.4 590 12.7 548 12.4 475 11.2
San Francisco 1,256 1.6 1,180 1.5 1,088 1.4 203 16.2 183 15.5 150 13.8
San Joaquin 1,641 2.1 1,834 2.3 1,820 2.3 253 15.4 269 14.7 248 13.6
San Luis Obispo 549 0.7 492 0.6 460 0.6 92 16.8 86 17.5 79 17.2
San Mateo 437 0.6 387 0.5 386 0.5 66 15.1 66 17.1 69 17.9
Santa Barbara 776 1.0 749 0.9 672 0.8 111 14.3 102 13.6 103 15.3
Santa Clara 1,628 2.1 1,685 2.1 1,689 2.1 205 12.6 205 12.2 213 12.6
Santa Cruz 419 0.5 407 0.5 377 0.5 47 11.2 56 13.8 43 11.4
Shasta 765 1.0 769 1.0 708 0.9 100 13.1 113 14.7 96 13.6
Siskiyou 175 0.2 173 0.2 157 0.2 32 18.3 27 15.6 20 12.7
Solano 516 0.7 515 0.7 564 0.7 84 16.3 86 16.7 85 15.1
Sonoma 733 1.0 680 0.9 616 0.8 173 23.6 142 20.9 140 22.7
Stanislaus 919 1.2 958 1.2 875 1.1 120 13.1 116 12.1 117 13.4
Sutter 188 0.2 172 0.2 182 0.2 35 18.6 40 23.3 36 19.8
Tehama 259 0.3 280 0.4 311 0.4 37 14.3 41 14.6 33 10.6
Tulare 1,221 1.6 1,363 1.7 1,435 1.8 169 13.8 166 12.2 165 11.5
Tuolumne 145 0.2 157 0.2 170 0.2 16 11.0 * * 16 9.4
Ventura 1,198 1.6 1,243 1.6 1,213 1.5 185 15.4 167 13.4 153 12.6
Yolo 334 0.4 372 0.5 377 0.5 45 13.5 41 11.0 43 11.4
Yuba 196 0.3 224 0.3 275 0.3 27 13.8 36 16.1 40 14.5
Other counties* 512 0.7 462 0.6 351 0.4 29 5.7 30 6.5 * *
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System and matched Medi-Cal pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with aggregate data reporting guidelines issued by the
Department of Health Care Services.
82 California State Auditor Report 2015-131
August 2016
Table A-2 lists the number and proportion of fi lled psychotropic
medication prescriptions for foster children for three fi scal years.
Th is Table shows that the number of psychotropic medication
prescriptions statewide dropped from more than 110,000 in fi scal
year 2012–13 to about 95,750 in fi scal year 2014–15, a decrease of
13 percent. Similarly, all but 12 counties had a decrease in their
number of psychotropic medication prescriptions from fi scal
year 2012–13 through 2014–15.
Table A-2
Number and Proportion of Filled Psychotropic Medication Prescriptions for Children in Foster Care,
Statewide and by County
FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415
NUMBER PERCENT OF PRESCRIPTIONS NUMBER PERCENT OF PRESCRIPTIONS NUMBER PERCENT OF PRESCRIPTIONS
Statewide 110,014 100.0% 106,510 100.0% 95,748 100.0%
Counties
Alameda 3,751 3.4% 3,469 3.3% 3,097 3.2%
Alpine 0 NA 0 NA 0 NA
Amador 211 0.2 226 0.2 214 0.2
Butte 1,244 1.1 1,058 1.0 1,139 1.2
Calaveras 79 0.1 226 0.2 358 0.4
Colusa 55 0.0 50 0.0 68 0.1
Contra Costa 3,091 2.8 2,918 2.7 2,585 2.7
Del Norte 236 0.2 184 0.2 217 0.2
El Dorado 771 0.7 853 0.8 702 0.7
Fresno 2,443 2.2 2,566 2.4 2,582 2.7
Glenn 136 0.1 162 0.2 84 0.1
Humboldt 465 0.4 512 0.5 414 0.4
Imperial 362 0.3 488 0.5 576 0.6
Inyo 61 0.1 11 0.0 0 NA
Kern 3,373 3.1 3,105 2.9 2,804 2.9
Kings 552 0.5 533 0.5 606 0.6
Lake 462 0.4 464 0.4 424 0.4
Lassen 117 0.1 185 0.2 212 0.2
Los Angeles 33,825 30.7 31,208 29.3 29,894 31.2
Madera 231 0.2 275 0.3 158 0.2
Marin 189 0.2 150 0.1 146 0.2
Mariposa 108 0.1 60 0.1 34 0.0
Mendocino 724 0.7 690 0.6 426 0.4
Merced 1,336 1.2 1,220 1.1 850 0.9
Modoc 17 0.0 44 0.0 53 0.1
Mono 30 0.0 21 0.0 * *
Monterey 1,156 1.1 1,286 1.2 1,067 1.1
Napa 451 0.4 415 0.4 265 0.3
Nevada 365 0.3 181 0.2 212 0.2
California State Auditor Report 2015-131 83
August 2016
FISCAL YEAR 201213 FISCAL YEAR 201314 FISCAL YEAR 201415
NUMBER PERCENT OF PRESCRIPTIONS NUMBER PERCENT OF PRESCRIPTIONS NUMBER PERCENT OF PRESCRIPTIONS
Orange 3,576 3.3% 3,368 3.2% 2,795 2.9%
Placer 454 0.4 585 0.5 603 0.6
Plumas 67 0.1 79 0.1 95 0.1
Riverside 6,214 5.6 6,753 6.3 6,024 6.3
Sacramento 4,804 4.4 5,241 4.9 4,391 4.6
San Benito 37 0.0 69 0.1 105 0.1
San Bernardino 8,291 7.5 7,979 7.5 7,192 7.5
San Diego 7,122 6.5 6,718 6.3 4,898 5.1
San Francisco 2,071 1.9 2,076 1.9 1,749 1.8
San Joaquin 3,115 2.8 3,183 3.0 2,919 3.0
San Luis Obispo 1,098 1.0 966 0.9 977 1.0
San Mateo 759 0.7 746 0.7 607 0.6
Santa Barbara 1,424 1.3 1,248 1.2 1,185 1.2
Santa Clara 2,608 2.4 2,410 2.3 2,165 2.3
Santa Cruz 490 0.4 428 0.4 354 0.4
Shasta 1,183 1.1 1,187 1.1 760 0.8
Sierra 11 0.0 0 NA * *
Siskiyou 380 0.3 365 0.3 303 0.3
Solano 837 0.8 905 0.8 792 0.8
Sonoma 2,126 1.9 1,809 1.7 1,479 1.5
Stanislaus 1,215 1.1 1,072 1.0 1,138 1.2
Sutter 556 0.5 643 0.6 508 0.5
Tehama 306 0.3 432 0.4 266 0.3
Trinity 79 0.1 25 0.0 72 0.1
Tulare 2,109 1.9 2,212 2.1 1,913 2.0
Tuolumne 189 0.2 119 0.1 164 0.2
Ventura 2,133 1.9 2,298 2.2 2,057 2.1
Yolo 486 0.4 455 0.4 422 0.4
Yuba 432 0.4 579 0.5 613 0.6
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case Management
System and matched Medi-Cal pharmacy data.
Notes: The term foster children refers to children aged zero to 17 in the foster care system.
The average number of fi lled prescriptions per foster child may refl ect that some foster children received more than one type of psychotropic
medication. Alternatively, it may indicate that some foster children had paid prescriptions of a single medication fi lled a number of times during the
year (perhaps on a monthly or bimonthly basis).
NA = Not applicable.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
For Table A-3 beginning on the following page, we separated
the number and proportion of prescriptions for psychotropic
medications into fi ve diff erent categories for fi scal year 2014–15.
Th is Table shows that antidepressants and antipsychotics each
made up 35 percent or more of all psychotropic medication
prescriptions, and stimulants made up 26 percent. Th e last
two classifi cations—antianxiety medications and mood stabilizers—
were a very small proportion of the total psychotropic medication
prescriptions, with each representing 2 percent or less. In many
instances, county-level data mirrored the State’s results.
August
2016
84
California
State
Auditor
Report
2015-131
Table A-3
Number and Proportion of Filled Prescriptions for Psychotropic Medications for Children in Foster Care in Fiscal Year 2014–15 by Classifi cation, Statewide and by County
TOTAL NUMBER OF ANTIANXIETY MEDICATIONS ANTIDEPRESSANTS ANTIPSYCHOTICS MOOD STABILIZERS STIMULANTS
FILLED PRESCRIPTIONS
FOR PSYCHOTROPIC PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF
MEDICATIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS
Statewide 95,748 852 0.9% 34,586 36.1% 33,303 34.8% 1,898 2.0% 25,109 26.2%
Counties
Alameda 3,097 22 0.7% 1,229 39.7% 1,154 37.3% 81 2.6% 611 19.7%
Alpine 0 0 NA 0 NA 0 NA 0 NA 0 NA
Amador 214 0 NA 64 29.9 51 23.8 4 1.9 95 44.4
Butte 1,139 5 0.4 273 24.0 464 40.7 26 2.3 371 32.6
Calaveras 358 1 0.3 98 27.4 123 34.4 13 3.6 123 34.4
Colusa 68 0 NA 36 52.9 10 14.7 0 NA 22 32.4
Contra Costa 2,585 29 1.1 972 37.6 953 36.9 43 1.7 588 22.7
Del Norte 217 1 0.5 26 12.0 22 10.1 15 6.9 153 70.5
El Dorado 702 3 0.4 294 41.9 231 32.9 20 2.8 154 21.9
Fresno 2,582 31 1.2 472 18.3 1,025 39.7 27 1.0 1,027 39.8
Glenn 84 2 2.4 20 23.8 11 13.1 12 14.3 39 46.4
Humboldt 414 4 1.0 124 30.0 159 38.4 16 3.9 111 26.8
Imperial 576 1 0.2 167 29.0 151 26.2 17 3.0 240 41.7
Inyo 0 0 NA 0 NA 0 NA 0 NA 0 NA
Kern 2,804 18 0.6 1,234 44.0 908 32.4 35 1.2 609 21.7
Kings 606 5 0.8 109 18.0 190 31.4 0 NA 302 49.8
Lake 424 15 3.5 128 30.2 165 38.9 13 3.1 103 24.3
Lassen 212 0 NA 96 45.3 86 40.6 0 NA 30 14.2
Los Angeles 29,894 301 1.0 12,217 40.9 9,791 32.8 477 1.6 7,108 23.8
Madera 158 1 0.6 72 45.6 64 40.5 0 NA 21 13.3
Marin 146 6 4.1 53 36.3 44 30.1 0 NA 43 29.5
Mariposa 34 0 NA 12 35.3 9 26.5 5 14.7 8 23.5
Mendocino 426 10 2.3 117 27.5 143 33.6 36 8.5 120 28.2
Merced 850 1 0.1 289 34.0 299 35.2 12 1.4 249 29.3
Modoc 53 0 NA 33 62.3 20 37.7 0 NA 0 NA
Mono * * * * * * * * * * *
Monterey 1,067 8 0.7 504 47.2 270 25.3 0 NA 285 26.7
Napa 265 0 NA 85 32.1 92 34.7 0 NA 88 33.2
continued on next page . . .
August
2016
California
State
Auditor
Report
2015-131
85
TOTAL NUMBER OF ANTIANXIETY MEDICATIONS ANTIDEPRESSANTS ANTIPSYCHOTICS MOOD STABILIZERS STIMULANTS
FILLED PRESCRIPTIONS
FOR PSYCHOTROPIC PERCENT OF PERCENT OF PERCENT OF PERCENT OF PERCENT OF
MEDICATIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS NUMBER PRESCRIPTIONS
Nevada 212 1 0.5% 88 41.5% 32 15.1% 15 7.1% 76 35.8%
Orange 2,795 30 1.1 821 29.4 1,087 38.9 81 2.9 776 27.8
Placer 603 3 0.5 221 36.7 240 39.8 27 4.5 112 18.6
Plumas 95 0 NA 35 36.8 23 24.2 0 NA 37 38.9
Riverside 6,024 47 0.8 2,117 35.1 2,499 41.5 178 3.0 1,183 19.6
Sacramento 4,391 17 0.4 1,392 31.7 1,718 39.1 109 2.5 1,155 26.3
San Benito 105 0 NA 30 28.6 41 39.0 0 NA 34 32.4
San Bernardino 7,192 42 0.6 2,597 36.1 2,657 36.9 83 1.2 1,813 25.2
San Diego 4,898 70 1.4 1,736 35.4 1,487 30.4 87 1.8 1,518 31.0
San Francisco 1,749 11 0.6 672 38.4 525 30.0 70 4.0 471 26.9
San Joaquin 2,919 20 0.7 839 28.7 1,005 34.4 75 2.6 980 33.6
San Luis Obispo 977 17 1.7 256 26.2 371 38.0 47 4.8 286 29.3
San Mateo 607 7 1.2 291 47.9 206 33.9 8 1.3 95 15.7
Santa Barbara 1,185 4 0.3 351 29.6 433 36.5 5 0.4 392 33.1
Santa Clara 2,165 25 1.2 771 35.6 859 39.7 18 0.8 492 22.7
Santa Cruz 354 2 0.6 182 51.4 90 25.4 0 NA 80 22.6
Shasta 760 7 0.9 206 27.1 220 28.9 18 2.4 309 40.7
Sierra * * * * * * * * * * *
Siskiyou 303 7 2.3 73 24.1 139 45.9 24 7.9 60 19.8
Solano 792 5 0.6 257 32.4 315 39.8 4 0.5 211 26.6
Sonoma 1,479 25 1.7 622 42.1 559 37.8 45 3.0 228 15.4
Stanislaus 1,138 7 0.6 448 39.4 392 34.4 11 1.0 280 24.6
Sutter 508 1 0.2 107 21.1 239 47.0 3 0.6 158 31.1
Tehama 266 0 NA 78 29.3 76 28.6 0 NA 112 42.1
Trinity 72 0 NA 19 26.4 32 44.4 0 NA 21 29.2
Tulare 1,913 27 1.4 476 24.9 607 31.7 60 3.1 743 38.8
Tuolumne 164 0 NA 51 31.1 71 43.3 10 6.1 32 19.5
Ventura 2,057 1 0.0 788 38.3 515 25.0 28 1.4 725 35.2
Yolo 422 12 2.8 174 41.2 106 25.1 19 4.5 111 26.3
Yuba 613 0 NA 164 26.8 321 52.4 21 3.4 107 17.5
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System and matched Medi-Cal pharmacy data.
NA = Not applicable.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with aggregate data reporting guidelines issued by the Department of Health Care Services.
86 California State Auditor Report 2015-131
August 2016
Table A-4 shows the number and proportion of foster children
within certain age ranges who had psychotropic medication
prescriptions fi lled during fi scal year 2014–15. As indicated in
the Table, almost three-quarters of foster children with fi lled
prescriptions for psychotropic medications were aged 12 to 17.
County-level data mirrored the state results: most psychotropic
medications in each county were also prescribed to foster children
aged 12 to 17.
California State Auditor Report 2015-131 87
August 2016
Table A-4
Number and Proportion of Children in Foster Care With Prescriptions for Psychotropic Medications That Were Filled
in Fiscal Year 2014–15 by Age Range
AGE RANGE
FISCAL YEAR 201415 TOTAL 01* 25* 611 1217
NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 100.0% 17 0.2% 217 2.3% 2,604 27.9% 6,895 74.0%
Counties
Alameda 298 3.2% 44 14.8% 254 85.2%
Butte 76 0.8 31 40.8 50 65.8
Calaveras 26 0.3 11 42.3 17 65.4
Contra Costa 215 2.3 45 20.9 175 81.4
El Dorado 69 0.7 16 23.2 54 78.3
Fresno 246 2.6 84 34.1 168 68.3
Humboldt 43 0.5 12 27.9 31 72.1
Imperial 75 0.8 30 40.0 43 57.3
Kern 249 2.7 61 24.5 193 77.5
Kings 51 0.5 22 43.1 31 60.8
Los Angeles 3,194 34.3 924 28.9 2,336 73.1
Merced 81 0.9 18 22.2 62 76.5
Monterey 94 1.0 19 20.2 72 76.6
Orange 257 2.8 66 25.7 201 78.2
Placer 56 0.6 16 28.6 41 73.2
Riverside 595 6.4 165 27.7 440 73.9
Sacramento 424 4.6 100 23.6 335 79.0
San Bernardino 660 7.1 213 32.3 460 69.7
San Diego 475 5.1 130 27.4 348 73.3
San Francisco 150 1.6 46 30.7 115 76.7
San Joaquin 248 2.7 88 35.5 168 67.7
San Luis Obispo 79 0.8 20 25.3 58 73.4
San Mateo 69 0.7 13 18.8 58 84.1
Santa Barbara 103 1.1 36 35.0 71 68.9
Santa Clara 213 2.3 40 18.8 178 83.6
Shasta 96 1.0 42 43.8 59 61.5
Solano 85 0.9 20 23.5 70 82.4
Sonoma 140 1.5 21 15.0 121 86.4
Stanislaus 117 1.3 27 23.1 90 76.9
Sutter 36 0.4 13 36.1 25 69.4
Tehama 33 0.4 11 33.3 22 66.7
Tulare 165 1.8 64 38.8 97 58.8
Ventura 153 1.6 38 24.8 120 78.4
Yuba 40 0.4 16 40.0 28 70.0
Other counties 406 4.4 102 25.1 304 74.9
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case
Management System and matched Medi-Cal pharmacy data.
Notes: Totals may not add up to 100 percent because some children aged into a new age range during fi scal year 2014–15.
The term foster children refers to children aged zero to 17 in the foster care system.
* The 0–1 year and 2–5 years age ranges for each county contained 10 or fewer foster children in at least one of the two age ranges. To protect
individual privacy, we omitted all county data for these two columns.
88 California State Auditor Report 2015-131
August 2016
Table A-5 shows the number of foster children in each age range
who had fi lled antipsychotic medication prescriptions in fi scal
year 2014–15. Similar to Table A-4, the majority of foster children
with fi lled prescriptions for antipsychotic medications were
aged 12 to 17. Again, county-level data mirrored the state results.
Table A-5
Number and Proportion of Children in Foster Care With Prescriptions for Antipsychotic Psychotropic Medications
That Were Filled in Fiscal Year 2014–15 by Age Range
FOSTER CHILDREN WITH AGE RANGE
FILLED PRESCRIPTIONS FOR
NUMBER OF FOSTER CHILDREN
ANTIPSYCHOTICS 01* 25* 611 1217
WITH FILLED PRESCRIPTIONS FOR
PSYCHOTROPIC MEDICATIONS NUMBER PERCENT NUMBER NUMBER NUMBER NUMBER
Statewide 9,317 4,339 46.6% 1,069 3,380
Counties
Alameda 298 147 49.3% 20 127
Butte 76 44 57.9 18 30
Contra Costa 215 108 50.2 17 95
Fresno 246 108 43.9 25 84
Kern 249 122 49.0 26 98
Los Angeles 3,194 1,409 44.1 389 1,051
Orange 257 127 49.4 33 98
Riverside 595 342 57.5 82 271
Sacramento 424 214 50.5 39 178
San Bernardino 660 359 54.4 87 279
San Diego 475 190 40.0 34 160
San Francisco 150 56 37.3 21 40
San Joaquin 248 111 44.8 37 82
San Luis Obispo 79 47 59.5 13 34
Santa Barbara 103 49 47.6 17 35
Santa Clara 213 108 50.7 19 91
Shasta 96 32 33.3 12 21
Tulare 165 71 43.0 23 51
Yuba 40 29 72.5 13 20
Other counties 1,534 666 43.4 144 535
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case
Management System and matched Medi-Cal pharmacy data.
Notes: Total percentages may not add up to 100 percent because some children aged into a new age range during fi scal year 2014–15.
The term foster children refers to children aged zero to 17 in the foster care system.
* The 0-to-1 year and 2-to-5 years age ranges for each county and the State contained fewer than 10 foster children in at least one of the two age
ranges. To protect individual privacy, we omitted all data for these two columns.
California State Auditor Report 2015-131 89
August 2016
Table A-6 shows the number and proportion of foster children
in fi scal year 2014–15 who had fi lled prescriptions for more than
one psychotropic medication in the same class for antidepressants,
antipsychotics, and stimulants, the three most widely prescribed
classifi cations from Table A-3. Th e data refl ect that it is more
common for foster children to be on multiple antidepressants than
on multiple antipsychotics or multiple stimulants. Th e county-level
data show the same trend as the statewide data.
Table A-6
Number and Proportion of Children in Foster Care With Multiple Filled Psychotropic Medication Prescriptions From
the Same Class, Statewide and by County, Fiscal Year 2014–15
FOSTER CHILDREN WITH FILLED FOSTER CHILDREN WITH FILLED FOSTER CHILDREN WITH FILLED
TOTAL NUMBER OF
PRESCRIPTIONS FOR MORE THAN PRESCRIPTIONS FOR MORE THAN PRESCRIPTIONS FOR MORE THAN
FOSTER CHILDREN WITH
ONE ANTIDEPRESSANT* ONE ANTIPSYCHOTIC* ONE STIMULANT*
FILLED PSYCHOTROPIC
MEDICATION PRESCRIPTIONS NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 851 9.1% 330 3.5% 193 2.1%
Counties
Alameda 298 36 12.1% 13 4.4% † †
Contra Costa 215 21 9.8 † † † †
Fresno 246 † † 21 8.5 † †
Kern 249 63 25.3 14 5.6 † †
Los Angeles 3,194 267 8.4 69 2.2 42 1.3%
Monterey 94 14 14.9 † † † †
Orange 257 12 4.7 18 7.0 † †
Riverside 595 71 11.9 26 4.4 † †
Sacramento 424 25 5.9 21 5.0 † †
San Bernardino 660 86 13.0 13 2.0 † †
San Diego 475 37 7.8 19 4.0 13 2.7
San Joaquin 248 17 6.9 11 4.4 † †
Santa Clara 213 19 8.9 † † † †
Sonoma 140 25 17.9 † † † †
Tulare 165 † † † † 11 6.7
Ventura 153 22 14.4 † † 18 11.8
Other counties 1,691 116 6.9 72 4.3 45 2.7
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’ California Medicaid Management Information
System, data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System, and matched Medi-Cal
pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* For our analysis, we only considered foster children to be on more than one psychotropic medication if they received more than one psychotropic
medication within the same medication classifi cation for more than 30 days.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
90 California State Auditor Report 2015-131
August 2016
Table A-7 shows the number of foster children by age range in fi scal
year 2014–15 whose number of fi lled prescriptions for psychotropic
medications exceeded Social Services and Health Care Services’ guidelines
for the safe administration of psychotropic medications to foster children.
Table A-7
Number of Children in Foster Care With Filled Prescriptions for Psychotropic Medications That Exceeded the State's
Recommended Guidelines for Age Groups, Statewide and by County, Fiscal Year 2014–15
TOTAL NUMBER OF FOSTER CHILDREN AGE 05 FOSTER CHILDREN AGE 611 FOSTER CHILDREN AGE 1217
FOSTER CHILDREN PRESCRIBED PRESCRIBED MORE THAN ONE PRESCRIBED MORE THAN TWO PRESCRIBED MORE THAN THREE
PSYCHOTROPIC MEDICATIONS PSYCHOTROPIC MEDICATION* PSYCHOTROPIC MEDICATIONS* PSYCHOTROPIC MEDICATIONS*
Statewide 9,317 29 159 90
Counties
Kern 249 † 12 †
Los Angeles 3,194 † 34 14
Riverside 595 † † 11
San Bernardino 660 † 17 †
Other Counties 4,619 17 † 55
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’ California Medicaid Management
Information System, data obtained from the California Department of Social Services’ Child Welfare Services/Case Management System, and matched
Medi-Cal pharmacy data.
Notes: State guidelines recommend that children aged zero to 5 take no more than one psychotropic medication, children aged 6 to 11 take no more
than two psychotropic medications, and children aged 12 to 17 take no more than three psychotropic medications.
The term foster children refers to children aged zero to 17 in the foster care system.
* For our analysis, we considered foster children to be on multiple psychotropic medications when their prescriptions overlapped for more than
30 consecutive days.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
Table A-8 shows the number of foster children in fi scal year 2013–14
who did not have follow-up medical appointments within 30 days
after starting at least one new psychotropic medication. As the Table
indicates, more than 29 percent of foster children who started new
psychotropic medications did not have a corresponding Medi-Cal claim
for a follow-up medication service visit.
Table A-8
Number and Proportion of Children in Foster Care With New Psychotropic Medication
Prescriptions Filled in Fiscal Year 2013–14 Without a Corresponding Medi-Cal Claim
for a Follow-Up Medication Service Within 30 Days, Statewide and by County
NUMBER OF FOSTER CHILDREN WITH AT LEAST
ONE FILLED PRESCRIPTION FOR A NEW
PSYCHOTROPIC MEDICATION WITHOUT A
NUMBER OF FOSTER CHILDREN CORRESPONDING MEDICAL CLAIM FOR A
WITH NEW PSYCHOTROPIC FOLLOWUP MEDICATION SERVICE
MEDICATION PRESCRIPTIONS* NUMBER PERCENT
Statewide 6,471 1,881 29.1%
Counties
Alameda 220 73 33.2%
Butte 54 20 37.0
Calaveras 17 † †
Contra Costa 136 37 27.2%
California State Auditor Report 2015-131 91
August 2016
NUMBER OF FOSTER CHILDREN WITH AT LEAST
ONE FILLED PRESCRIPTION FOR A NEW
PSYCHOTROPIC MEDICATION WITHOUT A
NUMBER OF FOSTER CHILDREN CORRESPONDING MEDICAL CLAIM FOR A
WITH NEW PSYCHOTROPIC FOLLOWUP MEDICATION SERVICE
MEDICATION PRESCRIPTIONS* NUMBER PERCENT
Del Norte 12 † †
El Dorado 43 17 39.5
Fresno 156 63 40.4
Glenn 13 † †
Humboldt 28 † †
Imperial 60 39 65.0
Kern 158 58 36.7
Kings 31 17 54.8
Lake 20 † †
Lassen 16 † †
Los Angeles 2,252 334 14.8
Madera 17 † †
Mendocino 32 15 46.9
Merced 50 27 54.0
Monterey 62 23 37.1
Napa 26 15 57.7
Orange 186 45 24.2
Placer 39 13 33.3
Riverside 406 167 41.1
Sacramento 283 83 29.3
San Bernardino 454 228 50.2
San Diego 372 86 23.1
San Francisco 116 28 24.1
San Joaquin 160 60 37.5
San Luis Obispo 58 21 36.2
San Mateo 45 22 48.9
Santa Barbara 63 25 39.7
Santa Clara 125 27 21.6
Santa Cruz 42 13 31.0
Shasta 75 20 26.7
Siskiyou 20 † †
Solano 60 26 43.3
Sonoma 90 46 51.1
Stanislaus 80 39 48.8
Sutter 25 † †
Tehama 35 13 37.1
Tulare 101 30 29.7
Ventura 114 19 16.7
Yolo 25 12 48.0
Yuba 24 † †
Other counties 70 36 51.4
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’
Paid Claims and Encounters System, data obtained from the California Department of Social Services’
Child Welfare Services/Case Management System, and matched Medi-Cal pharmacy data.
Notes: The term foster children refers to children aged zero to 17 in the foster care system.
* We defi ned a new prescription as any prescription for a psychotropic medication that the child had
not been prescribed in the prior 120 days and, as discussed in the Scope and Methodology section on
page 17, we applied the National Committee for Quality Assurance's methodology for follow-up care.
† To protect individual privacy, we omitted this number because it would identify 10 or fewer foster
children. Such omission is in accordance with aggregate data reporting guidelines issued by the
Department of Health Care Services.
92 California State Auditor Report 2015-131
August 2016
Table A-9 shows the number of foster children in fi scal
year 2013–14 who had at least one instance in which they did
not receive psychosocial services within 30 days, either before or
after receiving a prescription for psychotropic medications. In
addition, Table A-9 shows the number of foster children in the
same fi scal year who had at least one instance in which they did
not receive psychosocial services within 180 days, either before or
after beginning a new prescription. As shown in the Table, between
3,965 and 7,489 (41 and 77 percent) of foster children statewide had
at least one instance in which they did not receive corresponding
psychosocial services within 30 days of receiving a prescription.
We report a range in the number of foster children who did not
receive psychosocial services to accommodate for diff erences in
the way the Department of Health Care Services and the National
Committee for Quality Assurance use procedure codes to defi ne
psychosocial services.
Further, when compiling statewide data, we found that Social
Services' data is not formatted in a way that allows us to defi nitively
identify if court authorizations or parental consents are associated
with a specifi c psychotropic medication. As a result, we analyzed
the statewide data to identify the frequency with which court
authorizations or parental consents existed for any medication and
if that approval was either 180 days before or 30 days after the date
the psychotropic medication prescription was fi lled. Table A-10
on page 94 shows the number and proportion of foster children in
fi scal year 2014–15 who had prescriptions fi lled for psychotropic
medications and the type of authorization they received. As the
data show, only 35 percent of the foster children statewide had
court authorizations or parental consents for all their psychotropic
medications. Th e other 65 percent were missing authorizations
or consents for at least one psychotropic medication. Further,
only 11 of the 35 counties shown had court authorizations or
parental consents rates of 50 percent or more for all psychotropic
medications prescribed for foster children.
Table A-9
Number of Children in Foster Care With Filled Prescriptions for Psychotropic
Medications Without a Corresponding Medi-Cal Claim for Psychosocial Services,
Statewide and by County,
Fiscal Year 2013–14
NUMBER OF FOSTER CHILDREN
FOSTER CHILDREN WITH WITH AT LEAST ONE INSTANCE OF NO SERVICE WITHIN...
FILLED PRESCRIPTIONS ...30 DAYS BEFORE ...180 DAYS BEFORE
FOR PSYCHOTROPIC OR AFTER FILLING OR AFTER FILLING
MEDICATIONS A PRESCRIPTION A PRESCRIPTION
Statewide 9,707 3,965–7,489 1,564–4,512
Counties
Alameda 323 134–242 44–131
California State Auditor Report 2015-131 93
August 2016
NUMBER OF FOSTER CHILDREN
FOSTER CHILDREN WITH WITH AT LEAST ONE INSTANCE OF NO SERVICE WITHIN...
FILLED PRESCRIPTIONS ...30 DAYS BEFORE ...180 DAYS BEFORE
FOR PSYCHOTROPIC OR AFTER FILLING OR AFTER FILLING
MEDICATIONS A PRESCRIPTION A PRESCRIPTION
Butte 85 44–* 14–65
Contra Costa 221 88–165 32–118
El Dorado 64 37–* 23–*
Fresno 234 118–193 59–118
Humboldt 38 17–* *–14
Imperial 68 47–* 21–56
Kern 253 124–210 48–134
Kings 46 33–* 15–33
Lake 34 *–* *–15
Los Angeles 3,267 742–2,185 204–994
Mendocino 55 25–* 14–43
Merced 85 53–73 24–50
Monterey 116 51–82 *–36
Napa 36 22–* 13–*
Orange 301 107–275 46–210
Placer 57 32–45 16–30
Riverside 600 385–556 146–363
Sacramento 456 196–367 80–225
San Bernardino 680 442–545 196–343
San Diego 548 206–349 92–224
San Francisco 183 59–103 26–42
San Joaquin 269 116–252 65–184
San Luis Obispo 86 37–63 18–31
San Mateo 66 31–* *–32
Santa Barbara 102 59–83 35–61
Santa Clara 205 73–180 27–118
Santa Cruz 56 16–43 *–23
Shasta 113 57–* 12–91
Siskiyou 27 *–* 12–*
Solano 86 40–* *–53
Sonoma 142 98–* 56–98
Stanislaus 116 60–103 29–76
Sutter 40 16–* *–20
Tehama 41 21–* *–*
Tulare 166 72–142 34–80
Ventura 167 44–124 16–74
Yolo 41 *–* 21–*
Yuba 36 20–* *–19
Other counties 198 131–175 61–137
Sources: California State Auditor’s analysis of data obtained from the Department of Health Care Services’
Paid Claims and Encounters System, data obtained from the California Department of Social Services’
Child Welfare Services/Case Management System, and matched Medi-Cal pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster
children. Such omission is in accordance with aggregate data reporting guidelines issued by the
Department of Health Care Services.
94 California State Auditor Report 2015-131
August 2016
Table A-10
Number and Proportion of Children in Foster Care With Filled Prescriptions for Psychotropic Medications by Type of
Consent Recorded in Social Services’ Data, Statewide and by County, Fiscal Year 2014–15
TYPES OF CONSENT
TOTAL NUMBER OF
FOSTER CHILDREN WITH NO COURT AUTHORIZATION
FILLED PRESCRIPTIONS FOR COURT AUTHORIZATION OR NO COURT AUTHORIZATION OR OR PARENTAL CONSENT
PSYCHOTROPIC MEDICATIONS PARENTAL CONSENT FOR ALL PARENTAL CONSENT FOR ANY FOR ONE OR MORE
IN FISCAL YEAR 201415 PSYCHOTROPIC MEDICATIONS PSYCHOTROPIC MEDICATIONS PSYCHOTROPIC MEDICATIONS
NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT
Statewide 9,317 100.0% 3,232 34.7% 3,448 37.0% 6,085 65.3%
Counties
Alameda 298 3.2% 39 13.1% 174 58.4% 259 86.9%
Butte 76 0.8 21 27.6 12 15.8 55 72.4
Fresno 246 2.6 141 57.3 58 23.6 105 42.7
Humboldt 43 0.5 28 65.1 13 30.2 15 34.9
Imperial 75 0.8 14 18.7 29 38.7 61 81.3
Kern 249 2.7 143 57.4 54 21.7 106 42.6
Kings 51 0.5 17 33.3 18 35.3 34 66.7
Lake 33 0.4 13 39.4 11 33.3 20 60.6
Los Angeles 3,194 34.3 920 28.8 1,475 46.2 2,274 71.2
Mendocino 48 0.5 25 52.1 * * 23 47.9
Merced 81 0.9 31 38.3 28 34.6 50 61.7
Monterey 94 1.0 57 60.6 * * 37 39.4
Napa 30 0.3 13 43.3 * * 17 56.7
Orange 257 2.8 106 41.2 51 19.8 151 58.8
Placer 56 0.6 16 28.6 24 42.9 40 71.4
Riverside 595 6.4 300 50.4 121 20.3 295 49.6
Sacramento 424 4.6 176 41.5 135 31.8 248 58.5
San Bernardino 660 7.1 227 34.4 201 30.5 433 65.6
San Diego 475 5.1 227 47.8 133 28.0 248 52.2
San Francisco 150 1.6 76 50.7 34 22.7 74 49.3
San Joaquin 248 2.7 108 43.5 54 21.8 140 56.5
San Luis Obispo 79 0.8 15 19.0 21 26.6 64 81.0
San Mateo 69 0.7 29 42.0 12 17.4 40 58.0
Santa Barbara 103 1.1 56 54.4 23 22.3 47 45.6
Santa Clara 213 2.3 50 23.5 69 32.4 163 76.5
Santa Cruz 43 0.5 18 41.9 15 34.9 25 58.1
Shasta 96 1.0 76 79.2 * * 20 20.8
Solano 85 0.9 29 34.1 33 38.8 56 65.9
Sonoma 140 1.5 31 22.1 65 46.4 109 77.9
Stanislaus 117 1.3 12 10.3 65 55.6 105 89.7
Sutter 36 0.4 21 58.3 * * 15 41.7
Tehama 33 0.4 13 39.4 * * 20 60.6
Tulare 165 1.8 17 10.3 73 44.2 148 89.7
Ventura 153 1.6 65 42.5 25 16.3 88 57.5
Yuba 40 0.4 23 57.5 * * 17 42.5
Other counties 562 6.0 79 14.1 369 65.7 483 85.9
Sources: California State Auditor’s analysis of data obtained from the California Department of Social Services’ Child Welfare Services/Case
Management System and matched Medi-Cal pharmacy data.
Note: The term foster children refers to children aged zero to 17 in the foster care system.
* To protect individual privacy, we omitted this number because it would identify 10 or fewer foster children. Such omission is in accordance with
aggregate data reporting guidelines issued by the Department of Health Care Services.
California State Auditor Report 2015-131 95
August 2016
*
* California State Auditor’s comment appears on page 103.
96 California State Auditor Report 2015-131
August 2016
California State Auditor Report 2015-131 97
August 2016
98 California State Auditor Report 2015-131
August 2016
California State Auditor Report 2015-131 99
August 2016
100 California State Auditor Report 2015-131
August 2016
1
California State Auditor Report 2015-131 101
August 2016
102 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 103
August 2016
Comment
CALIFORNIA STATE AUDITOR’S COMMENT ON THE
RESPONSE FROM THE CALIFORNIA DEPARTMENT OF
SOCIAL SERVICES
To provide clarity and perspective, we are commenting on the
response from the California Department of Social Services
(Social Services) to the audit. Th e number below corresponds to the
number we have placed in the margin of its response.
Our audit report did not “fail to acknowledge” measures 5a.1 (use 1
of psychotropic medications by foster children) and 5a.2 (use of
antipsychotic medications by foster children) as Social Services
asserts; we intentionally omitted them. On page 66 of our report,
we indicate that only one measure—5F—published on the website
for the California Child Welfare Indicators Project addresses the
number of foster children authorized to receive psychotropic
medications. Despite Social Services' statement that measures 5a.1
and 5a.2 have been published since October 2015, Social Services
waited until April 2016 to inform counties of their availability
through an all-county letter. In an all-county letter to county child
welfare directors and other county offi cials dated April 28, 2016,
Social Services mentioned that county child welfare and probation
agencies could view the results of these two measures at the
California Child Welfare Indicators Project website. Because the
contents of the all-county letter had no direct bearing on our report’s
fi ndings, conclusions, or recommendations, we opted to not mention
the two new measures.
104 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 105
August 2016
106 California State Auditor Report 2015-131
August 2016
California State Auditor Report 2015-131 107
August 2016
108 California State Auditor Report 2015-131
August 2016
California State Auditor Report 2015-131 109
August 2016
110 California State Auditor Report 2015-131
August 2016
California State Auditor Report 2015-131 111
August 2016
*
* California State Auditor’s comments begin on page 115.
112 California State Auditor Report 2015-131
August 2016
1
2
3
California State Auditor Report 2015-131 113
August 2016
4
5
6
114 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 115
August 2016
Comments
CALIFORNIA STATE AUDITOR’S COMMENTS ON THE
RESPONSE FROM LOS ANGELES COUNTY
To provide clarity and perspective, we are commenting on
Los Angeles County’s response to the audit. Th e numbers below
correspond to the numbers we have placed in the margin of
its response.
Although we appreciate Los Angeles County’s suggested wording 1
change, we believe that it does not diff er substantially from the
current wording of our recommendation.
Th e page numbers on Los Angeles County’s redacted draft copy of 2
the audit report do not correspond to the page numbers of the fi nal
audit report. Th e content Los Angeles County refers to appears on
page 38 of our fi nal report.
Los Angeles County appears to restate one of the key points from 3
Chapter 2 of our report; namely, certain psychosocial services
provided to foster children are not included in the State’s information,
including the Health and Education Passports. As we mention on
page 55 of our report, all 80 of the Health and Education Passports
we reviewed were missing information about the corresponding
psychosocial services foster children should have received for
at least one psychotropic medication. Furthermore, Figure 4 on
page 56 summarizes the process for providing updated information,
including psychosocial services, for the Child Welfare Services/
Case Management System operated by the California Department
of Social Services (Social Services) and the resulting Health and
Education Passports. A key source of that updated information is
the health care provider, regardless of where that provider works. In
fact, state law states that caregivers are responsible for obtaining and
maintaining accurate and thorough information from physicians to
be included as part of Health and Education Passports. Th erefore,
Los Angeles County’s statement underscores the need for counties to
ensure that caregivers and county staff are properly updating Health
and Education Passports with mental health information to give
counties a more accurate and up-to-date picture of foster children’s
mental health treatments.
We appreciate Los Angeles County’s acknowledgement of the 4
concern regarding unauthorized psychotropic medications
for foster children and its idea for a longer-term solution, a
concern that can be included as part of the discussions during
the collaboration between Social Services and the counties as we
recommend in Chapter 2. However, because it is not yet clear
whether or when such a solution may be implemented, counties
116 California State Auditor Report 2015-131
August 2016
need to take steps in the near term to better ensure that foster
children receive appropriate court authorizations or parental
consents for their psychotropic medications, as we recommend
on page 49.
5 We appreciate Los Angeles County’s acknowledgement of the
concern regarding weaknesses in Social Services’ data system and
its idea for a longer-term solution. We anticipate that Los Angeles
County can include this longer-term solution as part of the
discussions during the collaboration between Social Services and
the counties as we recommend in Chapter 2.
6 Los Angeles County appears to not fully understand our point
regarding public health nurses. We agree fully that public health
nurses should focus their unique skills on more pressing duties
and not on entering data into Social Services’ data system. Th at
is why we point out on page 59 of our report that the federal
government will cover 75 percent of the costs for necessary
support staff for skilled professional medical personnel like public
health nurses. Th ese support staff could enter information into
the Health and Education Passports, freeing public health nurses
to oversee the support staff ’s work and to perform other, more
pressing responsibilities.
California State Auditor Report 2015-131 117
August 2016
*
* California State Auditor’s comments begin on page 121.
118 California State Auditor Report 2015-131
August 2016
1
2
California State Auditor Report 2015-131 119
August 2016
3
120 California State Auditor Report 2015-131
August 2016
Blank page inserted for reproduction purposes only.
California State Auditor Report 2015-131 121
August 2016
Comments
CALIFORNIA STATE AUDITOR’S COMMENTS ON THE
RESPONSE FROM RIVERSIDE COUNTY
To provide clarity and perspective, we are commenting on
Riverside County’s response to the audit. The numbers below
correspond to the numbers we have placed in the margin of
its response.
Riverside County recommends in its response that we include 1
rehabilitation and case management services as services that
also meet our recommendation regarding the provision of
psychosocial services before or concurrent with foster children
receiving psychotropic medications. We, in fact, included
psychosocial rehabilitation in our analysis. As we mention on
page 41 of our report, we based this analysis on the defi nition of
psychosocial services contained in the Healthcare Eff ectiveness
Data and Information Set (HEDIS), a set of health care performance
measures used by more than 90 percent of the health care plans
in the United States. Although the HEDIS defi nition includes
psychosocial rehabilitation, it does not include case management.
We therefore stand by our methodology and the results we present
in our report.
Riverside County appears to restate one of the key points 2
from Chapter 2 of our report; namely, some quantities of
psychosocial services provided to foster children are invisible to
the county and the State. As we mention on page 55 of our report,
all 80 Health and Education Passports we reviewed were missing
information about the corresponding psychosocial services
foster children should have received for at least one psychotropic
medication. Furthermore, Figure 4 on page 56 summarizes the
process for providing updated information, including psychosocial
services, for the Child Welfare Services/Case Management System
operated by the California Department of Social Services and the
resulting Health and Education Passports. A key source of that
updated information is the health care provider, regardless of where
that provider works. In fact, state law states that caregivers are
responsible for obtaining and maintaining accurate and thorough
information from physicians to be included as part of Health and
Education Passports. Th erefore, Riverside County’s statement
underscores the need for counties to ensure that caregivers and
county staff are properly updating Health and Education Passports
with mental health information to give counties a more accurate
and up-to-date picture of foster children’s mental health treatments.
122 California State Auditor Report 2015-131
August 2016
Riverside County states that certain types of services fell outside 3
our defi nition of psychosocial services. As we mentioned earlier
under Comment 1, we analyzed those types of psychosocial
services included within the HEDIS defi nition. We included within
our analysis any HEDIS psychosocial service regardless of the
source—whether provided by group homes, foster family agencies,
or other provider types—when we saw evidence of those services in
the county’s or the State’s records. Furthermore, we did not include
services such as intensive care coordination and assessments
within our analysis because they are not mentioned in the HEDIS
defi nition of psychosocial services. We therefore stand by our
methodology and the results we present in the report.
California State Auditor Report 2015-131 123
August 2016
*
* California State Auditor’s comments begin on page 129.
124 California State Auditor Report 2015-131
August 2016
The County of Sonoma’s Response to
the California State Auditor Report on California’s Foster Care System *
The County of Sonoma appreciates the opportunity to respond to the draft of the State Auditor report
on California’s Foster Care System received on May 31, 2016.
The County was asked to respond to both the report’s statewide recommendations as well as those
specific to Sonoma County. These responses can be found in the pages that follow this introduction.
INTRODUCTION
Sonoma County is dedicated to protecting and promoting the safety, health and well-being of children
and teens in foster care. The County continues to develop and implement high-quality, responsive
programs that support foster youth. This vulnerable population can enter the foster care system for
many reasons, including physical or sexual abuse in the home, neglect, abandonment, or mental health
needs that are beyond the ability of caregivers to properly manage. Youth in the Juvenile Probation
system may also be placed in out-of-home care. Due to their experiences and the subsequent trauma
those experiences generate, these youth often need significant mental health support and treatment.
Providing effective services to these youth is a primary concern in Sonoma County and statewide.
In 2013, two years prior to the Auditors’ visit, Sonoma County identified that data showed higher
numbers of local foster children authorized to take psychotropic medications than the statewide
average. Addressing that issue became a high priority, as reflected the County’s 2014-19 System
Improvement Plan (SIP). Since then, the County has made system-wide changes to ensure that foster
youth receive clinically appropriate psychotropic medication. Among these changes, in July 2015, the
Sonoma County Human Services Department used prioritized funding to contract with an independent
psychiatrist who reviews the recommendations of the treating psychiatrist prior to the social worker
seeking court authorization for administration of psychotropic medication. It has been the County’s
intent to add this review to cases in which the court has delegated the authority to consent to
psychotropic medication to the child’s parent.
As another example, ongoing training for social work staff regarding best practices for psychotropic
medications, side effects and options treatment continues. Two areas of focus also include how to
clearly and effectively communicate with prescribing physicians and with foster youth regarding their
experience with those medications and their use and monitoring for potential side effects. Sonoma
County is proud of the services it provides to foster youth, including necessary mental health treatment.
Nonetheless, it welcomes outside reviews and input on ways to improve. The County intends to
implement all the recommendations of the State Auditor, as discussed more fully below. At the same
time, the County takes issue with some of the narrative in the audit report, and would like to address
those before turning to the recommendations.
Page 1 of 5
* California State Auditor’s comments begin on page 129.
California State Auditor Report 2015-131 125
August 2016
The audit report has underscored the need for a high-level of detail in documentation. Systematic and
consistent documentation is important to monitor and evaluate data, as noted in the audit report, and
Sonoma County has focused on improving this since 2014. Sonoma County acknowledges the
deficiencies in documentation described in the audit report and is working to improve its
documentation.
However, as the audit report notes, missing information does not mean that, in fact, foster children
were taking psychotropic medications in excessive doses or multiple medications in the same category.
Mental health treatment information is maintained by the treatment provider, and in order to 1
understand the treatment received by an individual foster youth, one must review the actual mental
health treatment record. We are concerned that many of the cases referred to in the report did not 2
reference the actual treatment decisions of the providers and the data for the audit was based less on
chart review and more on claims data.
In addition, these medications can only be prescribed to foster youth by medical professionals who have
standards to which they must adhere. Furthermore, the judicial system provides oversight, including
providing these foster youth with legal counsel, who meet frequently with the youth and advocate on
behalf of their client’s best interests.
We are confident that if the auditors had an opportunity to look deeper into each child’s records, they 1
would have found that Sonoma County foster youth receive clinically appropriate amounts and types of 2
psychotropic medication.
The audit report also gives the incorrect impression that Sonoma County foster youth are not provided 1
non-pharmacological interventions. This is untrue. Foster youth are provided mental health, substance
and other alternative services to pharmacological interventions before and/or concurrent with the
prescription of psychotropic medication as clinically indicated. This information is often documented in
contract, authorization and payments systems of the Human Services Department. The audit report
findings do not take these documentation realities into account. Information is also required to be kept 1
by licensed residential treatment providers and individual private practice psychiatrists. An audit of 2
these records would have supplemented the audit report with additional specific information.
In addition, the audit report gives the false impression that Sonoma County does not follow generally 3
accepted professional standards when prescribing psychoactive medication to foster care youth. In fact
Sonoma County prescribers (who treat serious and severe mental illnesses through the County Mental
Health Plan to youth in and outside the foster care system), are bound by and adhere to the prescribing 4
standards established by federal and state law governing county mental health plans. As the audit
report points out, Sonoma County’s policies were in need of updating, and the County has made those 5
updates. County policies now incorporate the most current version of the Los Angeles Department of
Mental Health, Parameters 3.8, for Use of Psychotropic Medication in Children and Adolescents and the
California Guidelines for the Use of Psychotropic Medication with Children and Youth in Foster Care
(including appendices A-D). If the recommended prescribing guidelines are not met, or if medications
Page 2 of 5
126 California State Auditor Report 2015-131
August 2016
are prescribed outside the recommended parameters, the prescribers will be urged to seek peer
consultation and/or clinical review with the Sonoma County Behavioral Health Medical Director.
Finally, the County has some questions and suggestions about the methodology of the report. First, it
6 would have been helpful to have a clear breakdown between the departments involved with foster
youth: Family, Youth and Children’s Services Division and Probation. Children in each of these areas have
differing needs for mental health interventions and care. A further description of the methodology in
general and case review selection process would help the County understand how these cases relate to
the child welfare population taking psychotropic medications, as well as the general child welfare
population as a whole. In addition, the data reporting would be enhanced by hypothesis and
proportions testing.
We note also that some statewide and Sonoma County recommendations, such as those calling for
better documentation, are similar, which reinforces our belief that many issues highlighted in the report
7 affect counties across the state. We hope that the State will offer additional guidance and resources to
all counties to enhance consistency and clarity of implementation of these recommendations.
Therefore, with some caveats, Sonoma County finds the audit report recommendations for 1) all
counties statewide and 2) Sonoma County are reasonable and constructive measures that will advance
our mission of promoting the well-being of foster children in our care.
RESPONSE TO THE STATEWIDE RECOMMENDATIONS:
Recommendation 1. Implement procedures to more closely monitor requests for authorizations for
psychotropic medications for foster children that exceed the state guidelines for
multiple prescriptions or excessive dosages. When request for authorizations
exceed the state guidelines, counties should follow-up with providers about the
medical necessity of the prescriptions and should document their follow-up in
the foster children’s case files. In instances in which counties do not believe
that a provider has adequate justification for exceeding the state guidelines,
counties should relay their concerns and related recommendations to the court
or parent.
RESPONSE: Sonoma County supports this recommendation.
Recommendation 2. Ensure that prescribing physicians follow up within 30 days with all foster
children to whom they prescribed new psychotropic medications.
RESPONSE: Sonoma County supports this recommendation.
Page 3 of 5
California State Auditor Report 2015-131 127
August 2016
Recommendation 3. Implement a process to ensure that foster children receive any needed mental
health, psychosocial, behavioral health, or substance abuse services before and
concurrently with receiving psychotropic medications.
RESPONSE: Sonoma County already ensures that foster children receive these services 8
before or concurrently with medication, but will work on putting systems in
place that better track and document these services, and therefore Sonoma
County supports the recommendation.
Recommendation 4. Implement a systemic process for ensuring that court authorizations or parental
consents are obtained and documented before foster children receive
psychotropic medications and that court authorizations for psychotropic
medications are renewed within 180 days as required. The process should also
ensure that the counties better document these authorizations in the foster
children’s case files.
RESPONSE: Sonoma County supports the recommendation.
Recommendation 5. Develop and implement a process for county staff and caregivers to work
together to ensure that psychotropic medications are approved before
administering medications. This process should also ensure that the counties
obtain accurate medication start dates from caregivers.
RESPONSE: Sonoma County supports the recommendation.
RESPONSE TO THE SONOMA COUNTY RECOMMENDATIONS
Recommendation I. Immediately adopt the state guidelines for its physicians’ use when prescribing
psychotropic medications and the county’s review of court authorization
requests.
RESPONSE: Sonoma County supports this recommendation. The County was aware of a
need to update policies around psychotropic medication before the auditors
began their review and have been working on those updates. We have already 5
completed the policy revision necessary to adopt the current state guidelines
Page 4 of 5
128 California State Auditor Report 2015-131
August 2016
for physicians’ use when prescribing psychotropic medications and for review of
court authorization requests.
Recommendation 2. Within six months, implement a process to review psychotropic medications
that parents, rather than courts, are able to approve for children.
RESPONSE: Sonoma County supports the recommendation.
Recommendation 3. Update its policies to describe an acceptable method for obtaining and
documenting parental consent for psychotropic medications.
RESPONSE: Sonoma County supports the recommendation.
Page 5 of 5
California State Auditor Report 2015-131 129
August 2016
Comments
CALIFORNIA STATE AUDITOR’S COMMENTS ON THE
RESPONSE FROM SONOMA COUNTY
To provide clarity and perspective, we are commenting on Sonoma
County’s response to the audit. Th e numbers below correspond to
the numbers we have placed in the margin of its response.
Sonoma County apparently misunderstands the scope of our audit. 1
Namely, we were directed to examine state and county oversight
of psychotropic medications prescribed to foster children, as
we state on page 15 of our report. As such and contrary to its
statement, we did not need to review provider health records or
charts for each foster child to understand the treatment received by
individual foster children nor to determine whether each foster child
received clinically appropriate amounts and types of psychotropic
medication. Rather, to review Sonoma County’s oversight we
examined its records, and when necessary, records maintained by
relevant state oversight agencies. We did this to understand, analyze,
and assess the processes Sonoma County used to oversee such
prescriptions, including whether and how Sonoma County ensured
that foster children under its charge received psychosocial services
in advance of or concurrent with their prescribed psychotropic
medications as recommended by relevant guidelines. We stand by
the methodology and the results we present in our report.
As we stated in the previous comment, we stand by the methodology 2
we used and the results attained by our implementation of that
methodology. To identify information relevant to the audit, we
examined available records at Sonoma County, such as documents
from foster children’s welfare case fi les and behavioral health fi les.
We also examined records within certain of the State’s data systems,
including the Paid Claims and Encounters System operated by the
Department of Health Care Services (Health Care Services) for each
foster child. Contrary to Sonoma County’s assertion, reviewing
provider records or charts for each foster child was not only
unnecessary, it was not within the scope of our audit. Furthermore,
we provided Sonoma County opportunities during our audit to
provide additional records for every potential Sonoma County
exception we identifi ed.
Finally, as we indicate on page 21 of our report, we understand that
medically appropriate reasons may exist to explain why a provider
requests psychotropic medications for foster children in amounts
and dosages that exceed the state guidelines. However, if counties
do not follow up with providers to obtain assurance that such
instances are medically appropriate, counties miss opportunities to
better protect their foster children from inappropriate psychotropic
medication prescriptions.
130 California State Auditor Report 2015-131
August 2016
3 Sonoma County is incorrect; we do not state, nor do we imply,
that it does not follow generally accepted professional standards
when prescribing psychoactive medication to foster children. Th e
methodology we followed enabled us to examine Sonoma County’s
oversight to determine whether it was ensuring whether provider’s
prescribed psychotropic medications were within academy and
state guidelines and whether it reasonably questioned those
prescribers when they prescribed psychotropic medications outside
these guidelines. As we mention on pages 14 and 15 of our report,
the California Department of Social Services (Social Services) and
Health Care Services stated that the prescribing standards within
the state guidelines are current best practices, and that they serve
as a foundation for review to ensure that children receive the
appropriate amounts and dosages of psychotropic medications.
Th e academy and state guidelines are appropriate yardsticks to use
for our analysis of the counties, and we stand by our conclusion
that we often found little indication that counties followed up
with providers to ensure the appropriateness of psychotropic
medications prescribed in excess of the state guidelines.
4 Sonoma County’s statement that its providers “are bound by and
adhere to the prescribing standards established by federal and state
law governing mental health plans” is irrelevant to this audit; we
did not assess such compliance. As stated in earlier comments,
the scope of our audit was to examine the State and county
oversight of psychotropic medications prescribed to foster children.
Furthermore, as we mention on pages 14 and 15, Social Services
and Health Care Services stated that their prescribing standards
are current best practices, and that they serve as a foundation for
review to ensure that children receive the appropriate amounts
and dosages of psychotropic medications. Th e academy and state
guidelines are appropriate yardsticks to use for our analysis of the
counties, and we stand by our conclusion that we often found little
indication that counties followed up with providers to ensure the
appropriateness of psychotropic medications prescribed in excess
of the state guidelines.
5 Sonoma County only recently adopted the state guidelines. Sonoma
County informed us on June 3, 2016, that it had adopted the state
guidelines the previous day.
6 We acknowledge Sonoma County’s statement that children
entering foster care through the child welfare system may have
diff erent mental health needs than children entering through the
probation system. However, this point is not relevant for purposes
of our audit. Th e methodology we used to assess Sonoma County’s
oversight of psychotropic medications prescribed to foster children
and its adherence to relevant academy and state guidelines is
applicable to children entering foster care through either system.
California State Auditor Report 2015-131 131
August 2016
Implementation of the recommendations we make to 7
Social Services beginning on page 74 of our report should address
Sonoma County’s comment regarding additional guidance and
resources from the State. We recommended that Social Services
collaborate with counties and other relevant stakeholders to
develop and implement a reasonable oversight structure.
Despite its assertion that Sonoma County already ensures that 8
foster children receive psychosocial services before or concurrently
with psychotropic medications, our audit demonstrates that
Sonoma County’s records cannot provide such assurance. As
we show in Table 11 on page 39 of our report, Sonoma County
was unable to provide evidence showing that some of the foster
children whose case fi les we reviewed had received corresponding
psychosocial services in the six months before starting at least
one psychotropic medication. We look forward to reviewing
Sonoma County’s future updates on the implementation of our
recommendation and its eff orts to put systems in place to better
track and document these services.